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Abstract
OPTIMIZATION OF A TRI-LAYERED VASCULAR GRAFT: THE INFLUENCE OF
MECHANICAL AND CELLULAR PROPERTIES
By Michael James McClure, M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy in Biomedical Engineering at Virginia Commonwealth University.
Virginia Commonwealth University, 2011
Major Director: Dr. Gary L. Bowlin
Professor, Biomedical Engineering
Electrospinning is a polymer processing technique which allows for the production
of nano to micro size fibers and scaffolds which can be composed of numerous synthetic
biodegradable materials and natural biopolymers. Natively, elastin and collagen are the
main components of vascular tissue. Arranged in a tri-layered structure, they create a
specific mechanical environment that can withstand the rigors of circulation. The goal of
this study was to develop a mechanically ‘biomimicking’ vascular graft composed of three
distinct layers through the process of electrospinning. We hypothesize that the use of
bioactive agents such as elastin, collagen, and silk to supplement poly(caprolactone) at
specified ratios for each layer would provide a finely tuned vascular replacement. This
was accomplished by establishing cross-linking parameters for the biopolymer materials
and then assessing the mechanical properties of individual materials and eventually a
whole tri-layered graft. Additionally, while mechanical testing can lead to a good graft, a
replacement graft requires excellent cellular properties as well to promote cell infiltration,
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proliferation, and migration. Therefore, the conclusion of this study examines the integrin
binding characteristics of the electrospun biopolymers.
First, the results from the preliminary cross-linking study examined the dissipation
of soluble elastin when uncross-linked v. cross-linked. It was determined through this
initial study that synthetic scaffolds blended with soluble proteins such as elastin require a
fixation in order to retain their protein mass within the scaffold. Retaining this mass,
incrementally changed the material properties of the blended scaffolds. This initial study
was then carried further to establish optimal cross-linking parameters using two different
types of reagents: carbodiimide and genipin. It was found that lower cross-linking
molarities produced excellent results based on assays performed to assess cross-linking
percentages and rate of reaction. Some differences in mechanical properties were seen, but
they did not constitute a choice of one cross-linker over the other. The next portion of this
study aimed to design a tri-layered graft. This was performed with the aid of mathematical
analysis to observe circumferential wall stresses based on simple tensile properties. A
series of tri-layered grafts were electrospun using poly(caprolactone), elastin, and collagen.
The medial layers of these grafts were changed while the intima and adventitia remained
constant. Differences were demonstrated as the elastin content of the medial layer
decreased, proving that each layer had an affect on the overall graft properties and that it
was possible to tune graft mechanics. A larger tri-layered study looked to evaluate
changes in the adventitial and medial layers while keeping the intimal layer constant using
poly(caprolactone), elastin, collagen, and silk fibroin. In this study, differences were
exhibited under compliance and burst strength testing, narrowing the scope of material
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choices. Results from a 4 week degradation study with the best tri-layered grafts revealed
no evidence of degradation, but did generate some positive compliance results for two of
the grafts. Finally, integrin binding and protein analysis portrayed results that were
indicative of the existence of ligand binding sites for collagen scaffolds and the possibility
of a small amount of ligand sites on silk. Elastin, however, displayed low to non-existent
adhesion. These studies produced results that allowed us to continuously narrow the scope
of materials as the experiment progressed towards an optimized tri-layered vascular graft.

CHAPTER 1: Vascular Structure and Graft Development
Preface: The following manuscript is currently published in the Journal of Drug Delivery
Science and Technology. The work reviews a large range of vascular grafts for tissue
engineering from the use of acellular biodegradable polymers to autologous cell lines
without the use of a scaffold material.

1

2

Bioengineered Vascular Grafts: Improving Vascular
Tissue Engineering Through Scaffold Design
Michael J. McClure, Patricia S. Wolfe, Isaac A. Rodriguez, and Gary L. Bowlin
Department of Biomedical Engineering, Virginia Commonwealth University, Richmond,
Virginia 23284
Abstract
Arteriosclerosis has accounted for three quarters of the deaths related to
cardiovascular disease (CVD). Arteriosclerosis is a vascular disease that is characterized
by a thickening of the arterial wall and subsequent decrease in the arterial lumen,
eventually causing loss of circulation distal to the site of disease. Small diameter arteries
(< 6 mm) are affected the most by CVD due to their already decreased blood flow. The
increasing populations of people who are obese, diabetic, or aging supplement a strong
need for the production of a commercially available small diameter vascular graft. Tissue
engineering has become a promising approach for generating a biocompatible vessel with
the potential to regenerate new tissue. Multiple factors have to be accounted for when
designing a vascular graft that has the ability to self-repair and self-remodel such as the
choice of polymer, choice of cell type, and choice of growth conditions. To date, historical
landmarks such as the initial research of Weinberg and Bell have led researchers closer and
closer to a functional end product.
Keywords: Tissue Engineering, Vascular Grafts, Biodegradable, Collagen, Elastin
Introduction
CVD, specifically coronary heart disease resulting from arteriosclerosis, remains
the leading cause of death in the United States and has been so virtually every year since
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1900 [1]. Once blood flow in the coronary artery is compromised, vascular bypass is an
option to restore blood flow to tissues distal to the restriction or blockage [2]. In 2005
there were 469,000 bypass procedures performed due to CHD [1], which typically involve
the replacement of a coronary artery with a patients own saphenous vein or internal
mammary artery. Biological grafts are a formidable option since they already retain the
natural architecture that arteries require. When these grafts are used as replacements, they
begin to adapt to their new environment, altering their structure to match the mechanical
requirements of the tissue.
While these autologous replacements have an acceptable patency rate, they are not
always a viable option as the patient may also suffer from peripheral vascular disease;
affecting upwards of 8 million Americans and up to 20% of those 65 years of age or older
[1]. Further complicating the use of autologous vessels is the fact that they are limited in
number and a previous bypass operation may have already required the vessel’s use [3].
Currently available commercial alternatives to the autologous vessel gold standard are
limited to synthetic vessels made of ePTFE and woven or knitted Dacron®. These
materials have been used with moderate success as medium and large diameter prosthetics,
but their efficacy is severely limited when used as small diameter vessels. Larger diameter
vessels experience higher flows and less resistance than small diameter vessels, such as the
popliteal or coronary arteries, where low blood flow and high shear makes the synthetic
graft more prone to thrombus formation and intimal hyperplasia [2-13]. Dacron® and
ePTFE grafts are non-degradable and lack the ability to promote native tissue regeneration,
making them a permanent fixture in the body. As a permanent fixture, the graft is
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constantly threatened with attack from the patient’s own foreign body response as well as
bacterial graft infection [10, 12, 14]. To this extent, a vascular replacement that matches
the body’s mechanical and cellular requirements is highly necessary in the field of vascular
tissue engineering, requiring “ideal” characteristics.
A tissue engineered vascular graft needs to meet several criteria to be considered ideal:
1. Easy for surgeons to handle with excellent suture retention and resistance to kinking
while remaining flexible.
2. Grafts need to be biocompatible and retain non-toxic, non-thrombogenic, and infection
resistant characteristics. All of which are associated with a confluent, quiescent,
nonactivated endothelium.
3. They must induce an appropriate healing response that does not result in inflammation,
hyperplasia, or fibrous capsule formation.
4. It is necessary for the grafts to be leak resistant yet have sufficient porosity to allow for
the ingrowth of autologous tissue, leading to tissue that is indistinguishable from the native
vessel.
5. Mechanical strength is a paramount concern where grafts must retain a compliance, the
ability to withstand long-term hemodynamic stress without failure, similar to that of native
artery to prevent intimal hyperplasia while;
6. Resisting creep and permanent deformation leading to aneurysm formation.
7. Grafts should express physiological properties such as vasoconstriction and relaxation.
8. Finally, they should be easy to manufacture, produce, sterilize, and store, as well as be
economical and available off-the-shelf in a variety of sizes [10, 15].

5

Vascular tissue, more specifically arterial tissue, is subdivided into two separate
categories: elastic (> 6 mm inner diameter (ID)) and muscular (< 6 mm ID). The
architecture of both elastic and muscular arteries is composed of three separate layers:
intima, media, and adventitia, which vary in thickness and composition as a function of
anatomic location. The intima is the innermost layer of all blood vessels and is composed
of a single layer of ECs lining the vascular wall, a thin basal lamina, and a subendothelial
layer containing collagenous bundles, elastic fibrils, smooth muscle cells (SMCs), and
some fibroblasts (FBs). The media, the thickest of the three layers, is made up of SMCs, a
various number of laminae depending on location, bundles of collagenous fibrils, and a
network of elastin fibrils. The adventitia is the outermost layer of the vessel wall and like
the media, its thickness varies as a function of anatomic location, consisting of dense
fibroelastic connective tissue containing FBs [16, 17]. Incorporated with these three
layers, is the vasa vasorum, a network of blood vessels which innervate both the media and
adventitial layers to supply oxygen and nutrients to the cells in those regions.
As arteries move away from the heart and towards the periphery, their diameter
decreases. This decrease in diameter coincides with changes in the architectural makeup.
Structurally, the intima is similar in both elastic and muscular arteries and therefore does
not affect the overall properties when comparing the two. Instead, both the medial and
adventitial layers change in thickness and composition as arteries move away from the
heart and toward the periphery. Those arteries with larger diameters, such as the aorta or
carotid, contain a medial layer with SMCs and numerous elastic laminae. Muscular
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arteries, such as the femoral, retain the three layered structure yet their medial layer
contains a higher density of SMCs and a lower number of elastic laminae. As for the
adventitia, elastic arteries contain a relatively thin outer layer that constitutes only 10% of
the vascular wall whereas in muscular arteries the adventitia often occupies 50% of the
vascular wall. Functionally, for the media, this design change is due to a smaller
circumferential stress in the wall of the muscular artery, decreasing the overall demand for
elastic recoil and energy dissipation [18], while increases in nerve innervations account for
the increased adventitial thickness [16].
Blood vessels are continuously subjected to stress and strain in the circumferential
and longitudinal directions. In the circumferential direction, the pulsatile nature of blood
pressure induces a cyclic stretch on the arterial wall. Each layer in the wall plays a
significant mechanical role to its proper functionality. In vivo studies and clinical
observations have shown that decreased values of tensile and shear stress in surgically
injured vessels are correlated with activation of cell proliferation and extracellular matrix
(ECM) production, leading to vessel occlusion [19]. A decrease in tensile properties is not
just a change in the circumferential direction, but a multi-directional change. As a
consequence, compliance, hoop stress, and overall hysteretic properties can be affected.
These changes can affect cell and fiber orientation.
In addition to circumferential and longitudinal stress, one of the most important
stresses exerted on the inner lumen of arterial tissue is shear stress. Arteriosclerosis tends
to develop in regions of the circulation where flow is either low or turbulent, such as
regions where arteries bifurcate [20-22]. ECs respond to increased blood flow by causing
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the relaxation of the surrounding smooth muscle through nitric oxide. Conversely,
decreased flow induces vessel narrowing that is also mediated by signals from the
endothelium, and in severe cases low flow leads to vessel regression and apoptosis of ECs
[23].
Besides the ultimate importance of shear stress, circumferential stress due to cyclic
loading also mediates proper functionality of the arterial wall, preventing arteriosclerosis.
Vascular ECs sense and respond to cyclic strain both morphologically and phenotypically.
The influence of cyclic strain on ECs is visually apparent as early as 15 minutes after strain
with the formation of actin stress fibers and morphological alignment of cells
perpendicular to the force vector [22]. However, if hypertension occurs in a blood vessel,
ECs, in addition to SMCs, are highly affected. Accumulating evidence demonstrates that
high cyclic strain affects ECs, whereby in one study Reape et al. found that monocyte
chemotactic protein-1 is synthesized when ECs are subjected to high mechanical
deformation [24], while other studies have found that mechanical strain in hypertensive
models influences atherosclerotic plaque development through increased expression of
adhesion molecules [25-27]. SMCs are mostly affected by increases or decreases in blood
pressure. Normal blood pressure and flow allows both SMCs and ECs to cross-talk and
maintain the integrity of the vascular wall over time. If blood pressure rises over a long
period of time, signal transduction pathways begin to break down the ECM and remodel
the arterial wall, resulting in vascular hypertrophy [28]. If the pathophysiology involved in
vascular disease was better understood, then this knowledge may produce vascular graft
designs that approach what would be considered ideal.
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Historical Vascular Replacements
Vascular grafts have been in the process of development since the late 19th century
when Eck attempted the first delineation of a basic technique for vascular suture,
performing a lateral anastomosis of the portal vein to the inferior vena cava [29].
However, it was not until the early 20th century when Alexis Carrel explored the basic
patterns of healing of arteries and veins, the reactions to different types of sutures, and the
possibility of organ transplantation, winning him the Nobel Prize for Physiology or
Medicine in 1912 [30].
There were many ventures into bridging the gap of a particular blood vessel. In
World War I, German surgeons treated aneurysms by bridging the defect with pieces of the
patient’s vein [30]. A femoro-popliteal bypass with a reversed saphenous vein graft was
first performed by Kunlin in 1948. During the same period, fresh arterial allografts were
beginning to be used in human vascular reconstructive surgery. In 1952, Blakemore and
Voorhees developed one of the first synthetic vascular prostheses, Vinyon-N cloth, which
was used to bridge arterial defects in dogs [31]. Although early clinical results were
promising, Vinyon-N did not display sufficient long-term stability, nor did it provide an
appropriate scaffold for tissue in-growth. These historical experimentations paved the way
towards tissue engineered vascular grafts, and set into motion the quest for the ideal
vascular replacement.

Endothelial Cell Seeding
This quest began by modifying materials that were already approved for vascular
replacement surgeries, ePTFE and Dacron. In 1978, Herring et al. introduced a single-
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stage technique whereby venous ECs were seeded onto Dacron grafts with enhanced
patency in canine models [32]. Since this point, numerous methodologies have been used
to gain a confluent monolayer of ECs: gravitational, hydrostatic, and electrostatic. The
most basic and extensively studied of these is gravitational EC seeding. Coating the graft
surface prior to this method of seeding has been performed in many cases. For instance,
Zilla and associates have looked into multiple ways in which to increase EC attachment
onto ePTFE grafts through lining the graft with fibronectin [33] and fibrin glue [34].
However, outcomes from these studies demonstrated insufficient cell density, poor
adhesion under flow conditions, and failure to achieve confluence. Another major
disadvantage of this technique is any surface that is not covered by ECs becomes highly
thrombogenic. Poor adhesion of cells under flow conditions was due to a number of
factors, one of which being cell seeding duration was too short (<2 hours) [35]. This was
leading to a significant loss of cells upon implantation. Therefore, studies such as Shindo
et al. and Prendiville et al. were performed to increase maturation time [36, 37].
Biological glues and adhesive proteins such as fibronectin, collagen, laminin, fibrin, FB
matrix, and plasma have been extensively studied as further means to adhere ECs to the
inner lumen surface of a vascular graft [38-44]. The necessity for an incubation period to
allow for significant adhesion and maturation of ECs is related to the basic nature of the
electrostatic interactions between the polymeric graft materials and the cells. Clinically
successful vascular prosthetics such as ePTFE are highly negatively charged, which can
repel cells. Several in vitro studies have been performed utilizing the electrostatic seeding
technique. Bowlin et al. found that when umbilical vein ECs were seeded onto ePTFE
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through electrostatics, complete nodal area coverage of morphologically mature ECs was
obtained within 16 minutes [45]. Using this same technique under flow conditions with a
wall shear stress of 15 dynes/cm2 for up to 120 minutes revealed no significant loss of ECs
[46]. However, problems associated with permanent synthetic graft material still pose
major hurdles. Therefore, bioresorbable vascular grafts became of interest since they
deviate from the permanent scaffolding and resorb in situ while autologous tissue remodels
the graft.

Scaffold-Based Approaches to Improve Vascular Grafts
Bioresorbable grafts are advantageous due to the fact that a resorbable vascular
prosthetic with adequate mechanical properties can be implanted and degraded gradually
over a period of time, leaving behind no permanent synthetic materials to initiate a chronic
foreign-body reaction [12]. Through the years, there have been many different approaches.
Wesolowski et al. first introduced the concept of a bioresorbable vascular prosthetic in the
early 1960s. These first bioresorbable incarnations were composed of a variety of Dacron®
yarns, COL coatings, and COL fibers. The permanent Dacron® provided mechanical
stability, while the COL added bioactivity to the structure and promoted the ingrowth of
native tissue as it was degraded and remodeled [47, 48]. The 1970s and ‘80s saw the
advent of a number of different aliphatic polyesters (poly(lactic acid) (PLA), poly(glycolic
acid) (PGA), polydioxanone (PDO), etc.). These polymers breakdown through hydrolysis
in the body, and can have their rate of degradation tailored by altering their structures [12,
49-53]. While this preliminary work failed to result in a successful commercially available
graft, it laid the foundation for current research in bioresorbable prosthetics and
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demonstrated the possibilities of in situ tissue engineering. Despite the ability of
bioresorbable grafts to have products added to or subtracted from the created matrix to aid
the body in regeneration, other approaches find that the body alone is not sufficient enough
to sustain a fully regenerative capacity, and that much of that work should be done in vitro.
This type of tissue engineering approach can be accomplished with the combination of
cells and specific scaffold materials. Regardless of approach, the way in which a scaffold
material is designed is equally as important as the source of the cells that utilized in the
experimental procedures.
The ideal cell source should be non-immunogenic, functional and easy to achieve
and expand in culture. Cells are arguably the most important element in any tissue
engineering model. For an arterial replacement, a functional graft cannot be achieved
without an endothelium-like interface to the circulating blood and vasoactive SMCs within
the wall [54]. Autologous ECs and SMCs isolated from patients themselves are usually the
first choice. However, this procedure is quite limited in the number of cells that are able to
come from a single biopsy punch of an autologous vascular tissue. Therefore, stem and
progenitor cells become a more viable option as they have a higher capacity to expand in
culture. Endothelial progenitor cells (EPCs) typically circulate throughout the bloodstream
and can be isolated using techniques such as those done by Asahara et al.[55, 56], where
magnetic beads coated with antibodies such as CD34, AC133, or markers common to both
early and more differentiated progenitors were used to capture EPCs. Autologous bone
marrow sources have also shown promise through studies that have been done by Shin’oka
et al.[57], seeding the cells onto a PLCL copolymer and then implanting in humans.
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Campbell et al. have shown that the cells located in the peritoneal cavity will display
promise, where silicone tubing was implanted into the peritoneal and pleural cavities of
dogs for 2-3 weeks, and cells from those cavities migrated onto the tubing, subsequently
forming a biological graft material [58, 59]. Nieponice et al. has shown how musclederived stem cells are also a plausible autologous source for vascular tissue engineering,
combining these cells with PEUU scaffolds through a vacuum seeding procedure and
implanting them as an aortic interposition bypass graft [60]. Non-autologous cell sources
also include those of embryonic stem cells, which have the capability to differentiate into
several different cell types including those of the vasculature.
The combination of specific cell types and biomaterials to create a structure which
mimics both mechanically and architecturally the native tissue is at the heart of the tissue
engineering field. Vascular tissue engineering has looked at a myriad of scaffold based
approaches involving the use of pure polymer, polymer blends, and manufacturing copolymers to achieve its ideal goal.
Poly(glycolic acid), Poly(lactic acid), and Copolymer Blends
PGA is a biodegradable aliphatic polyester with a glass transition temperature
between35-40°C, melting point between 225-230°C, and acrystallinefraction of 45-55%
(Table I). Within the field of vascular surgery, PGA was first used as a biomaterial for
sutures in the 1970s [61, 62]. In 1983, Lauritzen was the first to conduct preliminary
studies on PGA tubes as vessel grafts. This experiment suggested PGA tubes as a
promising construct for instant and absorbable microvascular grafts [63]. Since then,
various approaches to improving PGA grafts have been developed and extensively studied.
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Niklason et al. fabricated tubular PGA scaffolds with a chemically modified surface
(NaOH) and seeded grafts with bovine SMCs exposed to pulsatile flow conditions for 8
weeks. After 8 weeks of culture, the gross appearance of the scaffolds was similar to native
arteries with histology showing migration of SMCs forming a smooth luminal surface for
EC seeding. After 4 weeks implantation in pigs, scaffolds showed 100% patency [64]. In
order to minimize residual polymer fragments after culture, Prabhakar et al. treated PGA
mesh tubes by exposing them to heat, 1.0M NaOH, and γ-irradiation to hasten degradation.
Porcine carotid SMCs were cultured on treated PGA scaffolds under pulsatile conditions.
After 8 weeks of culture, treatment with NaOH increased polymer degradation rate under
hydrated conditions and NaOH and γ-modified scaffolds showed native vessel
morphology, a more even distribution of SMCs, and fewer polymer residual fragments. It
was also noted that the COL content of some scaffolds were approximately similar to that
of native vessels, however, the mechanical integrity of the engineered scaffolds was less
than native [65]. Boland et al. were the first to publish results on electrospun PGA as a
tissue engineering scaffold comprised of submicron fiber diameters. In this study, HCl
pretreated PGA scaffolds were incorporated into the surrounding tissue and showed
increased cell proliferation rates when implanted in rats [66]. The above studies have
demonstrated that independent of scaffold fabrication technique, PGA grafts with a
chemically modified surface can serve as potential vascular grafts. More recently, Iwasaki
et al. bioengineered a three-layered tubular scaffold where PGA, PCL, and PGA layered
sheets were seeded with three types of vascular cells under pulsatile conditions to mimic
artery structure, integrity, and blood flow. Results from this study demonstrated that the
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engineered vessels produced sufficient amounts of COL and elastin (ELAS) and exhibited
similar appearance, elasticity, and ultimate strength as native arteries [67].
Table 1. PGA, PLA, and Copolymer Blends
Biodegradable Manufacturing Improvement Cell Seeded
Polymer
Method

Culture
Condition

Ref

PGA
Nikalson et al.

64

SMCs

Pulsatile and Pig
Implant
Pulsatile

__

Rat Implant

66

Cell attachment,
proliferation,
collagen, and elastin
content

EC, SMC, FB

Pulsatile

67

Electrospun PLA w/
wound collagen
Electrospun PLA and
silk-gelatin
Surface modified w/
gelatin/N-Maleic acylchitosan

Cell attachment and
orientation
Mechanical strength

SMC

Static

73

__

__

74

hUVEC

Static

75

Hibino et al.

PGA and PCL/PLLA
woven fabric

__

Human Implant

76

Mooney et al.

PGA mesh coated w/
PLGA

SMC and EC

Static and Rat
Implant

77

Wen et al.

70:30 PLGA sponge

SMC and EC

Static

83

Izhar et al.

PELA coated filamentwound Lycra

__

Dog Implant

85

Roh et al.

PGA mesh coated w/
P(CL/LLA)

No evidence of
rupture, infection,
calcification, or
aneurysm
Mechanical
properties and cell
proliferation
Cell attachment and
proliferation
Enhanced healing
and mechanical
properties
Pre-seeding led to no
calcification, a neointima, and neotissue formation

BMC

Static and Lamb
Implant

84

Prabhakar et al.
Boland et al.
Iwasaki et al.

Chemically modified w/
NaOH
Mesh tube w/ NaOH, γirradiation
Chemically modified
electrospun PGA w/
HCL
PGA, PCL, PGA layered
sheets

Cell attachment and
proliferation
Cell attachment and
proliferation
Cell proliferation

SMCs

65

PLA/PLLA
Stitzel et al.
Wang et al.
Zhu et al.

Cell attachment,
proliferation, and
high expression of
CD31 and vWF

PGA-PLA

PLA is a biodegradable aliphatic polyester with a glass transition temperature
between 60-65°C, melting temperature between 173-178°C, and crystallinity of
approximately 37%. PLA can exist in several distinct isoforms, most commonly as poly-Llactic acid (PLLA). In the 1980s the first studies were conducted exploring the possibilities
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of PLA as a vascular graft coating [68] and PLLA as a microporous, compliant,
biodegradable vascular graft [69-72]. In 2001 Stitzel et al. developed a tubular scaffold
comprised of a helical wind of COL fibers encompassed by a layer of electrospun PLA
fibers. After 10 days incubation, SMCs formed a 100% confluent monolayer on the
tubular scaffold oriented along the principle stress lines [73]. Within the past few years
electrospun PLA and PLLA have been extensively studied and are considered an ideal
biomaterial candidate for tissue engineering blood vessels. Wang et al. electrospun a
tubular graft composed of PLA (outside layer) and silk fibroin-gelatin (inner layer) with a
porosity of 82 ± 2%, breaking strength (2.2 MPa), pliability (60.6%), suture retention
strength (4.6 N), and a burst pressure strength of 1596 mmHg [74]. Whereas many PGA
studies use surface modifications to achieve desired results, PLA can be more readily used
“as is” to produce vascular engineered scaffolds. However, there are certain advantages to
chemically modifying PLA surfaces. To improve EC biocompatibility, Zhu et al. grafted a
gelatin/N-Maleic acyl-chitosan (gel/NMCS) complex on the surface of PLA films. This
study concluded that gel/NMCS modified PLA enhanced human umbilical vein EC
proliferation and expressed a higher structured CD31 and vonWillebrand Factor (vWF),
ultimately suggesting photo-initiated grafting of gel/NMCS complexes as an effective
method for modifying the surfaces of vascular grafts [75].
PGA and PLA have also been combined to create novel biodegradable vascular
tissue engineering scaffolds. Most recently in 2010, Hibino et al. developed a tubular
woven fabric vascular scaffold composed of PGA and poly(caprolactone) (PCL)/PLLA
which was implanted in 25 human patients as a extracardiac cavopulmonary conduit. After
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a mean follow up of 5.8 years, scaffolds showed no evidence of rupture, infection, ectopic
calcification, aneurysm formation, or scaffold related mortality. One patient had partial
thrombosis and four patients had scaffold stenosis but all were successfully treated [76].
PGA and PLA have been combined with each other as well as other polymers to
form new copolymers: PLGA, poly(ethylene glycol/lactic acid) (PELA), and PLLA-PCL
to name a few. PLGA was first used in vascular tissue engineering in 1996 when Mooney
et al. coated PGA mesh tubes with PLGA (50:50) [77]. Since then many have focused on
prolonged sustained release of drugs and growth factors [78-82]. Wen et al. developed
vascular scaffold segments by coculturing human vascular SMCs and ECs on a PLGA
(70:30) sponge and concluded that cells could successfully be grown on the scaffold and
after 2 months complete cell layers similar to native artery were formed [83]. Roh et al.
implanted vascular scaffolds comprised of PGA mesh tubes coated with a copolymer of
P(CL/LLA) pre-seeded with bone marrow derived vascular cells in juvenile lambs and
assessed patency for up to 30 days. All scaffolds were patent without signs of thrombosis
or calcification, exhibited neo-endotheliaization, and the neo-tissue formed was composed
of ECM, mesenchymal stem cells, and residual polymer matrix [84]. A PELA coated
filament-wound Lycra graft was developed by Izhar et al., which compared to ePTFE graft
controls, showed enhanced healing and improved mechanical properties when implanted in
mongrel dogs for up to 12 weeks [85]. Shum-Tim et al. demonstrated 100% patency at 5
months of a copolymer scaffold (PGA and polyhydroxyalkanoate) seeded with cells from
lamb carotid arteries and implanted into lamb aorta [86]. Overall, the versatility of PGA
and PLA fuels the use of these polymers as practical materials for fabricating vascular
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grafts. Although, both these synthetic polymers have demonstrated promising results there
are several drawbacks to using such materials. Both PLA and PGA are stiff and
significantly different from native artery, which could lead to hyperplasia at the site of
anastomosis. Additionally, PGA’s quick degradation characteristics make it desirable for
designing a functional artery and dangerous as an implant which could lead to aneurysm or
rupture.
Poly(caprolactone) and Copolymer Blends
PCL is a semicrystalline, non-toxic, tissue compatible biomaterial with a
degradation rate of around 12 months (Table II). Mechanically, PCL displays highly
desirable characteristics for vascular grafts, mostly high strength and excellent compliance.
Surface properties of biomaterials, such as surface roughness, affect cell behavior and may
induce thrombotic clots in some cases. Researchers have found that rough and smooth
surfaces will encourage different types of cell adhesion [87]. Some groups have attempted
to modify the hydrophobic surface of PCL to provide more hydrophilic groups. Zhu et al.
first looked to modify PCL’s surface chemistry with poly(methacrylic acid) (PMAA) [88].
This was accomplished by immersing a PCL membrane in a quartz tube with 30%
hydrogen peroxide, and subsequently exposing the tube to UV light. The photo-oxidized
membrane was then placed in a copolymerization tube containing 4% PMAA and
irradiated with UV, leading to a higher EC attachment when compared to non-modified
grafts.
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Table 2. PCL and Copolymer Blends
Biodegradable Manufacturing Improvement Cell Seeded
Polymer
Method

Culture
Condition

Ref

PCL
Zhu et al.
Serrano et al.
Ma et al.
Duling et al.
Pektok et al.
Drilling et al.
Lee et al.
Vaz et al.

Surface modified PCL
film w/ PMMA
Surface modified PCL
film w/ NaOH
Surface modified
electrospun PCL w/
carboxyl groups
Electrospun PCL
Electrospun PCL
Different concentrations
of electrospun PCL
Thermal treatment of
electrospun PCL
Electrospun PCL and
PLA

Hanson et al.

Dip casted PCL and PLA

Watanabe et al.

50:50 P(CL/LA) poured
into PGA mesh

Cell attachment
Increased
hydrophilicity and
cell attachment
Increased
hydrophilicity and
cell attachment
Mechanical
properties
In situ degradation
Optimized burst
pressure
Suture retention,
burst pressure
Cell attachment and
mechanical
properties
Mechanical
properties
Mechanical
properties and cell
attachment

EC

Static

88

EC and SMC

Static

89

EC

Static

91

__

__

92

__
__

Rat Implant
__

93
96

__

__

97

FB and myoFB

Static

98

__

Canine

100

Mixed population
from femoral vein

Canine

101

Serrano et al. used a NaOH treatment of the PCL grafts to provide better adherence
of vascular ECs and SMCs through increased hydrophilicity [89]. In this study, PCL films
were prepared by hot pressing and then submerged in a solution of 2 N NaOH for two
hours. Scanning electron microscopy (SEM) analysis of cell morphology showed both cell
types growing properly on NaOH treated films, but untreated films did not seem
appropriate substrates to support cell growth by causing cytoplasmic retraction. Serrano et
al. then followed this preliminary study up 3 years later, evaluating EPC adherence
proliferation to NaOH treated films, and the effect of PCL on nitric oxide content [90]. EC
derived cells from EPCs were first characterized using classical markers CD31, von
Willebrand factor, and endothelial nitric oxide synthase (eNOS) using flow cytometry,
where CD31 is a clear marker of EC maturation. After 4 days, it was found that PCLNaOH films contained large numbers of cells on their surface, however, PCL films had
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significantly lower numbers, further demonstrating the benefits of NaOH treatment.
Furthermore, Ma et al. improved the surface chemistry of PCL through modification of
electrospun fibers with air plasma treatment, introducing carboxyl groups on PCL
nanofiber surfaces. These carboxyl groups were then used to bind gelatin to the surface,
increasing hydrophilicity and increasing EC proliferation when compared to no treatment
[91]. Surface modification of PCL films to increase hydrophilicity, definitively improved
scaffold materials for enhanced cellular attachment. However, an implanted vascular graft
will not respond well to a tubular film, leading to encapsulation with no cellular infiltration
of the scaffold material. For this reason, porous scaffolds have been manufactured through
the process of electrospinning.
Mechanically, PCL is a highly desirable material for vascular tissue engineering in
addition to other soft tissue applications. Several studies have set out to characterize the
mechanical behavior of PCL. Duling et al. punched out “dogbone” shapes from
electrospun nanofibers to test for stress relaxation, loading response, tensile failure testing,
and cyclic stress relaxation, comparing these results using Fung’s quasilinear viscoelastic
theory [92]. Others have looked at the degradation characteristics both in a rat descending
aorta for 24 weeks (Pektok et al.) [93], and in vitro in Ringer solution stirred gently for 6
months (Bolgen et al.) [94]. Pektok et al. found that after 24 weeks molecular weight
decreased by 20%, while Bolgen found that molecular weight decreased by only 5%,
indicating that in situ degradation occurs faster. In these cases if degradation occurs too
fast or too slow, then the vascular graft will either become too weak and develop an
aneurysm or not dissolve out quickly enough causing other downstream affects.
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Therefore, optimization of graft mechanical and cellular parameters is necessary. Nottelet
et al. demonstrated an optimal design for electrospun PCL grafts in a rat model by
electrospinning several combinations of solvent/polymer concentrations [95]. Drilling et
al. optimized burst pressure results of electrospun PCL grafts through analyzing several
different solvent/polymer concentrations, resulting in 5 mm diameter grafts that could
withstand in excess of 2000 mmHg [96]. Lee et al. demonstrated increased mechanical
properties through thermal treatment of electrospun PCL grafts, which resulted in
increased suture retention and burst pressure, without much change in compliance [97].
While there are many studies surrounding the sole use of PCL as the vascular graft
material, other studies have combined PCL and other synthetics by copolymerizing the two
structures together or separately manufacturing them.
Vaz et al. selected two different polymers to be electrospun together, PCL and
PLA, in a multilayered approach, characterizing their properties through uniaxial tensile
testing, 3T3 mouse FBs, and human venous myofibroblasts (myoFBs) [98]. While this
study produced good results, the addition of a stiff material such as PLA could
significantly reduce compliance and increase the downstream affects of compliance
mismatch. Williamson et al. created a more compliant structure from a PCL-polyurethane
(PU) composite vascular graft using gravity spun PCL fibers out of acetone while PU
fibers electropun directly on top of the PCL to create a bi-layered graft [99]. In 1988,
Hanson et al. looked into the mechanical properties of selected copolymers, PLA and PCL
[100]. These vascular grafts were dip casted using three different kinds of copolymers to
produce single layer and bi-layered grafts. These grafts were then tested for compliance,
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tensile strength, and kink resistance. Mechanical results looked promising except for
compliance, which was significantly lower than a canine femoral artery, where this once
again demonstrates the stiffness of PLA. Watanabe et al. synthesized a P(CL/LA)
copolymer in a 50:50 combination to be poured into a PGA nonwoven fabric and
subsequently freeze dried. Mechanical testing, cell seeding, and implantation of the
vascular scaffold into the inferior vena cava of a canine were performed with promising
results as an “ideal” venous scaffold with antithrombogenic activity [101]. However, a
venous graft is not subjected to the same circumferential and shear stresses that occur in
the arterial network. Several other poly(D,L-lactide-co-ε-caprolactone) (PLCL)
copolymers have been used for vascular tissue engineering applications demonstrating the
possible use of bone marrow cells (BMCs) seeded onto scaffolds and implanted into a nonhuman model [102, 103], and evaluating electrospun PLCL scaffolds with SEM,
porosimetry, tensile testing, and cell culture analysis using human umbilical ECs [104].
Poly(dioxanone)
PDO is a colorless, crystalline, bioabsorable polymer that was developed
specificially for wound closure sutures. PDO exhibits a crystalline fraction of 55% and a
glass transition temperature between -10oC and 0oC (Table III). Greisler et al. were the
first to have published several results on PDO absorbable vascular prosthetics using a mesh
tube with 250 micron fiber diameter and 400 micron pore size. Evaluations of these first
took place in a rabbit aorta [53] at 2 weeks up to 12 months, displaying myoFB migration
occurring in parallel to the macrophage-mediated degradation of the PDO structure. This
study was followed with the aorta-iliac canine model using 70% PDO and 30%
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polypropylene. Results from the study of up to a 1 year implantation demonstrated 86%
patency rates compared to Dacron® and ePTFE which had a rate of 68% and 54%,
respectively. An additional study examined prostacylin (PGI2) and thromboxane A2
production from the endothelium. The rationale for this was based on the importance of
these components with the endothelium non-thrombogenic properties. This is attributed to
a balance between PGI2 and TxA2 (or the PGI2/TxA2 ratio), where it is more desirable to
have a higher PGI2 levels than TxA2 in native vessels. The results of Greisler’s study
demonstrated that the explanted PDO graft had the highest ratio of PGI2/TxA2 versus PGA
and almost equal to native aorta control [105].
Since Dr. Greisler’s extensive research using animal models, PDO has only been
used in a handful of studies. Teebken et al. performed a comparison study between EC
seeded decellularized carotid arteries and woven 4 mm diameter PDO prostheses,
concluding that decellularized vascular tissue had higher patency rates than that of PDO
prostheses [106]. A few years later, Boland et al. produced a study on electrospinning
PDO into non-woven nanofibers examining the effects of polymer concentration on fiber
diameter, pore area, and mechanical properties [107]. This led to several studies out of the
same lab to test PDO in combination with biopolymers such as ELAS [108-111], COL
[111, 112], and silk [113] to determine both cellular and mechanical behavior. Sell et al.
developed PDO-ELAS vascular conduits using a range of polymer-ELAS blends and
characterized them utilizing compliance, suture retention, uniaxial tensile testing, and
cellular seeding with human dermal FBs. Since compliance mismatch between the graft
and native artery is one of the major causes of graft failure, the authors of this manuscript
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have tested several combinations of PDO and ELAS in order to determine its mechanical
behavior in vitro [109]. A difference in this study, compared to other publications of
vascular graft compliance, was that compliance was determined under dynamic conditions
mimicking physiological parameters, therefore providing a lucid interpretation as to how
the graft should perform in the body. In this study, it was determined that certain
PDO/ELAS blends closely matched those of native artery.
Mechanical properties, specifically compliance, are of utmost importance in order
to prevent a mismatch and ultimately intimal hyperplasia at the site of anastomosis;
however, chemical properties of the vascular materials once implanted inside the body
must also be evaluated so as to determine the material’s response to monocytes and
macrophages in vivo. Garg et al. aimed to evaluate the angiogenic potential of PDO-ELAS
vascular grafts to promote in situ arterial tissue regeneration by measuring the amount of
vascular endothelial growth factor (VEGF), acidic fibroblast growth factor (aFGF), basic
fibroblast growth factor (bFGF), and transforming growth factor beta-1 (TGF-β1) released
upon interaction between the macrophages and the polymer-ELAS blend [114]. Results
demonstrated that macrophages remained on the surface of high ELAS content PDOELAS blends, but penetrated both low ELAS content blends and pure PDO grafts. As a
consequence, at day 28 VEGF was high for all grafts, aFGF was found to remain largely
independent of graft material, and TGF-β1 was gradually decreased from day 7 to day 21.
Another study done by Wolfe et al. observed the thrombogenic potential of PDO materials
through acute monocyte tissue factor expression [115]. In this study, PDO concentrations
of 60, 80, 120, and 160 mg/ml were electrospun and seeded with human peripheral blood
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monocytes. The results from the study revealed that PDO grafts did not result in levels of
tissue factor expression capable of a higher risk than that of the current standard, ePTFE.
Through these studies, PDO has proven itself to retain low thrombogenicity and excellent
mechanical properties by itself and when blended with other biopolymers. However, more
information still needs to be examined in regards to cellularization of the scaffold materials
and degradation characterization.
Polyester Urethane Urea
For engineering soft tissues such as the vascular system, elastic scaffolds are highly
desirable since they are amenable to mechanical conditioning regimens that might be
desirable to tissue development [116]. Martz et al. developed one of the first small
diameter vascular graft from Mitrathane, a polyether urethane urea [117]. However, after a
subsequent study in a canine carotid artery, all grafts were occluded after 4 to 6 months
[118]. Since then, polyurethanes have been redeveloped by Wagner and associates (Table
III) through synthesis of two kinds of biodegradable poly(urethane ureas), namely
poly(ester urethane) urea (PEUU) and poly(ether ester urethane) urea (PEEUU) from PCL,
poly(caprolactone)-b-poly(ethylene glycol)-b-poly(caprolactone), 1,4-diisocyanatobutane
and putrescine. Grafts were fabricated by thermally induced phase separation and
subsequent solvent extraction. Hydrolytic degradation of the grafts demonstrated a clear
loss in scaffold weight after 56 days. Grafts were also conducive to SMC attachment and
growth after 7 days in culture [116]. This sparked the use of PEUU by both the Wagner
and Vorp labs using several different scenarios: electrospinning to form a whole tube
[119], electrospinning on top of a porcine internal jugular vein as a reinforcement for
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venous graft replacements [120], thermally induced phase separation (TIPS) to create a
tubular scaffold for cell seeding with muscle derived stem cells [121], a TIPS tubular
scaffold with an additional electrospun PEUU layer on top [122], and a blended
electrospun scaffold using PEUU and poly(2-methacryloyloxyethyl phosphorylcholine-comethacryloyloxyethyl butylurethane) [123]. These studies have had excellent results in
terms of mechanical properties associated with their application and cellular seeding and
proliferation in vitro and in situ. However, one of the possible disadvantages of using
PEUU, especially in human implantation models, is its cytotoxicity due to the urethane
component as the scaffold material degrades.
Table 3. PDO and PEUU
Biodegradable Manufacturing
Polymer
Method

Improvement Cell Seeded

Culture
Condition

Ref

PDO
Greisler et al.
Boland et al.

70:30
PDO:Polypropylene
Mesh Tube
Electrospun PDO

Sell et al.

Electrospun PDO and
elastin

Garg et al.

Electrospun PDO and
elastin
Electrospun PDO

Wolfe et al.

Lower thrombogenic
properties compared
to PGA
Mechanical
properties
Mechanical
properties and
compliance
Cell penetration of
low elastin content
Low thrombogenic
potential

__

Rabbit Aorta

105

__

__

107

FB

Static

109

Macrophage

Static

114

Monocyte

Static

115

SMC and Pericytes

Static and Vacuum
Seeding

116,
119123

PEUU
Wagner, Vorp, et al.

Thermally induced phase
separation and
electrospun PEUU

Cell attachment,
proliferation, and
mechanical
properties

Collagen
COL is the most abundant protein in the human body, a key element of the ECM,
and imparts structural integrity and tensile strength to tissues. Tissue disruption following
injury requires COL for the repair and restoration of structure and function. Excessive
COL deposition at a wound site results in loss of anatomical structure, function and
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fibrosis. Conversely, if insufficient amounts of COL are deposited, the wound is weak and
may rupture [124]. This confers directly towards vascular tissue engineering; a vascular
graft can be initially strong due to a synthetic polymer, however, once degradation occurs
to a point where that strength is lost, there must be something to take over the mechanical
requirements. In this case, not enough COL remodeling will cause the graft to develop an
aneurysm and rupture.
COL has been used in a variety of tissue engineering applications because of its
predominance in the ECM, non-immunogenicity and available methods of isolation from a
variety of sources (Table IV). However, the typical procedures used to isolate and
reprocess this natural scaffolding into an engineered material may compromise many of its
biological and structural properties [125]. COL fibers also possess some unique structural
properties important for tissue engineering: they transmit forces, dissipate energy, prevent
premature mechanical failure and provide biological signals to adjacent cells that regulate
functional responses. Additionally, COL is resorbable, has high water affinity, low
antigenicity, very good cell compatibility and ability to promote tissue regeneration [126].
These factors combine to make COL one of the most ideal biopolymers available for tissue
engineering applications.
In vascular tissue engineering, COL alone has been used in a number of
applications. In 1986, Weinberg and Bell were the first to pioneer the idea of living blood
vessels produced in vitro using cell seeded COL gel tubes [127]. The Weinberg and Bell
arterial graft consisted of an adventitia of bovine FBs embedded in a COL gel; a media of
gelled COL and bovine SMCs, and a lumen lined by ECs. One of the main limitations of
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this approach was the lack of mechanical strength, demonstrating a burst pressure of only
90 mmHg. Investigators thereafter have attempted a number of other strategies to increase
burst pressure strength, and maintain the biological aspect using ECs and SMCs. Berglund
et al. mixed COL and human dermal fibrolasts together in the form of gels, which were
subsequently crosslinked under different conditions to impart higher mechanical strength,
resulting in a burst pressure over 600 mmHg [128]. Cummings et al. performed a similar
experiment using the same manufacturing protocol, but with higher concentrations of COL
and no cross-linking [129]. Matthews et al. forewent the COL gel construct and used
electrospinning. Cells were well incorporated into cylindrical COL constructs placed in a
55 mL bioreactor with aortic SMCs [130]. COL by itself provides a construct that is
advantageous for cellular seeding, but comes with drawbacks mechanically. Therefore,
synthetic biodegradables are highly desired to provide mechanical stability for COL based
grafts. PCL and COL constructs have been studied extensively and have been produced
mostly through the form of electrospinning [131-133]. Each of the studies found that when
PCL and COL were combined, COL provided increased cellular attachment and
proliferation for FBs, ECs, and SMCs. Additionally, Ju et al. found that fiber diameter
highly affected SMC penetration of the PCL/COL scaffolds under static culture. Other
synthetics that have been investigated include electrospun PDO/COL [112], surface
modified electrospun PLLA-co-CL with an air plasma coating of COL [134], a porous
COL mold with electrospun PLGA [135], and a combined COL gel/particulate leached
PLCL graft [136], where each study has clearly shown the cellular benefits associated with
the addition of COL. COL is a very attractive protein to add to vascular grafts, increasing
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adhesive properties and cellular infiltration and penetration. However, mechanically it can
add significant stiffness to the material, therefore the proper amounts of COL need to be
paid special attention when utilizing it.
Elastin
In vivo, ELAS is a chemically inert, highly insoluble polymer composed of
covalently cross-linked molecules of its precursor, tropoelastin, a soluble, nonglycosylated and highly hydrophobic protein. Tropoelastin expression and subsequent
ELAS synthesis typically occurs in FBs, vascular SMCs, ECs, and chondrocytes [137].
During the process of elastogenesis, tropoelastin is synthesized, preventing its premature
intracellular aggregation and protecting it from proteolytic degradation by binding a 67
kDa galactoectin (elastin binding protein, EBP). This association lasts until the complex is
excreted into the extracellular space. EBP then interacts with galactosugars of the
microfibrils, dramatically decreasing its own affinity for tropoelastin. In order for proper
elastogenesis to occur, the interaction of the N-terminal part of the microfibrillarassociated glycoprotein with the C-terminal end of tropoelastin is required. Once aligned,
lysyl oxidase deaminates and oxidizes the lysyl residues to allysine following the action of
Cu2+. Cross-links are then formed by the reaction of the allysines with themselves or with
an unmodified lysine [137-139].
As a biomaterial, ELAS is becoming more and more popular for tissue engineering
applications as one of the main structural components of the vascular ECM (Table IV).
The incorporation of ELAS into biomaterials has been used in several different forms,
including insoluble ELAS occurring in autografts, allografts, xenografts, decellularized
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ECM, and in purified ELAS preparations where the insoluble ELAS is hydrolyzed to a
soluble form of α, β, and κ ELAS [140]. Although insoluble ELAS in its different graft
forms could be considered a more “natural state,” there is an advantage to its solubility
which makes handling and analysis of the material more straightforward. Additionally,
ELAS peptides influence signaling, chemotaxis, proliferation, and protease release via the
ELAS receptor [141]. Daamen et al. not only found that solubilized ELAS induced
angiogenesis, but also increased elastic fiber synthesis and displayed no signs of
calcification when compared to grafts containing its insoluble form [142]. Leach et al.
created α-ELAS discs using a diepoxy crosslinker, finding that vascular SMCs adhered
well to the substrates [143]. This is one of many studies that have proven soluble ELAS to
be an advantageous biopolymer.
As stated previously, tropoELAS provides the necessary building blocks to form
native ELAS in vivo. Li et al. demonstrated that recombinant human tropoelastin could be
electrospun to form both nanofibers and microfibers, depending on the delivery rate [144].
In their study, both tropoelastin and solubilized α-elastin were electrospun. The
parameters were optimized and the final products were compared through microscopy,
mechanical tensile moduli, and cellular activity with human embryonic palatal
mesenchymal cells. Welsh et al. manufactured crosslinked ELAS-like polypeptide films,
and performed tensile testing where stress-strain curves produced the low stress toe region
of native tissue J-curves [145]. Again, like COL, ELAS by itself will fail to perform
properly under the physiological stresses imposed by the vasculature. Investigators have
looked into the combination of ELAS and synthetic materials. As mentioned previously,
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PDO/ELAS grafts were electrospun and tested mechanically to find that certain blends
emerged as comparable to native artery [109]. This study subsequently led to another
blending PDO and ELAS in a layered fashion with PDO sutures as reinforcement between
each layer [108]. ELAS-like polypeptide has also been implemented into vascular tissue
engineering. Nicol and Urry explored the possibility of incorporating cell recognition
peptide sequences into ELPs in order to promote EC adhesion, finding that too small an
amount of RGD sequence significantly decreased cellular attachment [146]. More
recently, tropoelastin was combined with PCL to form a bi-layered vascular scaffold with
pure electrospun tropoelastin on the inner layer and combined PCL/tropoelastin on the
outer layer [147]. Results displayed enhanced EC interaction, improved blood
compatibility, excellent mechanical properties, and full cell penetration of the scaffold
structure when implanted in situ. While ELAS is known as an essential, key factor in
vascular arteries, its addition to scaffold materials comes with both advantages and
disadvantages. Mechanically, ELAS enhances compliance and distensibility of scaffold
material. From the cellular perspective, it has come with mixed results where specific
types of ELAS are conducive to cellular attachment and others are not. These factors must
be considered when working with ELAS as a biomaterial.
Combined Elastin and Collagen
As COL and ELAS are two of the most prevalent protein constituents in native
vessel, it is only logical that they are often used in concert as tissue engineering scaffolds
for vascular applications (Table IV). Berglund et al. looked to take their previous COL gel
study and enhance its biomechanical properties through the incorporation of organized
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intact ELAS to form hybrid constructs [148]. Histological staining from the study revealed
that both the COL gel control and the COL/ELAS hybrid exhibited dense layers of cells
along their outer walls. Additionally, ELAS incorporation increased mechanical properties
by 11 fold. Boland et al.[2], in an attempt to create a biomimicking layered vascular
structure, first electrospun an 80/20 COL type I/ELAS tube on a 4 mm diameter mandrel.
This tube was subsequently seeded with both FBs and SMCs. Another tubular scaffold of
30/70 COL type I/ELAS was electrospun on a 2 mm diameter mandrel. This electrospun
scaffold was then inserted into the 4 mm diameter scaffold and the lumen was filled with a
SMC suspension. After 3 days in culture, a suspension of human umbilical vein endothelial
cells (HUVECs) was injected into the lumen, and the entire construct was cultured for 2
more days. Histological examination revealed complete cellular infiltration into the threelayered construct after 21 days. The artificial intima was covered by morphologically
mature ECs and SMCs were present throughout the media, and had begun to align
circumferentially around the axis of the scaffold. The FBs and SMCs in the adventitia
created a dense population throughout the outermost wall. This study proved that an
electrospun scaffold that mimics the native ECM is highly beneficial in the field of
vascular tissue engineering. However, the lack of synthetic polymers in the tubular
structures did not allow for sustained mechanical viability.
In a study by Buttafoco et al.[149], soluble COL type I from calf skin and soluble
ELAS from bovine neck ligament were electrospun from aqueous acidic solutions in order
to avoid the use of organic solvents. To ensure continuous and homogenous fibers,
poly(ethylene oxide) (PEO) and sodium chloride (NaCl) was added. Meshes composed of
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fibers with diameters ranging from 220 to 600 nm were obtained by spinning the
COL/ELAS solutions. Scaffolds completely devoid of PEO and NaCl were obtained by
cross-linking with EDC and N-hydroxysuccinimide (NHS). SMCs were successfully
cultured on cross-linked scaffolds and a confluent layer of cells was observed after 14 days
on the surface of the different scaffolds.
Combinations of COL and ELAS with synthetic polymers have also been used in
order to create scaffold and graft materials with desirable mechanical properties,
bioactivity, and sustained mechanical integrity. Nanofiber grafts were fabricated using a
mixture of 40% COL type I, 15% ELAS and 45% PLGA by weight electrospun onto a
4.75 mm diameter cylindrical mandrel. Compliance testing results showed that the
diameter change was approximately 9% for native vessels and 12–14% for electrospun
grafts under a physiologic pressure range. In vitro cell proliferation of SMCs and ECs
showed an average of 82% of SMCs and 72% of ECs survived on the grafts [150].
In a similar study, an array of synthetic materials with 45% COL, 15 % ELAS, and
40% biodegradable synthetic (PLGA, poly(L-lactide) (PLLA), PCL, and poly(D,L-lactideco-ε-caprolactone) (PLCL)) were electrospun. Tubular grafts were characterized through
SEM, uniaxial tensile testing, and biocompatibility. Once again it was demonstrated that
graft mechanical properties were improved with the addition of synthetic polymers. This
study also demonstrated that in order for a graft to remain patent when using biopolymers
such as COL and ELAS, the addition of a synthetic is necessary for sustained stability
[151]. Recently studies have come out that have looked to mimic the natural architecture
of blood vessels with the use of synthetic polymers, COL, and ELAS. McClure et al. used
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electrospun PCL, ELAS, and COL in different ratios to develop a cross-linked
mechanically tunable vascular graft characterized by compliance, tensile properties, suture
retention, and burst pressure strength [152]. Thomas et al. performed a similar study with
the use of an uncross-linked, electrospun polyglyconate, ELAS, and gelatin, demonstrating
a distinctive tri-layered design [153]. Working with the natural polymers and architecture
that are provided by Mother Nature could prove to be an advantageous method for vascular
tissue engineering.
Table 4. Collagen, Elastin, and Collagen/Elastin Blends
Biopolymer
Manufacturing Improvement Cell Seeded
Method

Culture
Condition

Ref

Collagen
Weinberg and Bell
Berglund et al.
Cummings et al.

Collagen gel
Crosslinked collagen gel
High concentration
collagen gel
Electrospun collagen

Cell proliferation
Mechanical strength
Mechanical strength

SMC, FB, and EC
FB
SMC

Collagen nanofibers
for cell attachment
and proliferation

SMC

Leach et al.
Li et al.

Crosslinked elastin discs
Electrospun tropoelastin

Welsh et al.

Elastin-like polypeptide
film

Cell attachment
Mechanical elasticity
and cell attachment
Stress-strain curve

Mechanical
properties and cell
proliferation
Cell proliferation and
native arterial
architecture
Cell attachment and
proliferation

Matthews et al.

Static
Static
Cyclic mechanical
stimulation
Rotary Bioreactor

127
128
129

SMC
Meschymal Stem
Cell
__

Static
Static

143
144

__

145

FB

Static

148

FB, SMC, EC

Rotary Bioreactor

149

SMC

Static

150

__

__

152

__

__

153

130

Elastin

Collagen and
Elastin
Berglund et al.

Collagen and elastin gel

Boland et al.

Electrospun collagen and
elastin in three layers

Buttafoco et al.

Electrospun collagen and
elastin with PEO and
NaCl additives
Crosslinked electrospun
PCL, collagen, and
elastin

McClure et al.

Thomas et al.

Uncrosslinked
electrospun elastin,
gelatin, polyglyconate

Mechanical
compliance and burst
pressure with
tunable properties
Tunable properties
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Decellularized Vessels
One obvious choice for vascular tissue engineering is finding a hollow tissue with
the appropriate extracellular matrix components and removing cells from the construct
(Table V). Several types of decellularized tissues have already been developed including
human veins [154], bovine ureters [155], canine arteries [156], and small intestine
submuscosa (SIS) [157]. Results found varying signs of proximal and distal hyperplasia
with a varying patency rate between 40 and 100%. Lantz et al. grafted dog jejunal
submucosa as an autologous vascular graft and found that after 28 days the graft was
histologically similar to native vessel [158]. More recently, Gui et al. developed a
decellularized human umbilical artery with a compliance of 4.3% / 100 mmHg and a
maximum burst pressure of 970 mmHg [159]. As most of the aforementioned
decellularized matrices were COL-based, there are some groups who have looked into
ELAS-based products. Lu et al. utilized the Rasmussen protocol [160] on aorta samples to
obtain an ELAS network [161]. The advantages of ELAS-based scaffolds is their
distensibility, which, according to the experiment, remained the same as native aorta and
significantly higher than COL-based aorta tested under the same conditions; however,
tensile strength was severely decreased. Additionally, hDF studies revealed that ELAS
based scaffolds had a higher degree of cellular infiltration after 28 days in rotary culture.
Berglund et al. used the Starcher and Galione extraction method [162] with carotid arteries
[148]. These ELAS grafts were repopulated using cells encapsulated in a COL gel,
cultured, and then tested mechanically. Positive aspects of decellularized tissues include a
more “off the shelf” type graft with no maturation time. However, despite a readily
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available supply of artificial arteries is attractive, drawbacks include the inability to tailor
the matrix content and architecture.
Fully Biological Grafts
The concept of a completely biological living graft implies the ability to remodel,
grow, self-repair and respond to the immediate environment (Table V). The graft would
also contain enough COL and ELAS proteins to display desirable viscoelastic properties,
and would lack any synthetic foreign material that would initiate chronic inflammatory
responses or be susceptible to infection [31]. L’Heureux developed an approach to
biological scaffolds using human FBs and vascular SMCs in sheet form, which were
subsequently wrapped around a PTFE coated mandrel [163]. The assembled constructs
required an 8 week maturation period and were then seeded with human ECs, resulting in
burst pressures able to withstand 2000 mmHg. Recently, L’Heureux and associates have
performed a human trial using rolled cell sheets for radial artery, A-V shunts, and lower
limb indications. This study demonstrated grafts that were able to withstand burst
pressures in excess of 3000 mmHg while retaining an average compliance of 8.8%/100
mmHg after 6 months implantation [164]. Campbell et al. produced another graft through
an inflammatory reaction, where a silastic tube was placed in the peritoneal cavity of rats
and rabbits for 2 weeks and was covered in a layered fashion with myoFBs, COL matrix,
and a single layer of mesothelium [58]. Lengths of myoFB-rich tubes were then grafted by
end-to-end anastomoses into the carotid artery of a rabbit and the abdominal aorta of a rat.
In situ, cells responded to local environmental cues, remodeled, and produced structures
similar to those of native vessel. More recently, Stickler et al. aimed to assess the
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possibility to strengthen these peritoneal cavity grafts, shortening the time for development
[165]. This was achieved through the use of an implantable device which consisted of an
inner stretchable tub, a perforated external tube and a transabdominal tube. So, as tissue
grew onto the device, it was subjected to cyclic stretch to enhance growth. Mechanically,
pulsed tubes displayed a significantly higher failure strength and failure strain compared to
unpulsed tissue. This was most likely attributed to the higher organization of COL in the
circumferential direction. While work in the area of fully biological grafts has
demonstrated promise in vascular tissue engineering, there are still some drawbacks to the
process, including culture time, risk of infection during the culture period, and a prolonged
maturation time that takes away from “off the shelf” capabilities.
Table 5. Decellularized and Fully Biological Grafts
Biopolymer
Manufacturing Improvement Cell Seeded
Method

Culture
Condition

Ref

Decellularized
Lantz et al.
Gui et al.

Jejunal submucosa
Umbilical artery

Lu et al.

Aorta with elastin
network
Carotid artery with
collagen gel

Berglund et al.

Histologically similar
Compliance and
burst pressure
Higher cell
penetration
Mechanical
properties

__
__

Canine implant
__

158
159

FB

Rotary Bioreactor

161

FB

Static

148

SMC

Static

163

__

Rat Implant

58

__

__

165

Fully Biological
Graft
L’Heureux et al.

Rolled SMC sheets

Campbell et al.

Silastic tube in peritoneal
cavity
Silastic tube in peritoneal
cavity with cylic strain

Stickler et al.

Mechanical
properties and
autologous cell use
Structure similar to
native vessel
Mechanical
properties

Drug Delivery for Improved Vascular Grafts
Delivery of growth factors from scaffolds has been gaining interest as a therapy for
a variety of tissue engineering applications, including vascular graft regeneration (Table
VI). Growth factors play a critical role in the communication and information transfer
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between cells and their environment by binding to specific receptors on cell surfaces. They
modulate a variety of cell activities, including proliferation, differentiation, migration,
adhesion, and gene expression. Due to their ability to play such a key role in cell activity,
cell fate, tissue development, and repair, especially in the vascular system, it is no surprise
that their use in therapies has been proposed. However, their success in clinical
applications has been limited. The delivery of one, or several, factors in therapies is
complicated, as there is limited knowledge behind the signaling and release of growth
factors physiologically. In addition, there are several parameters that must be considered,
including the delivery vehicle, the quantity/concentration of factor to deliver, the duration
of the delivery, and the ability to control the release both temporally and spatially [166170]. Furthermore, the route of travel by the growth factor(s)/drug(s) once it is delivered is
also an important parameter, particularly if there could be a potential detrimental effect
downstream.
Growth factors that play key roles in the angiogenic process necessary for vascular
graft regeneration include VEGF, FGF, platelet derived growth factor-bb (PDGF-bb),
stromal cell-derived factor-1α (SDF-1α), TGF-β, and angiopoietins-1 and 2 (Ang-1 and 2).
VEGF and bFGF are heparin-binding growth factors involved in the initiation of the
process, promoting EC proliferation and migration. PDGF-bb recruits SMCs and pericytes
which, along with TGF-β, promote ECM deposition to stabilize neovessels [167]. SDF-1α
plays an important role in angiogenesis as well by recruiting EPCs from the bone marrow
[171]. For vascular applications, numerous studies have been performed on the delivery of
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these growth factors, either alone, or in concert with one or two others, with the use of
different delivery vehicles, as well as different delivery methods.
Table 6. Biopolymers and Synthetic Polymers for Drug Delivery
Drug Delivery Drug Additive
Improvement Cell Seeded

Culture
Condition

Ref

Biopolymers
Pang et al.

R136K to bind to
collagen scaffolds
Immobilized heparin
onto collagen scaffolds

Lower thrombogenic
properties
Increased amounts of
bFGF to material and
cell proliferation

Thevenot et al.

PLGA salt-leached
scaffold injected with
SDF-1α

Mooney et al.

VEGF and PDGF-bb
released from PLGA
scaffolds
VEGF, HGF, Ang-1
released form PLGA
scaffolds

Cell proliferation,
angiogenesis, lower
inflammatory
response
Increased
angiogenesis and
maturation
Increased
angiogenesis and
maturation

Wissink et al.

__

__

189

EC

Static

192

EPC and MSC

Mouse Implant

203

__

Hindlimb Ischemia
Model

204

EPC

Hindlimb Ischemia
Model

206

Synthetic
Polymers

Saif et al.

Delivery methods and vehicles
Traditionally, growth factors are administered systemically (transdermal), orally, or
intravenously. However, these methods of delivery are likely to be ineffective due to the
short half-lives of the growth factors, their relatively large size, slow tissue penetration,
and their potential toxicity at high systemic levels [167, 168]. For these reasons, polymeric
materials, both natural and synthetic, are frequently used as delivery vehicles. Using
polymers for this application allows for a more timely and spatially controlled delivery.
Biomaterials used for this function must be nonimmunogenic, have degradation products
that are soluble and nontoxic, and must be able to be produced sterile and free of infectious
pathogens [169]. While natural polymers are beneficial due to their bioactive factor for cell
recognition and degradation, synthetic polymers have very controlled and reproducible
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chemical and physical properties. Another attractive feature of natural polymers are that
some have specific binding sequences for and intermolecular interactions with many
angiogenic growth factors [172].
Natural derived polymers
Natural polymers that have been previously used for delivery vehicles include
alginate [173-175], agarose [176], chitosan [177, 178], gelatin [179, 180], fibrin [181], and
COL [182-185]. They are often formed as a gel, or as microspheres, and are usually
processed by freeze-drying or cross-linking in an aqueous solution [186].
Often, fibrin glue, which is a mixture of fibrinogen and thrombin, is used
therapeutically, as it serves as a temporary platform for the gradual development of
granulation tissue. Clinical application of fibrin glue has been studied as a deliverer of
angiogenic growth factors to create a confluent endothelium on the luminal surface of
synthetic vascular grafts [181, 187]. After coating e-PTFE grafts with fibrin glue and FGF1, it was found to produce better EC retention and expansion after seeding, eliminating
graft thrombogenicity and improving graft patency [188]. Recently, Pang et al. studied the
affinity and distribution of a fusion protein consisting of R136K, a relatively thrombinresistant mutant derivative of FGF-1, and a COL-binding domain, to 3-D COL scaffolds
[189]. They found that R136K-COL binding domain had a greater affinity for COL
scaffolds than either R136K or FGF-1, demonstrating a 1.7 fold lower release rate.
To suppress initial burst release often seen in hydrogel-type delivery systems, and
still permit longer retention in the delivery carrier, heparinization has been proposed, either
by covalent conjugation of heparin molecules, or the encapsulation of growth factor
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together with heparin-binding material within the delivery vehicle. Modifying the network
structure, such as cross-linking with glutaraldehyde, has also been done, so as to couple the
rate of release to the rate of matrix degradation [190, 191]. Other studies have used N-(30
dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) and NHS to cross-link COL and
heparin, or COL and heparin sulfate, enhancing growth factor capture within the hydrogel,
enhancing HUVEC expansion onto the graft [192], and producing a strong and stable
vascularization throughout the hydrogel in a subcutaneous implant [193].
Synthetic derived polymers
Synthetic matrices that studies have reported on have been composed of poly(vinyl
alcohol) (PVA), poly(alpha-hydroxyester)s including poly(ethylene glycol) (PEG) [194],
PLGA [195-200], PLLA, or PCL [201], polyanhydrides, and polyorthoesters [180, 202].
They are typically processed into porous grafts that provide mechanical support for cells or
microspheres for injection and are fabricated by techniques such as solvent casting, gas
foaming, particulate leaching, double emulsion, electrospinning, and rapid prototyping
[186]. Synthetic matrices for this application must completely degrade and be resorbed into
the body, and must temporarily act as mechanical support to allow cells to infiltrate and
produce native ECM.
A PLGA salt-leached scaffold injected with SDF-1α was implanted subcutaneously
into mice to determine the ability of the scaffold to promote stem cell recruitment, reduce
inflammatory response and fibrosis, and enhance angiogenic processes [203]. MSC
migration and EPC engraftment near the SDF-1α incorporated scaffold were found to be
enhanced after 7 days over a PLGA control scaffold. In addition, there was decreased
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inflammatory cell recruitment, with reduced fibrotic capsule formation and
proinflammatory cytokines around the scaffold. Histological analysis illustrated improved
angiogenesis by EPCs throughout the SDF-1α incorporated scaffold over a PLGA control
scaffold, with vessel-like formations occurring at the interface of the scaffold. The results
from this study demonstrate the potential for these SDF-1α incorporated scaffolds to be
used in vascular graft applications, as they elicit improved tissue response and
regeneration.
Angiogenesis and tissue survival after implantation is essential for the survival of
any implant, including tissue engineered vascular grafts. Dual growth factor delivery from
synthetic grafts was first reported by Mooney’s group, where both VEGF and PDGF-bb
were released with distinct kinetics from grafts of PLGA fabricated by a high-pressure
carbon dioxide process [204]. In looking at blood vessel size and distribution in a hindlimb
ischemia model, relative to either growth factor delivered individually, both vessel size and
distribution were improved when the delivery of the two growth factors were together.
This demonstrates that therapies involving growth factor delivery for angiogenesis would
benefit from the actions of multiple growth factors over just a single delivery. For this
study, VEGF was responsible for the increase in blood vessel density, whereas PDGF
contributed to the maturation and size of the blood vessels. Another study fabricated
PLGA grafts from gas foaming and particulate leaching with VEGF and PDGF
incorporated into different layers of the graft [205]. This layered graft system allowed
compartmentalization of VEGF and PDGF and controlled spatial and temporal
presentation of the growth factors.

42
Saif et al. took it a step further and incorporated three growth factors into a scaffold
for delivery. In a murine hindlimb ischemia model, PLGA microparticles were fabricated
containing VEGF, hepatocyte growth factor (HGF), and Ang-1 using a double emulsion
technique [206]. These microparticles, along with cord blood-derived vascular progenitor
cells, were coadministered into the hindlimb of a mouse. This resulted in a robust
enhancement of vascularization, superior to any single growth factor administered.
Including increased muscular capillary density and enhanced number of conductant
vessels, with sufficient vessel stabilization and maturation.
In the presence of TGF-β1, SMCs cultured on adhesive ligand-modified glass
surfaces, specifically RGDS-modified surfaces, increased matrix production. In addition,
tethering TGF-β1 to PEG diacrylate hydrogel with RGDS resulted in a significant increase
in matrix production over the same amount of soluble, unmodified TGF-β1 incorporated
into scaffolds, most likely due to the diffusion of the soluble growth factor into the culture
medium [194].
The authors of this paper have successfully electrospun lyophilized platelet rich
plasma (PRP) with PCL to form nanofibrous grafts [207]. As PRP contains various
supraphysiologic, autologous growth factors and cytokines that enhance healing, its
addition to a synthetic construct has the potential to increase the bioactivity of the graft and
enhance regeneration through the release of growth factors contained within the PRP.
Results from a protein assay have demonstrated successful release from the electrospun
grafts for 35 days, as well as quantifiable release of PDGF-bb over 14 days. The PRP
containing grafts were also chemotactic towards macrophages, and significantly enhanced
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proliferation of adipose derived stem cells over synthetic grafts. These results are
promising for the use of electrospun grafts incorporated with PRP as an improved
therapeutic strategy for tissue engineering applications such as vascular grafts.
Other growth factors/drugs used to improve scaffolds for vascular graft
applications include heparin [208], a known anticoagulant, insulin [209], nitric oxide [210,
211], a known vasodilator and mediator of EC growth and function, cyclosporine [212], a
potent immunosuppressive that inhibits SMC proliferation and intimal hyperplasia, and
other antibiotics. A study by Javerliat et al. implanted vascular grafts preloaded with
antibiotics, rifampin and tobramycin, into the infrarenal aortas of dogs [213]. The grafts
implanted were: gelatin-sealed knitted polyester grafts used as controls, and antiobioticbonded gelatin-sealed knitted polyester grafts loaded with rifampin and tobramycin at
normal doses, and twice the normal doses. After 21 days, histological analysis of the grafts
revealed complete patency of all grafts, with no signs of local toxic response to the
antiobiotics. Healing of the preloaded grafts, whether at standard or twice standard loading
of antibiotics, was always similar to that of the conventional gelatin-sealed grafts, with no
signs of poor healing. These results are encouraging, seeing as how vascular prosthetic
infections still remain a serious complication of vascular surgery.

Conclusion
Despite the many obstacles to overcome in the creation of a successful vascular
graft, research from the last 10 years has exponentially increased our knowledge and
understanding of what is required of a vascular substitute. Biohybrid and tissue engineered
vascular grafts have been investigated using material properties, complex tissue culture,
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and cell seeding techniques. Investigators have looked at several approaches to the issues
that still prevent an ideal graft from being designed. At the present time, both in vivo and
ex vivo solutions have significant drawbacks; however, through the combination of
bioresorbables, biopolymers, drug delivery, and cells, we can surmount the setbacks and
ameliorate these problems.

Overview of the Current Study
As mentioned previously, arteries are designed in a tri-layered fashion represented
by the intima, media, and adventitia. Each of these layers imparts its own composition of
cells and ECM depending on its anatomical location and has an affect on the overall
mechanical properties. Mechanically, if we are able to mimic this tri-layered arterial
structure, then this could potentially make large strides towards a graft which would
adequately replace the diseased tissue for a significant period of time. Three layers
provides us with a multitude of options where microscopic and macroscopic properties can
be fine tuned through a series of tests with different synthetic biodegradable polymers and
biopolymers. At the microscopic end, graft properties such as fiber diameter, the addition
of proteins, and eventually drug delivery techniques can be employed to enhance both
mechanical and cellular properties. Macroscopically, we can derive polymer blends to
mimic native tissue through a series of tests so that compliance mismatch and aneurysmal
formations present less limitations. Additionally, biodegradable polymers can be tailored
to degrade different layers at different time points to potentially time the degradation of the
material and to match that of cellular occupation. These potential benefits due to a trilayered structure could lead us to a better vascular graft.
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The search for the ideal vascular graft has been defined by some as the search for
the “Holy Grail.” [214] It is a daunting task that many have investigated. Multi-layer
electrospinning was first attempted by Kidoaki et al. [215] using type I COL, gelatin,
segmented polyurethane, and PEO. Since then multi-layer electrospinning has been
studied using PCL, PLA, PDO, Poly(glycolide-co-trimethylene carbonate), gelatin, and
ELAS [98, 108, 153, 216]. These studies employed different uses of multilayered
techniques. Smith et al. [108] electrospun PDO-ELAS bilayered constructs with a suture
wound in the center for reinforcement. Vaz et al. [98] electrospun a bilayered tube
structure made of PCL and PLA, varying the anisotropy of the layers, but not including
natural polymers. Yang et al. [216] performed a layer-by-layer approach electrospinning
PCL and COL together, seeding HDFs, and then repeating the PCL/COL and HDF layers.
These cellularized constructs were done is sheet form and not with tubes. Thomas et al.
[153] utilized PGA, ELAS, and gelatin in a tri-layered form. However, the use of PGA
and gelatin would not be conducive to an arterial graft as gelatin, in vivo, has been shown
to display a large cytotoxic response [217] and PGA is a fast degrading polymer.
Vascular graft development has currently produced cellular and acellular products.
Cellularized grafts have made headway for many such as the completely autologous
vascular graft developed by Nicolas L’Heureux [163]. However, a cellularized structure
introduces an extremely high level of complexity, cost, and risk. Harvesting a patience
own cells, growing them in culture, and then coming out with a final product can take in
excess of 6 months. Additionally, during the culture process, the graft is prone to
infection. Within this time frame, the patient could die before receiving a fully developed
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cellularized vascular graft. This study, however, uses an acellular vascular graft providing
an off-the-shelf product that can be implanted immediately, and using the body as its own
natural bioreactor to regenerate and develop the native arterial tissue.
The materials chosen for this experiment were PCL, ELAS, COL, and silk fibroin
(SF). PCL is a semicrystalline, non-toxic, and tissue compatible biomaterial with a
degradation rate of around 12 months. Mechanically, PCL displays highly desirable
characteristics for vascular grafts, mostly high strength and good compliance. For this
study, PCL was utilized as the main vascular graft material, providing the mechanical
backbone for the biopolymers which are integrated into the scaffolding in different
quantities. ELAS is one of the main structural components of the vascular ECM,
imparting distensibility and elastic recoil. Daamen et al. not only found that solubilized
ELAS induced angiogenesis, but also increased elastic fiber synthesis and displayed no
signs of calcification when compared to grafts containing its insoluble form [142]. This is
one of many studies that have proven soluble ELAS to be an advantageous biopolymer.
COL is one of the most plentiful proteins found in native blood vessel, conferring
circumferential strength to the vessel wall. COL fibers also possess some unique structural
properties important for tissue engineering: they transmit forces, dissipate energy, prevent
premature mechanical failure and provide biological signals to adjacent cells that regulate
functional responses. Additionally, COL is resorbable, has high water affinity, low
antigenicity, very good cell compatibility and ability to promote tissue regeneration [126].
These factors combine to make COL one of the most ideal biopolymers available for tissue
engineering applications. Silk exhibits excellent biocompatibility with a foreign body
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response comparable to other degradable sutures, hemocompatibility, and oxygen and
water permeability. Silk also possesses remarkable mechanical properties not seen in other
naturally occurring proteins [218-220]. In this study, we observed the affect that each
polymer exhibited on one another through a series of mechanical and cellular tests.

CHAPTER 2: Preliminary Investigation of Chemical
Crosslinking
Preface: The following manuscript is currently published in the Journal of Electrospun
Fibers and Fabrics. This work investigates two goals to be achieved through this
experiment: 1. To determine the maximum amount of elastin that could be retained within
an uncrosslinked electrospun mat of soluble elastin and polydioxanone (PDO), and 2. To
investigate several different ways the soluble elastin can be cross-linked and the resulting
mechanical properties of those scaffolds.
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Elastin Blends: Material Characterization
Michael J. McClure, Scott A. Sell, Catherine P. Barnes, Whitney C. Bowen, and Gary L.
Bowlin
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Virginia 23284
Abstract
The purpose of this study was to establish whether material properties of ELAS coelectrospun with PDO would change over time in both the uncross-linked state and the
cross-linked state. First, uncross-linked scaffolds were placed in phosphate buffered saline
(PBS) for three separate time periods: 15 minutes, 1 hour, and 24 hours, and subsequently
tested using uniaxial materials testing. Several cross-linking reagents were then
investigated to verify their ability to crosslink ELAS: EDC, ethylene glycol diglycidyl
ether (EGDE), and genipin. Uniaxial tensile testing was performed on scaffolds crosslinked with EDC and genipin, yielding results that warranted further investigation for
PDO-ELAS blends. Material properties of the cross-linked scaffolds were then found
within range of both pig femoral artery and human femoral artery. These results
demonstrate PDO-ELAS blends could potentially be favorable as vascular grafts, thus
warranting future in vitro and in vivo studies.
Key Words: electrospinning, vascular graft, elastin, polydioxanone, cross-linking

Introduction
For over a hundred years, CVD has remained the number one cause of death in the
United States. In 2003, preliminary mortality data showed CVD accounted for 37.3% of
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all deaths (16.7% of those people were under the age of 65). Atherosclerosis accounted for
three quarters of deaths related to CVD. This thickening of arterial wall due to disrupted
blood flow can lead to a myriad of complications [221, 222]. In an attempt to treat patients
with this disease, an estimated 467,000 bypass surgeries occurred in 2003 [221].
Currently, for small diameter (< 6mm) vascular grafts, autologous blood vessels,
such as the saphenous vein, are the standard. However, many patients do not have a
suitable vessel for use because of peripheral vascular disease, amputation, or prior harvest
[29, 30, 223]. If autologous blood vessels are unavailable, then the replacement must be
prosthetic. Several options are available when choosing among the number of grafts
currently on the market. The most common options are ePTFE and Dacron®. However, at
the small diameter level, the properties of these materials have generally proved inadequate
due to acute thrombogenicity of the graft, anastomotic intimal hyperplasia, aneurysm
formation, infection, and progression of atherosclerotic disease [223]. Therefore, new
design criteria must be implemented. Qualities of an ideal design would include the ability
to be nonthrombogenic, nonimmunogenic, infection resistant, capable of inducing an
appropriate healing response, flexibile, kink resistant, easily manufactured, affordable,
easily stored, available in a variety of sizes (lengths and diameters), and mechanically
compliant [222-225].
Arteries require a complex design in order to withstand high flow rates and high
pressures at pulsatile intervals. The vessels themselves can be considered as viscoelastic
tubes, where their diameter is maintained by the balance between elasticity and strength
imparted by the different components of the wall and the applied transmural pressure [22650
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228]. These tubes experience two primary hemodynamic forces: the circumferential force
resulting from the wall tension due to blood pressure, and the frictional force or shear
stress resulting from blood flow along the vessel wall. The relationship between shear
stress, vascular restructuring, and growth has led to speculation of an association between
shear stress and the formation of atherosclerotic lesions [229]. Therefore, in low flow
environments, such as small diameter blood vessels, it is essential to match the mechanical
forces of a vascular graft with the native artery for proper graft functionality.
To elicit these specific properties, the proper choice of polymers and fabrication
must be made. While other scaffold fabrication techniques exist for vascular conduits,
electrospinning has emerged as one of the leading techniques for generating biomimetic
scaffolds made of synthetic and natural polymers. Electrospinning uses an electric field to
control the formation and deposition of polymer fibers and is remarkably efficient, rapid,
and inexpensive [230]. Using this technique, a number of biomaterial constructs have been
fabricated [150], including constructs that hold potential for blood vessel engineering
[231]. Previous research has shown COL types I and III, ELAS, and PDO to be readily
spinnable into submicron scale fibrous scaffolds [144, 222, 232-235]. Therefore, creating
a scaffold that combines the mechanical strength of a biodegradable polymer with the
bioactive properties of the ECM could prove to be a beneficial design in the quest for a
bioresorbable vascular grafts [236]. Ideally, once these scaffolds are processed and
implanted in situ, cells will recognize the surface, adhere, migrate, and proliferate.
In vivo ELAS [137-139] strongly differs from its soluble form [140], α-ELAS and
β-ELAS, which is commonly used in vascular engineering scaffold fabrication. Previous
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experiments have blended COL and ELAS scaffolds [222, 232], leading to the
instantaneous dissolution of the electrospun fibers in water as demonstrated by Buttafoco
et al. However, the characteristics of ELAS dissipation, when co-electrospun with PDO,
are unknown. Therefore, cross-linking the scaffolds may be a necessity. The most
common crosslinker, glutaraldehyde, has been used with numerous types of electrospun
scaffolds [222, 233, 237-240], but with cytotoxic drawbacks [241]. EDC and genipin, on
the other hand, have exhibited lower cytotoxicity [241-243], making them better suited for
implantation.
This study focused on the 50:50, 60:40, 70:30, 80:20, 90:10, and 100:0
PDO:α,β−ELAS blend ratios, and their behavior as an uncross-linked scaffold when
immersed in PBS solution for three separate time periods: 15 minutes, 1 hour, and 24
hours. All scaffolds were tested for dry weight loss and material properties. Cross-linked
scaffolds were subsequently investigated to determine if any material property changes
occurred over time.

Materials and Methods
Electrospinning
The following were blended in ratios of 100:0, 90:10, 80:20, 70:30, 60:40, 50:50,
and 0:100 (250 mg/ml for electrospinning pure ELAS fibers) by volume (PDO:ELAS) and
dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol (HFP, Sigma Aldrich Co.): PDO (Ethicon,
Inc.) with a concentration of 100 mg/mL and ELAS concentration from bovine neck
ligament, α-ELAS and β-ELAS, (Elastin Products Co., Inc.) of 200 mg/mL. These
solutions were then inserted into a plastic 5 ml Becton Dickinson syringe with a blunt tip
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18 gauge Becton Dickinson PrecisionGlide® needle. The syringe and needle were placed
in a KD Scientific syringe pump to be dispensed at a rate specific to the PDO:ELAS blend
(between 4 and 8 ml/hr). The solutions were electrospun onto a flat rotating mandrel (2.5
cm wide x 10.2 cm long x 0.3 cm thick) to produce a flat sheet with random fiber
orientation for weight testing and uniaxial tensile testing. Each sample was electrospun
with an applied voltage of 22 kV at a distance of 10-13 cm from the needle tip to the
mandrel and a rotational speed of 500 revolutions per minute (rpm).
Weight Loss After Hydration
Scaffolds were cut randomly into rectangular shapes (approximately 1.5cm x 1cm)
from the electrospun sheet, weighed, and randomly placed into a specific time group (15
minutes, 60 minutes, or 24 hours) based on ELAS’s instantaneous dissolution in PBS. The
scaffold was placed in a 35x10mm Petri dish with 3mL of PBS for the specified time. The
scaffolds were then extracted and washed 3 times with 3 mL of deionized water. The
scaffolds were placed in a desiccation chamber for 24 hours to dry. Each sample was then
weighed to determine any weight loss (percent remaining)
% Remaining = Weight Time × 100
Weight Initial

(1)

where WeightTime was specified as the weight remaining after being soaked in PBS and
dried, and WeightInitial was specified as the initial dry weight of the sample prior to its PBS
soak.
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Dry Scaffold Characterization
Scaffold characterization was performed using scanning electron microscopy on
small pieces cut from the electrospun mats (SEM, JEOL JSM-820 JE Electron
Microscope). SEM images were digitized with a Hewlett-Packard Scanjet 5550c flatbed
scanner and analyzed with ImageTool 3.0 software (Shareware provided by UTHSCSA).
Characterization included determining the average fiber diameter for the electrospun
structure by taking the average of 60 measurements chosen randomly from across the
image. For all of the measurements made from the SEM images, calibration of the
ImageTool software was done with the scale bar on each image. The sample size for each
measurement was n = 60.
Uniaxial Tensile Testing
Uniaxial tensile testing was performed on dry and hydrated samples at each time
point. Uniaxial tensile testing was also performed on ePTFE, 100% electrospun ELAS,
and decellularized pig femoral artery. “Dog-bone” shaped samples were punched from
the electrospun mat (2.75 mm wide at their narrowest point with a gage length of 7.5 mm)
and tested on a MTS Bionix 200 testing system with a 50 N load cell (MTS Systems
Corp.) and an extension rate of 10.0 mm/min. Tangential modulus, peak stress, and strain
at break were calculated using Test Works version 4. The sample size for each specimen
was n = 6.
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Cross-linking
Scaffolds were cross-linked using EDC (Fluka Biochemika), genipin (Wako Pure
Chemical Industries, Ltd.), and ethylene glycol diglycidyl ether (EGDE, Sigma Aldrich,
Inc.).
Cross-linking with EDC
For EDC crosslinking a 50x molarity solution (166.5 mM) was prepared in
accordance with Barnes et al. [244] in ethyl alcohol (Fisher Scientific). Scaffolds were
placed in the EDC solution, and allowed to cross-link for 18 hours followed by a 0.1M
Na2HPO4 rinse for 1 hour and a PBS rinse for 1 hour.
Cross-linking with Genipin
A 30mM solution of genipin dissolved in ethyl alcohol was used to cross-link
ELAS scaffolds. Scaffolds were electrospun and placed in the cross-linking solution for a
period of 72 hours [245], followed by a PBS rinse for 2 hours.
Cross-linking with EGDE
Based on the work performed by Leach et al. [143], ELAS scaffolds were crosslinked using 50% EGDE. At room temperature electrospun ELAS scaffolds were placed
in a Petri dish with EGDE and allowed to crosslink for 24 hours followed by a PBS rinse
for 2 hours.
Visual Inspection of Cross-linked Scaffolds
Cross-linked scaffolds were initially placed in PBS for a 24 hour period to
determine structural stability. Observations were recorded at time intervals of 0 minutes,
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15 minutes, 1 hour, and 24 hours and scaffolds were subsequently measured for free amine
groups.
Determination of Free Amino Groups
The concentration of free primary amine groups present in cross-linked electrospun
ELAS was determined using 2,4,6-trinitrobenzenesulfonic acid (TNBS, Research
Organics) [244]. Scaffold samples were electrospun, punched into “dog bone” shapes,
massed and cross-linked using the procedures listed above. Samples were placed in 15mL
Fisherbrand® centrifuge tubes. NaHCO3 (1.0 mL 4% w/v) and TNBS (1.0 mL 0.5% w/v)
were added and placed in an incubator at 40oC for 2 hr. 3.0 mL of 6M HCL was then
added to the solution, which was placed in an oven at 60oC for 2 hr. The samples were
diluted with 9 mL of PBS, cooled to room temperature. The absorbance at 345 nm was
measured using a SPECTRAmax® PLUS384 microplate spectrophotometer. Measured
absorbance values were then placed into a percent cross-linking equation
⎤
⎡ Absc
Massc ⎥
⎢
%Cross − linked = 1 − ⎢
⎥
Absnc
⎥
⎢
Mass
nc ⎦
⎣

(2)

where Absc is the measured absorbance of the cross-linked solution, Absnc is the measured
absorbance of the non-cross-linked solution, Massc is the dry mass of the cross-linked
scaffold, and Massnc is the dry mass of the non-cross-linked scaffold. The sample size for
each measured absorbance group was n = 9.
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Statistical Analysis
Anaylsis of variance (ANOVA) was performed in NCSS® 2004 statistical software
(NCSS, USA) using a Kruskal-Wallis test (p <0.01) to determine if at least two medians
were different, and a Tukey-Kramer pair wise multiple-comparison test (p < 0.01) to
ultimately determine significant differences between groups.

Results and Discussion
Weight Loss After Hydration
Soluble ELAS is known to immediately dissociate into aqueous solutions. PDO
and ELAS were electrospun together in order to demonstrate the possibility of PDO
retaining the ELAS fibers. Thus, PDO could prevent ELAS dissociation in PBS without a
cross-linking agent.
The total weight of each electrospun scaffold illustrated the relationship between
the different blends of PDO and ELAS; as the amount of ELAS increased, the weight of
the dry scaffold increased as well. Once hydrated, the results indicated that as the amount
of ELAS was increased, the faster the scaffold degraded or dissociated. PDO:ELAS
blends of 50:50 experienced a 50.4% reduction in the weight of the scaffold in the first 15
minutes alone. After 24 hours an additional 10.1% reduction in weight occurred, creating
an almost exponential decrease. As the initial amount of ELAS in the scaffolds was
reduced, weight loss over time tended to become more linear (Figure 1, Table 7).
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Table 7.Average Remaining Dry Weight

Graft
Material

Remaining
15
minutes
(%)

Remaining
60
minutes
(%)

Remaining
24 hours
(%)

50:50
60:40
70:30
80:20
90:10
100:0

50 ± 12
71 ± 17
94 ± 2.5
96 ± 3.3
106 ± 5.8
100 ± 2.9

41 ± 7.5
64 ± 11
77 ± 3.9
91 ± 7.4
107 ± 7.0
100 ± 3.8

39 ± 5.9
58 ± 2.7
67 ± 5.2
85 ± 2.1
99 ± 3.6
102 ± 2.0

Weight Remaining (%)

120
100
80
0 min
15 min

60

1 hr
1 day

40
20
0
50:50

60:40

70:30

80:20

90:10

100:0

PDO:Elastin

Figure 1. Percent of scaffold weight remaining after t = 0 minutes, 15 minutes, 60
minutes, and 24 hours, respectively in PBS.
The initial weight was significantly different from 15 minutes, 60 minutes, and 24
hours for both blends of 50:50 and 60:40; however, the 15 minutes, 60 minutes, and 24
hours blends were not different from each other. Therefore, the two blends lost most of
their weight in the first 15 to 60 minutes, leading to a slowed rate of loss as time
progressed. Significant differences existed among the three timed groups for 70:30, but
not between the initial weight and 15 minute batch time. Differences existed between the
initial weight, 60 minutes, and 24 hours batch times for 80:20. However, initial weight and
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15 minutes did not exhibit any differences for 80:20. This result indicates the scaffolds
were retaining their weight in the first 15 minutes in PBS, but as time progressed there was
a significant drop in scaffold weight. 90:10 and 100:0 results demonstrated no significant
differences.
As there was no change in PDO content of the scaffolds over such a short exposure
to an aqueous environment, all weight loss is attributed to the dissolution of ELAS.
Results indicate as the ELAS content decreased, it took longer for the ELAS to dissipate
out of the scaffold. This can be clearly observed in the 80:20, 70:30, 60:40, and 50:50
scaffolds, where a logarithmic relationship exists between time and weight percent (Figure
2).
120

100

80:20

Weight Percent

R2 = 0.72
70:30

80

2

R = 0.61
60:40
60

2

R = 0.98
50:50

40

2

R = 0.94

20

0
0

500

1000

1500

2000

Time (min)

Figure 2. Weight percent of PDO:ELAS blends 50:50, 60:40, 70:30, and 80:20 vs. time (0,
15, 60, and 1440 minutes). The data is fit to a logarithmic curve where R2 values display
the degree of association between weight percent and time.
So, as ELAS content increased its ability to dissipate in a shorter period of time
also increased with a high degree of association for 50:50 and 60:40 (R2 values). 90:10
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and 100:0 demonstrated no ELAS loss over time. The lack of ELAS loss could indicate
that with minimum ELAS content PDO may have successfully retained the ELAS fibers,
or it could indicate PDO is slightly hydrophobic and does not allow an aqueous solution to
fully dissociate the electrospun ELAS. Therefore, it was determined that electrospun
soluble ELAS was not able to be retained in scaffolds containing high percentages of
ELAS when co-electrospun with PDO. However, as the ELAS decreases and PDO
increases, there is evidence that the dissipation of ELAS from the scaffold is slowed, or
possibly stopped.
Dry Scaffold Characterization
Scanning electron microscopy demonstrated that PDO and ELAS were successfully
electrospun into a random non-woven mat Figure 3. This is demonstrated by the thin, flat,
ribbon-like fibers which represent ELAS compared to the more rounded fibers which
represents PDO. Mean fiber diameter and pore area were calculated for all scaffold types,
where mean fiber diameter ranged from 0.88 – 0.56 μm and mean pore area ranged from
4.7 – 1.5 μm2.
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0:100

50:50

60:40

70:30

90:10

80:20

100:0

Figure 3. Scanning electron micrograph of electrospun PDO:ELAS. All micrographs are
taken at 2500x magnification and the scale bar is equivalent to 10 microns.
Uncross-linked PDO:ELAS Uniaxial Tensile Testing
As weight sampling indicates, ELAS dissociation definitely occurs in some blends
over time. Consequently, scaffold mechanical properties could also change with time.
Results of uniaxial tensile testing are displayed in Figure 4 and Table 8 with peak stress,
tangential modulus, and strain at break.
The scaffolds were tested dry as well as at timed hydrations of 15 minutes, 60
minutes, and 24 hours. Timed hydration results for peak stress indicated there were no
differences among the 50:50 scaffolds. Samples at 24 hours were different from both 15
minutes and 60 minutes among the 60:40 scaffolds. Among the 70:30 scaffolds, times of
15 minutes, 60 minutes, and 24 hours were different from each other. There were no
significant differences among the 80:20 scaffolds. 90:10 scaffolds showed significant
differences between 24 hours and both 15 minutes and 60 minutes. The group timed at 15
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minutes was different from those timed at 60 minutes in the pure PDO scaffold. One
possible difference that could account for the differences seen in 90:10 and pure PDO
scaffolds are batch to batch differences in PDO or ELAS that occur during the
electrospinning process for use in the 24 hours hydration. Due to the preliminary nature of
this study, further investigation is required.
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Table 8. Material Properties of Uncross-linked PDO:Elastin at Times of 15 minutes, 1
hour, and 24 hours.
Graft
Material
50:50
15 minutes
50:50
60 minutes
50:50
24 hours
60:40
15 minutes
60:40
60 minutes
60:40
24 hours
70:30
15 minutes
70:30
60 minutes
70:30
24 hours
80:20
15 minutes
80:20
60 minutes
80:20
24 hours
90:10
15 minutes
90:10
60 minutes
90:10
24 hours
100:0
15 minutes
100:0
60 minutes
100:0
24 hours

Peak
Stress
(MPa)

Modulus
(MPa)

Strain at
Break
(mm/mm)

2.7 ± 0.2

6.1 ± 0.9

0.8 ± 0.04

2.7 ± 0.5

6.0 ± 0.9

0.8 ± 0.1

2.3 ± 0.4

6.5 ± 1.0

0.9 ± 0.1

5.1 ± 0.4

8.1 ± 1.2

0.9 ± 0.1

4.7 ± 0.7

7.3 ± 1.5

0.9 ± 0.03

3.0 ± 0.8

6.0 ± 1.9

0.7 ± 0.1

7.3 ± 0.4

6.2 ± 0.1

1.4 ± 0.1

6.2 ± 0.3

6.0 ± 0.8

1.4 ± 0.2

3.4 ± 0.4

4.1 ± 0.7

1.1 ± 0.1

5.9 ± 0.6

4.3 ± 0.4

1.7 ± 0.1

6.3 ± 0.3

4.9 ± 0.2

1.6 ± 0.1

5.3 ± 0.8

5.7 ± 0.8

1.3 ± 0.2

10 ± 0.6

13 ± 1.0

1.5 ± 0.1

12 ± 2.4

16 ± 4.7

1.3 ± 0.2

5.1 ± 0.3

5.2 ± 0.4

1.4 ± 0.1

6.3 ± 0.4

6.6 ± 0.5

2.8 ± 0.4

4.9 ± 0.7

7.5 ± 0.7

2.0 ± 0.3

5.6 ± 0.7

20 ± 0.7

2.1 ± 0.4

Trends of the tangential modulus results closely resembled those of peak stress for
the 50:50, 60:40, and 70:30 samples. Among the 80:20 scaffolds, the batch timed at 15
minutes was different from the batch timed at 24 hours. This discrepancy was also true for
the 90:10 and 100:0 blends, where times of 15 minutes and 60 minutes were different from
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24 hours in the 90:10 and pure PDO scaffolds. 90:10 actually increased in stiffness from
15 minutes to 60 minutes, but dropped dramatically after 24 hours. Results for 80:20 and
90:10 could once again be due to batch differences in ELAS or PDO; however, further
investigation is required to determine this.

64

65
16

Peak Stress (MPa)

14
12
10

Dry
15 min
1hr
1day

8
6
4
2
0
50:50

60:40

70:30

80:20

90:10

100:0

90:10

100:0

90:10

100:0

PDO:Elastin Ratio

Tangential Modulus (MPa)

70
Dry

60

15 min
1 hr

50

1 day

40
30
20
10
0
50:50

60:40

70:30

80:20

PDO:Elastin Ratio

3.5

Strain at Break (mm/mm)

Dry

3

15 min
1 hr

2.5

1 day

2
1.5
1
0.5
0
50:50

60:40

70:30

80:20

PDO:Elastin Ratio

Figure 4. Comparison of uniaxial tensile test values for peak stress, modulus, and strain at
break, for uncross-linked PDO:ELAS blends.
No significant differences existed among the 50:50, 60:40, and 90:10 scaffolds for
strain at break. Among the 70:30 scaffolds, the batch time of 15 minutes is different from
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24 hours, and 15 minutes and 60 minutes are different from 24 hours among the 80:20
scaffolds, indicating a change has occurred over a 24 hour period. In addition, the batch
timed at 15 minutes is different from 60 minutes in pure PDO scaffolds.
Material properties of the uncross-linked PDO:ELAS blends demonstrated overall
changes in the scaffolds over a time period of 24 hours. No differences were visible in the
50:50 and 60:40 scaffolds, indicating ELAS had dissociated too quickly in the 50:50 and
60:40 scaffolds for any noticeable change to be seen. However, 70:30 scaffolds,
demonstrated an overall change from 15 minutes to 24 hours for all material properties,
whereby the material became less stiff, peak stress decreased, and strain at break
decreased. 80:20 and 90:10 scaffolds showed changes over time as well, but not for all
properties. Therefore, the material properties change over a period of one day when the
scaffolds are uncross-linked, providing evidence suggesting PDO does not adequately
retain the soluble ELAS in the scaffolds, making cross-linking a necessity.
Cross-linking Elastin
The cross-linked results for electrospun ELAS scaffolds are illustrated in Figure 5,
where 166.5 mM EDC had a percent cross-link average of 45.1%, while genipin had an
average of 23.3%. EGDE was not calculated because the scaffolds dissociated
immediately in NaHCO3 solution prior to incubation, indicating minimal to no crosslinking. Statistical differences existed between the 166.5 mM EDC and 30mM genipin,
demonstrating 166.5 mM EDC had the maximum cross-linking among the groups.
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Cross-linking Reagent

Figure 5. Percent cross-linkage of EDC and genipin for electrospun ELAS scaffolds.
Cross-linking PDO:Elastin
Figure 6 shows the results of a weight loss study, clearly demonstrating ELAS
retention after cross-linking in a 50:50 PDO:ELAS scaffold after soaking in PBS for 24
hours. There is no statistical difference between the scaffold cross-linked with EDC and
the initial weight. However, there is a statistical difference between the initial weight of
the uncross-linked scaffold and its final weight after one day.

% Weight Remaining

120
100
80
60
40
20
0
Initial Weight

50-50 EDC

50-50 NO EDC

Figure 6. Percent of weight remaining of EDC cross-linked 50:50 PDO:ELAS scaffolds
and uncross-linked 50:50 PDO:ELAS scaffolds after being soaked in PBS for 24 hours.
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Cross-linked PDO:Elastin Uniaxial Tensile Testing
Since EDC had the highest degree of cross-linking, materials cross-linked by this
method were the focus of uniaxial tensile testing. The results obtained were compared to
ePTFE and pig artery. Peak stress, tangential modulus, and strain at break for particular
EDC scaffolds are contained in Table 9.
Table 9. Material Properties of EDC Cross-linked and Uncross-linked Electrospun
Scaffolds Compared to Human Femoral Artery [246, 247], ePTFE, and Decellularized Pig
Artery.
Graft
Material
Femoral
Artery

Peak Stress
(MPa)

Modulus
(MPa)

1.5 ± 0.5

11 ± 1.5

Strain at
Break
(mm/mm)
0.7 ± 0.1

Pig Artery

3.4 ± 1.6

2.7 ± 1.3

3.0 ± 0.8

ePTFE

5.8 ± 0.2

9.5 ± 0.6

10 ± 0.6

50:50

2.3 ± 0.5

6.5 ± 0.9

0.9 ± 0.1

50:50 EDC

1.4 ± 0.2

5.3 ± 0.6

0.7 ± 0.1

50:50 Gen

0.9 ± 0.1

3.1 ± 0.3

0.8 ± 0.1

70:30

3.5 ± 0.4

4.1 ± 0.7

1.2 ± 0.1

70:30 EDC

2.4 ± 0.2

6.3 ± 0.6

1.1 ± 0.2

70:30 Gen

3.8 ± 0.5

6.3 ± 0.5

1.0 ± 0.1

PDO

5.6 ± 0.7

30 ± 3.8

0.6 ± 0.1

In Figure 7, there was a noticeable gradual increase in average peak stress of EDC crosslinked PDO:ELAS ranges from 0:100-100:0. Similar to the uncross-linked scaffolds,
higher PDO content correlates to a higher peak stress value. Modulus results demonstrated
similar values over the PDO:ELAS ranges, 50:50-80:20. However, as PDO content
increased after this range, the modulus dramatically increased, which is also consistent
with the uncross-linked data. Strain at break results demonstrated increases as the PDO
content increased up to the 70:30 blend. However, at this strain at break point it began to
fall as it reached 100:0. Therefore, an unknown factor in the cross-linking process may
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affect the amount the graft is allowed to strain as PDO content increases, or there could
have been some batch differences as the scaffolds were electrospun.
Overall, peak stress demonstrated EDC cross-linked pure ELAS was statistically
different from all tested materials. 50:50 PDO:ELAS was statistically different from the
80:20-100:0 PDO:ELAS blends, pig artery, and ePTFE. 60:40 was statistically different
from PDO:ELAS ranges of 70:30-100:0, ePTFE, and pig artery. 70:30 was statistically
different from all materials except 50:50. 80:20-100:0 and ePTFE were statistically
different from all materials, and pig artery was statistically different from all materials
except 80:20.
In terms of modulus, EDC cross-linked pure ELAS was significantly different from
all materials except pig artery. 50:50 and 80:20 were significantly different from ePTFE,
90:10, and 100:0. 60:40 and 70:30 were both significantly different from 90:10 and 100:0
PDO:ELAS blends, as well as the pure ELAS. However, 60:40 was also significantly
different from the pig artery. 90:10 is significantly different from all materials except
ePTFE, and 100:0 was significantly different from all materials. ePTFE was significantly
different from 50:50, 80:20, 90:10, pure ELAS, and pig artery.
Strain at break consisted of a fairly smooth distribution when considering
PDO:ELAS ranges of 50:50-100:0. Pure ELAS was significantly different from both pig
artery and ePTFE. Pig artery and ePTFE were significantly different from the full range of
PDO:ELAS blends. Interestingly, the pure ELAS scaffolds cross-linked with EDC had
higher strain at break values than the 50:50 scaffolds. This result indicates higher ELAS
content alone was not the foremost cause of lower strain at break values. Therefore, the
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blending of PDO and ELAS as well as the properties provided to the scaffold result in
lower strain at break values.
Pig artery was used as a comparison tool for a native extracellular matrix (ECM)
containing COL, ELAS, and proteoglycans. The peak stress and tangential modulus of
PDO:ELAS blends were all within the range of the pig artery; however, strain at break was
not. In native artery, ELAS generally takes the majority of the initial load, while COL
stretches from its crimped position. Once the COL is fully stretched, stress increases
dramatically, even though the artery has already stretched a significant amount prior to
fracture. While this behavior was observed in the pig artery, the PDO:ELAS scaffolds, on
the other hand, do not contain this crimped structure. Thus, PDO and ELAS worked
together as the scaffold was stretched and subsequently fractured at a lower strain.
Pig artery demonstrated an average tangential modulus of 2.7 MPa, which is
significantly less than all tested materials with the exception of the EDC pure ELAS
scaffolds. This result illustrated a need for a decrease in the amount of synthetic polymer
blended into scaffolds, but at the cost of possible graft failure due to rupture or aneurysmal
formation. Therefore, a significant amount of materials testing outside of uniaxial tensile
testing is required, including compliance and burst strength, which involve biaxial stretch.
The importance of peak stress, tangential modulus, and strain at break for vascular
graft material properties are to give a preliminary understanding of material behavior if
implanted in situ. Peak stress is a good indicator for burst strength properties and
prevention of aneurysmal formation. Values obtained through tangential modulus are
related to the overall stiffness of the material and are indicative of the material compliance.
70

71
Strain at break is another indicator for compliance and distensibililty. Individually, these
properties only provide small details of the overall picture, but, when combined with a
description of the stress-strain curves and more advanced testing, these material properties
become more valuable at predicting the mechanical properties of a combination of
materials.
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Figure 7. Uniaxial tensile test values for peak stress, modulus, and strain at break for EDC
cross-linked PDO:ELAS blends, genipin, ePTFE, and pig artery.
Since genipin’s cytotoxic properties are considered to be conducive to the body,
PDO:ELAS blends of 50:50 and 70:30 cross-linked with genipin were examined through
uniaxial tensile testing in a side-by-side comparison with EDC cross-linked scaffolds and
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pig artery (Figure 8). Results revealed no statistical differences between the 50:50
scaffolds, but a difference existed between the 70:30 scaffolds. Additionally, the 70:30
scaffold cross-linked with genipin was not different from the pig artery. Tangential
modulus illustrated a difference between the 50:50 scaffolds, but not the 70:30 scaffolds.
No difference existed between the pig artery and 50:50 genipin scaffold. Finally, strain at
break did not show differences among the individual scaffolds, which had different strain
at break compared to pig artery. Therefore, cross-linking with genipin demonstrates a
decrease in the stiffness of the material compared to EDC when enough ELAS is added to
the scaffold. The same could be true for peak stress since the average peak stress
decreases for the 50:50. However, 70:30 demonstrates an increase in peak stress when
cross-linked with genipin. Thus, this inconsistency could be due to the cross-linker used or
to batch differences with higher PDO content compared to the scaffold cross-linked with
EDC.
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Figure 8. Uniaxial tensile test values for peak stress, modulus, and strain at break, for EDC
and genipin cross-linked PDO:ELAS blends of 50:50, 70:30, and pig artery.
Conclusion
The given results have shown that electrospun PDO-soluble ELAS blends
demonstrate changes in material properties over a period of one day when uncross-linked,
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leading to the conclusion that cross-linking is a necessity for ELAS containing scaffolds.
Several cross-linkers were investigated for this study, but only EDC and genipin were
considered for additional testing based on percent cross-linking and documented cytotoxic
properties. Mechanically, the addition of ELAS creates scaffolds that exhibited ranges of
properties resembling that of both pig artery and native human artery. Previous data
indicated uncross-linked PDO-ELAS cell culture with blends of 70:30 and 90:10
demonstrated excellent migration into the uncross-linked scaffolds [248]. Future studies
will investigate mechanical properties based on uniaxial hysteretic testing, compliance
testing, and the possible inclusion of COL.
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CHAPTER 3: Preliminary Methods Towards a Tri-Layered Design
Preface: The following manuscript is currently published in Acta Biomaterialia. This work
investigates the feasibility of designing and testing a tri-layered vascular graft composed
of PCL, elastin, and COL. Through the use of a tri-layered design, it is possible to change
material properties of individual layers, causing changes in the material properties of the
whole graft.
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Abstract
Throughout native artery, collagen and ELAS play an important role, providing a
mechanical backbone, preventing vessel rupture, and promoting recovery under pulsatile
deformations. The goal of this study was to mimic the structure of native artery by
fabricating a multi-layered electrospun conduit composed of PCL with the addition of
ELAS and COLwith blends of 45-45-10, 55-35-10, and 65-25-10 PCL-ELAS-COL to
demonstrate mechanical properties indicative of native arterial tissue, while remaining
conducive to tissue regeneration. Whole grafts and individual layers were analyzed using
uniaxial tensile testing, dynamic compliance, suture retention, and burst strength.
Compliance results revealed that changes to the middle/medial layer changed overall graft
behavior with whole graft compliance values ranging from 0.8 - 2.8 % / 100 mmHg, while
uniaxial results demonstrated an average modulus range of 2.0 - 11.8 MPa. Both modulus
and compliance data displayed values within the range of native artery. Mathematical
modeling was implemented to show how changes in layer stiffness affect the overall
circumferential wall stress, and as a design aid to achieve the best mechanical combination
of materials. Overall, the results indicated that a graft can be designed to mimic a trilayered structure by altering layer properties.
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Introduction
Although there is a strong patient demand for small diameter (< 6 mm) vascular
bypass grafts every year, the development of an ideal replacement has been a daunting task
with minimal success. All arteries are subjected to multiple stresses including
circumferential, longitudinal, torsional, and shear. These combined stresses account for an
artery’s unique arrangement as a tissue with three concentric layers: intima, media, and
adventitia. Each layer displays its own unique characteristics based on its location in vivo.
For example, larger arteries like the aorta, which experience high shear rates, and high
blood velocity have increased ELAS content compared to muscular arteries such as the
coronary or popliteal which experience lower shear and blood flow velocity. As blood
flow transitions from the large diameter arteries to small diameter arteries, the potential for
complications increase dramatically as there is more time for blood-borne components to
interact with the inner surface of the artery, posing problems for smaller diameter vascular
graft replacements.
Currently used bypass grafts such as Dacron® and ePTFE work well for larger
diameters but fail for small diameters due to acute thrombogenicity of the graft,
anastomotic intimal hyperplasia, aneurysm formation, infection, and progression of
atherosclerotic disease [223]. Therefore, efforts have been made to create a successful
bypass graft using biodegradable materials such as PGA [103, 249], PLA [250-252], PDO
[107-110], PCL [93, 99, 132, 253, 254], and several co-polymer blends [151, 255].
Nevertheless, most of these materials by themselves have had limited success. PGA is a
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rapidly degrading polymer which ultimately leads to failure of the graft material under
physiological pressures. Additionally, PGA has the potential to produce insults at the site
of the graft or downstream due to its rapid degradation and subsequent decreased pH levels
from glycolic acids. Although PLA is slower degrading than PGA, its stiffness makes it to
be less desirable when designing a vascular graft. PDO has been investigated by our lab
and has shown promise in vitro, but, when tested in situ in a rat model, degradation of the
PDO structure without enough cellular infiltration led to aneurismal formations
(unpublished data). PCL has been investigated and reported by many groups. Its long
degradation time, documented bioactivity for ECs and SMCs [256, 257], and innate
compliance makes it a suitable candidate for vascular graft material. Biodegradable
materials provide a key advantage. As the material degrades hydrolytically over time, cells
continuously infiltrate the matrix, producing COL, ELAS, and proteoglycans to replace the
degrading material. Eventually, a fully functional artery is created composed of
autologous smooth muscle and ECs. If PCL is utilized as the main vascular graft material,
providing the mechanical backbone, then its degradation should be slow enough for cells
to infiltrate and slowly take over mechanical function.
This concept, however, involves a critical time table. Biodegradable materials lose
their mechanical integrity over time, and regeneration of the vascular wall must take place
simultaneously as the material degrades. If regeneration time does not match degradation
time, then the implanted graft runs the risk of aneurysm or rupture. In order to attract cells
into the graft material, natural polymers such as COL and ELAS can be included in the
matrix. The native extracellular matrix (ECM) of the vasculature is composed mostly of
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COL and ELAS. These ECM components are constantly synthesized, secreted, oriented,
and modified by the cellular components that they support. Classically, the function of
native ECM was only believed to be as a structural framework for tissues. However the
ECM, through interaction with receptors on the surfaces of cells, directly takes part in
promoting cell adhesion, migration, growth, differentiation, and apoptosis. The ECM also
plays a role in cytokine activity and intracellular signaling, both of which serve numerous
functions in cell regulation and activation [258]. Extensive research has been performed
incorporating electrospun COL, gelatin, and ELAS [132, 232, 233, 259, 260] into vascular
conduit materials; however, no one has attempted to manufacture a multilayered
electrospun vascular tube with a profuse amount of native COL and ELAS. To date, high
natural polymer content decreases peak stress and modulus while increasing the risk of
aneurysm or rupture of the graft material. Nonetheless, if support is provided for the graft
material through multilayered electrospinning and/or chemical cross-linking, then high
natural polymer content becomes a viable option again.
The purpose of this study was to examine the concept of utilizing a three-layered
graft structure, mimicking the natural architecture of an artery while providing tunable
material properties for each layer. PCL, COL, and soluble ELAS were electrospun
sequentially at different polymer ratios in order to produce an inner (intima), intermediate
(media), and outer (adventitia) layer each with a unique polymer blend. PCL was chosen
as a synthetic polymer based on promising results from in vivo rat studies that have been
conducted by Pektok et al., whereby histological analysis revealed rapid
enthothelialization of the inner lumen of the graft and becoming confluent at 12 weeks
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[93]. Vascular tissue contains between 25-30 % COL and 40-50 % ELAS. Therefore,
ratios were chosen for each of the three layers based on native extracellular matrix design
while keeping mechanical integrity throughout the graft structure. The intimal layer (98-20 PCL-ELAS-COL) providing initial stiffness with a compact PCL dominated structure to
allow for the attachment of ECs while disallowing cellular infiltration, the medial layer
(45-45-10, 55-35-10, or 65-25-10 PCL-ELAS-COL) containing a high amount of ELAS to
decrease stiffness and a small portion of COL to attract cells into the layer, and the
adventitial layer (70-0-30 PCL-ELAS-COL) to prevent rupture and to attract cells from
outside the graft and into the matrix.
As described earlier, artery is subjected to circumferential, longitudinal, torsional,
and shear stress. Although important to the study of coronary arteries, torsion and shear
stresses do not ultimately dictate the mechanical behavior of an artery when considering
blood pressure supplying a force to the arterial wall in vivo. Therefore, mathematical
modeling was implemented to help describe circumferential wall stress (CWS) of the
individual layers and their mechanical effects on surrounding layers using the equations
developed by Vorp et al. [120, 261]. These results would aid in future design work,
providing valuable information regarding layered behavior which has yet to be tested in
vitro.
Materials and Methods
Collagen Extraction
COL type I was extracted from 6 month bovine corium through an acetic acid
based process previously described [262]. Briefly, tissue is homogenized, suspended in

81

82
acetic acid, and subsequently purified via a series of dissolutions, precipitations, and
dialyses [263]. Following the final dialysis, COL solutions were frozen and lyophilized.
Electrospinning
Concentrations of 100 mg/ml of PCL (MW: 65,000, Sigma Aldrich), 200 mg/ml of
soluble ELAS from bovine neck ligament (Elastin Products Co. Inc.), and 70 mg/ml of
COL I (6 month bovine corium) were dissolved in HFP (TCI America) and blended in
ratios of 98-2-0 PCL-ELAS-COL (intima), 45-45-10, 55-35-10, and 65-25-10 PCL-ELASCOL (media), and 70-0-30 PCL-ELAS-COL (adventitia).
To create vascular tubes, each polymer mixture was then loaded into a 3 ml plastic
Becton Dickinson syringe with an 18 gage blunt tip needle. Insulated Tygon tubing was
then run from the needle tip to a 3-1 (input-output) nozzle charged to 25 kV at an air gap
distance of 20 cm. The solutions were sequentially electrospun onto a 2 mm diameter
cylindrical mandrel rotating at 500 RPM with a translational speed of 6 cm/s over a
distance of 12 cm. Flow rates and volumes were as such: the intima was electrospun at a
rate of 4 ml/hr and a volume of 0.5 ml followed by a transition combining both intimal and
medial syringes for 0.2 ml at 2 ml/hr each. The intimal syringe was then shut off and the
medial layer was allowed to spin for 0.6 ml at 4 ml/hr followed by a transition between the
media and adventitia for 0.2 ml of polymer solution at 2 ml/hr each. Finally, the media
was stopped and the adventitia was allowed to spin for 0.4 ml at 4 ml/hr.
Each individual layer, 98-2-0, 45-45-10, 55-35-10, 65-25-10, and 70-0-30 PCLELAS-COL was electrospun onto a 2 mm diameter mandrel to observe the effect of
dynamic compliance on each layer. However, since the 2 mm diameter grafts were too
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small to use “dog bone” punches, rectangular mandrels were chosen for uniaxial tensile
testing. Blended ratios of 98-2-0 PCL-ELAS-COL (intima), 45-45-10, 55-35-10, and 6525-10 PCL-ELAS-COL (media), and 70-0-30 PCL-ELAS-COL (adventitia) were
electrospun separately onto a flat, rectangular mandrel at a rate of 4 ml/hr, 25kV, and an air
gap distance of 20 cm (2.5 cm wide x 10.2 cm long x 0.3 cm thick) at 500 RPM with a
translational speed of 6 cm/s over a distance of 12 cm to create separate layers for uniaxial
testing, utilizing the modulus for mathematical modeling.
All tubes and rectangular samples were cross-linked using a 50 mM solution of
EDC (Pierce) and 70 % ethanol (Sigma Aldrich) using a previously described method
[110].
Nonviable Pig Femoral Artery
Porcine femoral arteries were frozen in PBS, and subsequently washed 5 times for
30 minutes each in PBS. Artery was immediately tested thereafter. For uniaxial tensile
testing, samples were prepared by slicing the artery in the longitudinal direction, creating a
zero stress state. “Dog bone” shaped samples were then punched for testing. For dynamic
compliance, nonviable porcine femoral arteries were tested under the same simulated
physiological conditions.
Scaffold Characterization
Scaffold characterization was performed using scanning electron microscopy on the
electrospun mats (SEM, Zeiss EV050). SEM images were analyzed with ImageTool 3.0
software (Shareware provided by UTHSCSA). Multilayer electrospun vascular grafts were
dissected by cutting the graft in half in the longitudinal direction. Forceps were then used
to carefully peel apart the intimal, medial, and adventitial layers. These layers were then
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imaged on both sides and analyzed. Characterization included determining the average
fiber diameter and average pore area for the electrospun structure by taking the average of
60 measurements chosen randomly from across the image. Measurements for pore area
were defined as such: the space created by multiple fibers at a depth of only two fibers; no
fibers beyond the superficial surface were considered for pore area measurements. For all
of the measurements made from the SEM images, calibration of the ImageTool software
was done with the scale bar on each image.
Material Properties of Individual Layers
Uniaxial tensile testing was performed on six samples (n = 6) from one electrospun
sheet hydrated in PBS for 24 hours. “Dog-bone” shaped samples were punched from
electrospun mats (2.75 mm wide at their narrowest point with a gage length of 7.5 mm)
and tested on a MTS Bionix 200 testing system with a 100 N load cell (MTS Systems
Corp.) and an extension rate of 10.0 mm/min. Peak stress, modulus, and strain at break
were calculated using TestWorks version 4.
Mathematical Modeling
The constitutive equations developed by Vorp et al. [120, 261] are based on the
principle of the Lamé equations. Following similar assumptions as previously described
[261], a three-layered model (Figure 9) was used, describing CWS, at any radius, r, of the
three layers.
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Figure 9. Schematic adopted from [25, 26] showing cross-sectional view of the threelayered model. ADV (adventitia), MED (media), INT (intima).
Through this we come up with:

CWS =

R 2I PI − RO2 PO
RO2 − RI2

+

( PI − PO ) RI2 RO2
for RI≤ r ≤ RO
( RO2 − RI2 )r 2

(3)

Where RI is the inner radius of a particular layer, RO is the outer radius of a particular layer,
PI is the inner pressure of a particular layer, and PO is the outer pressure of a particular
layer.
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b3 (1 − υ INT ) + a 2b(1 + υ INT ) b3 (1 − υ MED ) + b 2c(1 + υMED )
+
(b 2 − a 2 ) EINT
(c 2 − b 2 ) EMED
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c 3 (1 − υ MED ) + b 2c(1 + υ MED ) c 3 (1 − υ ADV ) + d 2c(1 + υ ADV )
k2 =
+
(c 2 − b 2 ) EMED
(d 2 − c 2 ) E ADV

(7)

Where k1 and k2 are constants, EINT, EMED, and EADV represent the moduli for the intimal,
medial, and adventitial layers, respectively, υINT, υMED, and υADV represent Poisson’s ratio
for the intimal, medial, and adventitial layers respectively, and a, b, and c are the inner
radii for the intimal, medial, and adventitial layers, respectively, and d is the outer radii of
the adventitial layer (equations are adopted from [120, 260]).
Suture Retention
Suture retention testing was performed on six 2 mm inner diameter tubular
specimens (n = 6) from six different electrospun grafts, soaked in PBS for 24 hours at
37°C, on a MTS Bionix 200 testing system with a 50 N load cell (MTS Systems Corp.) and
an extension rate of 150.0 mm/min in accordance with the straight across procedure
described in section 8.8 of the American National Standards Institute (ANSI)/Association
for the Advancement of Medical Instrumentation (AAMI) ANSI/AAMI VP20:1994
entitled “Cardiovascular Implants – Vascular Graft Prostheses” [264]. 5-0 commercial
PDS™ II violet monofilament suture (Ethicon, Inc.) was placed 2 mm from the end of the
sample and extended until the suture had pulled through the graft. Peak load was recorded
in grams-force using TestWorks version 4.
Burst Pressure
Burst strength testing on six samples (n = 6) from six different electrospun grafts
was completed using a device designed in accordance with section 8.3.3.3 of ANSI/AAMI
VP20:1994 [264]. Tubes, 2–3 cm in length, were hydrated in PBS, fitted over 1.5 mm
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diameter nipples attached to the device, and secured with 2-0 SF suture. Air was
introduced into the system, increasing the pressure at a rate of 5 mmHg/s until the tubes
burst. Results are reported as the pressure in mmHg at which tubes ruptured.
Dynamic Compliance
Dynamic compliance was determined for six 2 mm inner diameter tubular grafts (n
= 6) taken from six different electrospun grafts at a length of 3 cm under simulated
physiological conditions in accordance with section 8.10 of ANSI/AAMI VP20:1994
[264]. Both individual layers and multi-layered tubular constructs were electrospun and
tested under the same conditions. The specimens were tested in an Intelligent Tissue
Engineering via Mechanical Stimulation (ITEMS™) Bioreactor developed by Tissue
Growth Technologies (Minnetonka, MN) filled with PBS at 37°C. The bioreactor
provided a cyclic (1 Hz, representing 60 beats per minute) pressure change to the inside of
the graft; three different pressure levels (90/50, 120/80, and 150/110 mmHg
systolic/diastolic) were investigated. Briefly, specimens were secured at either end to a
nipple with 2-0 SF suture and placed in the bioreactor chamber. PBS then filled the
chamber and was run continuously on the outside of the graft to maintain a temperature of
37oC and a pressure of 0 mmHg. Simultaneously, PBS was pumped through the inside of
the graft and an actuator in the bioreactor created the difference in pressure. Prior to
compliance measurements for each pressure level, all grafts were allowed to stress relax
for 30 minutes or 1800 cycles.
Internal pressure was measured with a pressure transducer capable of measuring
dynamic pressure up to 200 ± 2 mmHg, while the external diameter was recorded with a
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laser micrometer system with an accuracy of ±0.001 mm. Prior to insertion into the
bioreactor, the grafts were soaked in PBS at 37°C for 24 hours, after which time their
average wall thickness was measured. From this, the internal radii of the graft was
determined and used in the following equation to calculate compliance for each specimen:
% Compliance =

( R P 2 − R P1 ) / R P1

(P2 − P1 )

× 10 4

(8)

Where R is the internal radius, P1 is the lower internal pressure, and P2 is the higher
internal pressure [29]. Grafts were tested with individual layers electrospun at a wall
thickness of 200 μm, and with whole graft samples with an overall wall thickness of 500
μm.
Statistical Analysis
Unless otherwise stated, all statistical analysis was based on a Kruskal-Wallis one
way analysis of variance on ranks and a Tukey-Kramer pair-wise multiple comparison
procedure (α = 0.05) performed with the JMP®IN 4.0.3 statistical software package (SAS
Institute, Inc).

Results

Scaffold Characterization
SEM images in Appendix A depict the apparent differences between the inner and
outer surfaces of each layer. This demonstrates the differences in electrospun fibers when
transitioning from one polymer blend to the next. From the first layer, the intimal layer,
the two surfaces are fairly similar in appearance; however, differences arise when the inner
and outer surfaces of the medial and adventitial layers are considered, particularly at the
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transition from the medial to the adventitial layer. This transition produces very large
fibers that are most likely the result of wet electrospinning and fiber welding caused by the
blending of the two polymers and their subsequent electrical characteristics. While most
SEM images tended to contain a high packing density especially on the intimal and
adventitial layers, a wide range of fiber diameters were present. Cellular infiltration can be
inhibited by the packed fibers of the intimal layer containing lower amounts of natural
protein. However, where natural protein, such as COL, is more prevalent, infiltration and
migration may be more probable regardless of packing density. Here natural proteins can
attract cells inside the scaffold while larger fibers give way to large pores for migration.
As mentioned earlier, both COL and ELAS can provide the necessary recognizable protein
sequences to promote cellular interaction. A study by Barnes et al. demonstrated that
electrospun COL fibers promoted the infiltration of human FB [112]. Additionally, ELAS
peptides can influence signaling, chemotaxis, proliferation, and protease release via the
ELAS receptor [142].
After determining the feasibility of electrospinning three different polymeric blends
of both synthetic and natural polymers, the effect each individual layer posed on its
neighboring layers needed to be determined initially from the microscopic level.
Therefore, the medial layer was subjected to incremental increases in synthetic polymer,
PCL at 10 % each interval, and incremental decreases in natural polymer, ELAS at 10 %
each interval, resulting in medial blends of 45-45-10, 55-35-10, and 65-25-10 PCL-ELASCOL. At the macroscopic level, Figure 10 displays a dissected view of a three layered
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graft with a 45-45-10 PCL-ELAS-COL medial layer to provide a cross-sectional view and
the graft and demonstrate the relation of one layer to another.

Figure 10. Dissected view of a 45-45-10 three layered graft.
SEM images were taken of both the inner and outer surface, and average fiber
diameter was determined for each surface. Figure 11 displays the results of the inside and
outside fiber diameters of the intimal, medial and adventitial surfaces. Average fiber
diameter of each blend remained unchanged for the inner and outer surfaces of the intimal
layers. Medial surfaces, however, displayed a gradual decrease in average fiber diameter
for the outer surface, where 45-45-10 was significantly different (p< 0.05) from 65-25-10.
The inner surface remained unchanged with no significant differences. Adventitial layers
of all three blends demonstrated a gradual decrease in fiber diameter for the inner surface
with significant differences between 45-45-10 and 65-25-10, while the outer surface
remained unchanged.
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Figure 11. Average fiber diameter measurements taken from SEM images of the inside
and outside intimal (A), medial (B), and adventitial (C) layers of a 45-45-10, 55-35-10, and
65-25-10 PCL-ELAS-COL layer. * indicates significant differences between 45-45-10 and
65-25-10 (p< 0.05).
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Figure 12 displays the average pore area for the intimal, medial, and adventitial
layers. According to the results, like the average fiber diameter measurements in Figure
11, there was no change amongst the inner and outer surfaces of the intimal layers.
Similarities between Figure 11 and Figure 12 also existed for the medial surface and
adventitial surface where the average pore area values of the outer medial surface and inner
adventitial surface gradually decreased. This demonstrates a relationship between fiber
diameter and pore area, where larger fiber diameters can confer larger pores. Again
significant differences (p< 0.05) occurred between 45-45-10 and 65-25-10 for the outer
medial surface and inner adventitial surfaces. However, significant differences (p< 0.05)
also occurred between the 45-45-10 and 65-25-10 outer adventitial surfaces and between
the 45-45-10 and 55-35-10 outer medial surfaces.
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Figure 12. Average pore area measurements taken from SEM images of the inside and
outside intimal (A), medial (B), and adventitial (C) layers of a 45-45-10, 55-35-10, and 6525-10 PCL-ELAS-COL layer. * indicates a significant difference from 45-45-10 (p<
0.05).
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Uniaxial Tensile Testing of Individual Layers
Figure 13 displays the tensile properties of each layer electrospun individually onto
a flat mandrel. These properties provide further insight into how the materials will behave
when combined into one cohesive vascular graft. Initially, the medial layers, 45-45-10, 5535-10, and 65-25-10, display trends of increasing peak stress and tangential modulus with
increases in PCL content, while strain to break decreases. Average values for medial
layers gradually increased from 1.1 to 1.5 MPa for peak stress, 2.0 to 3.7 MPa for
tangential modulus, and gradually decreased from 0.9 to 0.7 mm/mm for strain to break.
Statistical differences for these medial layers existed only for strain to break values, where
45-45-10 was different from 55-35-10 and 45-45-10 was different from 65-25-10 (p<
0.05). Although medial layers revealed no differences for peak stress and modulus,
differences did exist for peak stress and modulus between all medial values and their
intimal (98-2-0) and adventitial values (70-0-30).
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Figure 13. Uniaxial tensile test values for peak stress, tangential modulus, and strain to
break for individual intimal, medial, and adventitial layers containing specific PCL-ELASCOL blends. * indicates significant differences between 55-35-10 and 65-25-10 while #
indicates a significant difference from 45-45-10, 55-35-10, and 65-25-10 (p< 0.05).
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Mathematical Modeling
Mathematical modeling was implemented in order to determine where we could
effect a change in graft behavior by altering individual layer moduli. Utilizing the
previously described equations, Figure 14A demonstrates that as stiffness increases for the
medial layer, there is both a subsequent decrease in CWS seen by the intimal layer and an
increase in CWS seen by the medial layer. So, when an increase in medial stiffness occurs,
it takes on more circumferential stress and decreases the amount of initial stress imposed
on the whole arterial wall. This could be beneficial for endothelial cell attachment and
proliferation. There is only a slight decrease in CWS for the adventitial layer.
Figure 14B displays an increase in the intimal modulus and how it affects the other
two layers. As modulus increases, the intimal layer is able to accept more stress and
relieve stress from the medial and adventitial layers, but only slightly. If the modulus is
increased in the adventitial layer, Figure 14C, then that layer is able to allow more stress
while it relieves a significant amount of stress from the intimal layer, and slightly increases
the amount of stress seen by the medial layer.
Finally, Figure 14D displays a comparison of the moduli values obtained from two
studies performed on human coronary arteries in comparison to the three-layered graft.
Values obtained from Lu et al. [265] are based on the assumption of a bi-layered scaffold
consisting of an intima-media and an adventitia, where moduli were 299 kPa and 132 kPa,
respectively. Additionally, values from Holzapfel et al. [266] considered a three-layered
structure, separating the intima, media, and adventitia for testing. The results for the
moduli were 7.56 kPa, 1.27 kPa, and 27.9 kPa for the intima, media, and adventitia,
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respectively. Figure 14D displays similar trends between Holzapfel values and the threelayered graft with the 45-45-10 PCL-ELAS-COL layer. Both decrease CWS from the
intimal to the medial layers, and both increase CWS transitioning from the medial to the
adventitial layer. This increase is more pronounced in the native artery since the
adventitial modulus is 22x larger than the medial modulus, whereas the adventitial layer in
the three-layered graft is only 5.6x larger. The adventitial layer in the Holzapfel study is
also responsible for the smaller decrease in CWS from the intima to the media, where both
the intimal moduli of the 45-45-10 and Holzapfel are 5.9x larger than the medial moduli.
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Figure 14. Mathematical modeling using equations 1-5 to determine CWS on increased
medial stiffness, increased intimal stiffness, increased adventitial stiffness, and a
comparison of the moduli found in [265] and [266] to the 45-45-10 medial layer graft.
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Suture Retention: Whole Graft
In Figure 15 suture retention results demonstrated that as PCL content in the medial
layer is increased and ELAS is decreased, an increase in force is required to pull the suture
through the graft. Average values ranged from 91-189 grams-force with significant
differences (p< 0.05) between 45-45-10 and 65-25-10 PCL-ELAS-COL. A nonviable
porcine femoral artery (nvPFA) and ePTFE were both used as comparison tools for the
three different grafts. nvPFA displayed a range of 235 - 358 gf while ePTFE ranged from
500 – 680 gf. This placed the 65-25-10 medial layer graft just within the range of nvPFA
with a peak value of 236 gf while peak values of 45-45-10 and 55-35-10 were lower.
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Figure 15. Suture retention with 5-0 PDS II suture for three-layered graft compositions
containing medial layers of 45-45-10, 55-35-10, and 65-25-10 PCL-ELAS-COL %.
nvPFA and ePTFE were tested as comparisons and the dashed line represents saphenous
vein [35]. * indicates significant differences between 45-45-10 and 65-25-10 (p< 0.05).
Burst Strength
Figure17 displays the burst pressure results of whole graft specimens for medial
layers 45-45-10, 55-35-10, and 65-25-10. Graft 45-45-10 PCL-ELAS-COL burst at an
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average pressure of 2387 mmHg whereas both 55-35-10 and 65-25-10 exceeded a pressure

Burst Strength (mmHg)

limit of 3000 mmHg on the pressure regulator being used to supply the burst system.
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Figure 16. Burst pressure results for whole graft specimens with medial layers of 45-4510, 55-35-10, and 65-25-10 PCL-ELAS-COL.
Dynamic Compliance: Individual and Whole Graft
Dynamic compliance measurements made with single layered graft specimens and
three-layered graft specimens provides an encompassing picture. Figure 17 displays the
compliance of individual layers at three different pressure readings. Calculated values
show that at lower pressures, the grafts displayed a larger standard deviation, indicating a
less stable reading. As pressure was increased these deviations decreased and better
measurements were obtained. At pressures of 120/80 mmHg, significant differences for
the medial layers included differences between 45-45-10 and 65-25-10 (p< 0.05), and
between 55-35-10 and 65-25-10 (p< 0.05). There was no difference between the 45-45-10
and 55-35-10 layers. This was also the case for pressures at 150/110 mmHg. 98-2-0 was
different from 70-0-30 for pressures of 120/80 and 150/110 (p< 0.05).
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Figure 17. Compliance determined from internal radii at three different mean arterial
pressures (90/50, 120/80, and 150/110 mmHg). *, ^, and # indicate significant differences
between 45-45-10 and 65-25-10, 55-35-10 and 65-25-10, and 98-2-0 and 70-0-30,
respectively (p< 0.05).
At 120/80 mmHg for Figure 17, average values were highest for the 98-2-0 layer at
2.45 % / 100 mmHg followed closely by 45-45-10 at 2.42 % / 100 mmHg and 55-35-10 at
2.41 % / 100 mmHg, sharing similar compliance values. 65-25-10 clearly demonstrates a
drop in compliance with an average value of 1.06 % / 100 mmHg, indicating a stiffer
material than the other two. This is confirmed by the tangential modulus results. 70-0-30
demonstrated the overall lowest compliance, 0.55 % / 100 mmHg, of all the grafts.
Figure 18 displays compliance values for whole graft combinations using the
materials tested in the individual layer compliance. Average values for these different
combinations ranged from 2.83 – 0.77 % / 100 mmHg at 120 mmHg with a gradual
decrease in compliance as PCL content in the medial layer was increased and ELAS
content was decreased. 45-45-10 was significantly different (p< 0.05) from both 55-35-10
and 65-25-10 for 90/50 mmHg, 120/80 mmHg, and 150/110 mmHg. Additionally, nvPFA
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and ePTFE were used as comparison tools. nvPFA was significantly different (p< 0.05)
from 55-35-10, 65-25-10, and ePTFE at a pressure of 120/80 mmHg, while 45-45-10 was
comparable to nvPFA. ePTFE was significantly different (p< 0.05) from all other
materials tested.
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Figure 18. Compliance determined from internal radii at three different mean arterial
pressures (90/50, 120/80, and 150/110 mmHg). *, # indicates significant differences
between 45-45-10 and 55-35-10, and 45-45-10 and 65-25-10, respectively (p< 0.05).
Discussion

Scaffold Characterization
Characterization and fiber measurements are important and help describe surface
morphology based on the electrospinning parameters used. This provides vital information
regarding potential cellular interaction with the surface and scaffold optimization at the
microscopic level. In this study, each individual layer needed to be examined for structural
analysis to provide key insights into future optimization strategies for a three layered
structure. This was accomplished by carefully separating the individual layers after a
complete multi-layered graft had been electrospun. Although the fibers between the layers

102

103
may have been slightly affected by pulling, stretching, and breaking, this method was
determined to be the best way in which to view between the layers.
Controlling the fiber diameter and tuning it to specific requirements can lead to
subsequent control over porosity and cellular behavior. This parameter is then adjustable
for each individual layer. To test the tunability of PCL, ELAS, and COL, SEM images
were taken of both the inner and outer surface of the media. These results showed that
fiber diameter gradually decreased on the outer surface and the inner surface of the media
and adventitia, respectively. Clearly, this demonstrates that as the blends decrease in
ELAS content and gain PCL there is a subsequent decrease in fiber diameter. This could
indicate two possibilities based on electrohydrodynamics: 1) fiber welding, displayed in
Figure 12 for both the medial and adventitial surfaces, decreases with the addition of PCL
and subtraction of ELAS, or 2) ELAS inherently has larger fiber diameters when
electrospun under these conditions; so, as ELAS content decreases, there is a direct
decrease in average fiber diameter as well. Three separate studies performed by our lab
have revealed that higher ELAS content conveys larger average fiber diameters [109, 110,
267]. One study demonstrated values at 0.8 μm for 50-50 PDO-ELAS blends and 0.4 μm
for 80-20 PDO-ELAS blends [109].
To demonstrate the further tunability of scaffold morphology, average pore area
measurements were also done. These measurements demonstrated that as fiber diameters
increased in size, pore area subsequently increased as well. From a structural perspective,
larger pores will allow for the dynamic movement of fibers as a scaffold is being subjected
to loads. Conversely, smaller pores restrict the fibers to a limited space and can cause the
103

104
scaffold to become stiffer without a change in polymer type or crystallinity, adversely
affecting the scaffolds mechanical properties. Cell-scaffold interactions are also changed
with a decrease or increase in pore area. A structure containing smaller pores will disallow
the movement of cells through the scaffold, causing them to attach and proliferate only on
the surface. Whereas, a structure that contains larger pores can permit the passage of cells
throughout the scaffold. These cell-scaffold characteristics also have the ability to change
the mechanical properties as tissue is formed and polymer degrades. Additionally, a larger
pore structure has a higher diffusivity and degraded polymer by-products can easily be
removed, changing the degradation rate. Therefore, scaffold optimization is of high
importance, especially when multiple polymers are chosen to create multiple scaffold
morphologies.
Uniaxial Tensile Testing of Individual Layers
Although spinning onto a flat mandrel may create slight alterations in the
electrostatic field in comparison to a cylindrical mandrel, the cylindrical mandrel for this
study was too small to perform mechanical testing in the circumferential direction. The
properties of individual layers provide some clues as to how a multi-layered vascular graft
should perform under physiological conditions when these results are used in conjunction
with a mathematical model. Firstly, peak stress indicates how much stress or pressure can
be applied to the structure prior to rupturing. If the desired medial layer is one that is fairly
weak with stress values around 1 MPa, its surrounding layers need to be able to take the
majority of the imposed stress. Secondly, modulus indicates how stiff the layer is going to
be, which will contribute to the overall compliance of the graft.
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Results from Figure 13 display a weaker medial layer surrounded by a strong
intima and adventitia, regardless of medial layer content. This is reflected in both peak
stress and tangential modulus graphs. Although the results are based on six samples
punched from a single electrospun sheet, similarities in uniaxial tensile values should be
seen if electrospun conditions remain the same. Electrospinning can be influenced by
several different factors, such as voltage, flow rate, concentration, solvent volatility,
temperature, and humidity, directly influencing fiber size and cellular interaction. In this
particular study, the authors made extensive efforts to keep all aspects of electrospinning
the same for consistent results.
Generally, native artery displays characteristics where the media bears the majority
of tension under in vivo conditions while the adventitia serves to protect the vessel from
overstretch. Lu et al. validated this notion by using an incremental model based on the
strain energy function, finding that in the circumferential direction the media and
adventitial layers of coronary artery bear 62 ± 13 % and 38 ± 13 % of tension, respectively
[265]. A separate study, Holzapfel et al., examined the individual layer-specific properties
of human coronary arteries and found their experimental data to indicate that the media
seemed to be the softest layer over the whole deformation domain, and intima and
adventitia exhibited considerable stiffness in the high loading domain [266]. Additionally,
ultimate tensile stress data indicated that the adventitia changes to a stiff “jacketlike” tube,
preventing the artery from overstretch or rupture.
Therefore, for the purpose of the theory behind this study, the intimal and
adventitial layers should be relatively stiff, while the medial layer is softer in comparison,
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but still able to take on a large amount of circumferential stress. So, the original concept of
the design is confirmed and can be applied to a whole graft scenario with the intimal layer
(98-2-0) providing initial stiffness with a compact PCL dominated structure to allow for
the attachment of ECs, the medial layer (45-45-10, 55-35-10, or 65-25-10) containing a
high amount of ELAS to decrease stiffness and a small portion of COL to attract cells into
the layer, and the adventitial layer (70-0-30) to prevent rupture and to attract cells from
outside the graft and into the matrix, producing three significantly different graft layers.
Mathematical Modeling
We wanted to observe the CWS at physiological pressures for changes in the
tangential modulus of medial layers 45-45-10, 55-35-10, and 65-25-10. Additionally, if
the material properties were to be fine tuned for the intimal and adventitial layers, then we
wanted to observe how these changes would affect the other layers. Finally, a comparison
of human coronary moduli (Figure 14D) [265, 266] was made with the 45-45-10 medial
layer graft to help further evaluate native arterial behavior in comparison to future graft
designs.
According to Figure 14A, 14B, and 14C, changes in layer stiffness can attribute
large or small changes in overall graft behavior. The most highly affected layer under all
three conditional changes is the intimal layer, relieving CWS or increasing CWS
depending on the layer that is changed. The medial layer is only affected through a direct
increase or decrease in layer modulus. Indirectly, it appears that it does not provide a
significant change to the whole graft. Current studies are being done to determine the
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validity of this hypothesis. Lastly, an indirect change in adventitia does not largely affect
graft mechanics, but a direct change causes major differences.
This model provides a picture as to how the graft will behave mechanically when
subjected to physiological pressures. Under these pressures, each layer is affected
differently as the stress travels through the wall of the graft. Vorp et al. [261] first
developed this model to predict how an implanted bioresorbable graft would behave in situ
by modeling a single layered graft encapsulated by tissue on either side of the graft. As the
graft degraded and the tissue grew, there would be changes to the moduli of both the graft
and tissue over time until the graft had fully resorbed, displaying again how critical the
time of graft degradation and tissue in-growth can be. Comparing the results of Vorp et al.
to this study, the three-layered behavior shows similarities when the inside and outside
layers increase in stiffness and the middle layer decreases in stiffness. This confirms that
the equations were properly interpreted for this study. From the standpoint of our design
implanted in situ, the transmural stress distribution will have to be modeled using a five
layered design to initially account for tissue growth on the inner and outer surfaces prior to
any type of cell migration.
The mechanical properties of human coronary artery from two separate studies
were compared to the multilayered graft with a medial layer of 45-45-10 PCL-ELAS-COL.
The moduli from each paper, Holzapfel et al. and Lu et al., were imported into equations 2
– 5 to calculate under the same assumed physiological pressure conditions as all other
specimens. Characteristics of graph shape were analyzed and it was shown that
Holzapfel’s intimal, medial, and adventitial moduli were similar to the shape of the 45-45107
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10 graph. While the 65-25-10 and 55-35-10 all have a drop in CWS from the intimal
layers to the medial layers, there is a slight drop in CWS transitioning from the medial
layer to the adventitial layer. Although it is not clearly evident, Figure 14D demonstrates a
slight drop in CWS from the intimal layer to the medial layer of Holzapfel et al. with a
large rise from the medial layer to the adventitial layer. The graph of Lu et al.
demonstrates instead a rise in CWS when transitioning from the intimal layer to the medial
layer with a large drop from the medial layer to the adventitial layer. This difference is
directly attributable to the testing conditions of those particular studies. Holzapfel
separated the three layers of an aged human coronary artery using a scalpel. Strips of the
separated tissue were then tested under uniaxial conditions. Lu et al. dissected an intact
coronary artery with the aid of a stereomicroscope. The intima-media was left intact and
tested under biaxial conditions with a circulative pump. The same was done with the
adventitia. Therefore, the results obtained from Lu et al.’s study were not as directly
related to our testing conditions and may have caused the difference seen in Figure 14D.
Additionally, the intima and media were left intact which provides a thicker wall and can
contribute to the larger stiffness seen in the medial layer compared to its adventitial layer,
299 kPa and 132 kPa respectively. Nonetheless, Holzapfel’s study is more closely related
to our testing conditions and should therefore be of main use for future mathematical
calculations.
Furthermore, Holzapfel’s study can be used as a tool to finely tune the
electrospinning parameters of each layer. The 45-45-10 graph shows similar trends, yet it
does not match the Holzapfel graph. In order to make the trends in either case equivalent,
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several options must be considered: 1) decreasing the stiffness in the intimal layer, 2)
increasing the stiffness of the medial layer, and 3) increasing the stiffness of the adventitial
layer. Relative to one another, the 45-45-10 graft contains a higher intimal stiffness and
lower medial and adventitial stiffness than Holzapfel. As Figure 14B demonstrated earlier,
a decrease in intimal stiffness will cause both the stress distribution of the medial and
adventitial layers to shift upward, taking on more stress. At the same time, an increase in
medial stiffness (Figure 14A) will cause the intimal layer to shift further downward,
decreasing the amount of stress imposed on it, while the medial layer shifts upward taking
on more stress. Finally, an increase in adventitial stiffness will once again create a
downward shift in the transmural stress distribution of the intimal layer with a slight
upward shift in the medial layer, while the adventitial layer has a significant upward shift.
These actions (decreasing the intimal stiffness, and increasing the medial and adventitial
stiffness) would have a pronounced effect on overall graft behavior and could match the
stress distribution seen with Holzapfel.
From an electrospinning standpoint, a full range of polymers blends would need to
be created. As we have shown, an increase in ELAS content will decrease the stiffness of
a material. Therefore, the addition of ELAS to the intimal layer would be a primary
starting point. Moreover, a higher ratio of PCL in the medial layer would cause an
increase in stiffness; however, the addition of PCL to the adventitial layer is questionable.
Here an increase in stiffness becomes a challenge since increasing the medial stiffness
creates a negative effect on the adventitial stress distribution. Therefore, a range of
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polymers with an increase in COL content and an increase in PCL content would be
required to determine the best course of action.
Suture Retention
In order for the implantation of a vascular graft to be successful a sufficient amount
of suture retention strength is needed. Although a graft may possess adequate strength that
will initially suffice, biodegradation of a vascular graft should be taken into consideration
as well. If a vascular graft is a rapidly degradable material, then the cyclic loads imposed
at the site of anastomosis could potentially fail. The “gold standard” for vascular bypass is
the saphenous vein. Ideally, suture retention results should fall within this range, a value
that averages 380 gf [268]. From our study, nvPFA is slightly below this average, and the
three-layered grafts tested in this study are also well below that of saphenous vein, while
ePTFE is significantly higher than saphenous vein and all grafting materials tested.
Nevertheless, it is encouraging that nvPFA displays values that are close to the grafts
manufactured for this study. Lastly, 45-45-10 and 65-25-10 were significantly different
from each other (p< 0.05), showing that a significant change in the medial layer provides a
significant change for the whole graft. Although biodegradation of PCL would be slow
enough to allow cellular infiltration and tissue development to occur, the results indicate
that further optimization of the graft design is needed.
Burst Strength
Burst strength of the three grafts demonstrated ample ability to withstand pressure.
The bursting properties also showed how changing the medial layer of the graft material
influenced its final burst pressure, proving that as the medial stiffness is increased the
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stresses imposed on both the intimal and adventitial layers are reduced and allowing the
graft to take on more pressure prior to bursting. Additionally, a separate test was
performed to test the influence of the “jacketlike” properties of the adventitial layer. After
the 55-35-10 and 65-25-10 grafts exceeded the pressure regulator, the adventitial layer was
slowly rubbed, causing a thin spot in the material. At this spot, an aneurysm formed
followed by graft bursting.
Dynamic Compliance: Individual and Whole Graft
The intimal layer, 98-2-0, had a surprisingly higher compliance value than
originally anticipated compared to the medial layer results. According to the modeling
results, there will not be a significant change in CWS seen by the medial layer and
adventitial layer with a slight increase or decrease in intimal stiffness, but a higher
compliance value could allow for a higher CWS in the medial layer than predicted, which
would result in an increased distension of the graft wall.
When enough PCL was added to the medial layer, the compliance dropped a
significant amount. Combinations of PCL and COL, though, clearly have a large impact
on scaffold compliance looking at the differences between 98-2-0, 65-25-10, and 70-0-30.
98-2-0, containing almost pure PCL, has a higher compliance than either of the other two
layers, but no COL is present. At the other side of the spectrum, 70 % PCL and 30 % COL
in the adventitial layer with 0 % ELAS has the lowest compliance of all the grafts. The
medial layer has a slight amount of COL present at 10 % and provides a similar
compliance value to 98-2-0 at significantly lower PCL percentages. COL’s impact is
somewhat contradictory to other studies which have shown that higher COL content
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dictates a higher compliance [257]. This could be explained by the extraction processes
undertaken between the two studies and the possible age difference in the skin used.
When these three layers are superposed in a whole graft, their individual
compliance results should be additive, contributing to the combined behavior of the three
layers. Medial layer differences were tested to see if a higher stiffness would significantly
alter the compliance of the whole graft. This was confirmed with the results. The highest
average compliance was demonstrated by the 45-45-10 PCL-ELAS-COL followed by 5535-10 and 65-25-10. This showed that when all of the layers worked together a lower
compliance value was achieved with decreases in ELAS and increases in PCL content in
the medial layer. Referring back to the individual compliance results of the three medial
layers tested, this is surprising considering that 45-45-10 and 55-35-10 were similar at
120/80 mmHg. The significant decrease in compliance found in the 55-35-10 graft (p<
0.05), which was found to be similar to 45-45-10 in Figure 17, could be different due to a
combination of a slight increase in stiffness and the outer 70-0-30 layer. As the medial
layer stiffness increases the adventitial layer is able to perform a better “jacket-like” duty
and prevent the graft from distending too far. This is confirmed by modeling where an
increase in medial stiffness provides an increase in the amount of CWS taken by it and a
decrease in the amount of CWS taken by the adventitial layer.
nvPFA demonstrated that ranges of both 45-45-10 and 55-35-10 PCL-ELAS-COL
fell within its range at 120/80 mmHg. Additionallly, these values also fell within the initial
compliance range of L’Heureux et al. tissue engineered blood vessel, an average of 3.4 % /
100 mmHg [164]. In the L’Heureux study, the graft was explanted after 6 months and
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demonstrated a remarkably higher average compliance value of 8.8 % / 100 mmHg which
was comparable to that of internal mammary artery. This is encouraging for this study,
indicating that the initial compliance does not have to exactly match native arterial
compliance values. Although mismatch can lead to intimal hyperplasia and graft failure, a
complete match of graft and arterial compliance properties may end up in graft failure as
well since the construct may be too weak. In vivo, mechanical properties can change
drastically when using a bioresorbable scaffold. Theoretically, compliance could increase
significantly as the synthetic polymer structures degrade. Therefore, an identical starting
compliance could lead to aneurysm due to polymer degradation, while an initially lower
compliance could end up an identical match long before intimal hyperplasia.As an
alternative approach to vascular design, compliance values could actually be slightly lower
than native tissue so as to allow for future increased compliance upon scaffold degradation
and remodeling.
General Discussion
Multi-layer electrospinning was first attempted by Kidoaki et al. [215] using COL,
gelatin, segmented polyurethane, and PEO. Since then multi-layer electrospinning has
been studied using PCL, PLA, PDO, Poly(glycolide-co-trimethylene carbonate), gelatin,
and ELAS [98, 108, 153, 216]. These studies employed different uses of multilayered
techniques. Smith et al. [108] electrospun PDO-ELAS bilayered constructs with a suture
wound in the center for reinforcement. Vaz et al. [98] electrospun a bilayered tube
structure made of PCL and PLA, varying the anisotropy of the layers, but not including
natural polymers. Yang et al. [216] performed a layer-by-layer approach electrospinning
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PCL and COL together, seeding human dermal fibroblasts (HDF), and then repeating the
PCL/COL and HDF layers. These cellularized constructs were done is sheet form and not
with tubes. Thomas et al. [153] utilized PGA, ELAS, and gelatin in a 3 layered form.
However, the use of PGA and gelatin would not be conducive to an arterial graft as gelatin,
in vivo, has been shown to display a large cytotoxic response [217] and PGA is a fast
degrading polymer. Additionally, only one study used a cross-linker to stabilize the
natural polymer, Smith et al. The use of PCL, ELAS, and COL in tubular form with
unique combinations for each layer, taking a closer look at how electrospun constructs
containing different polymer blends in different layers had yet to be done until now. This
technique allows one to control the parameters of each layer, tuning it to the specific
desired outcome. Native tissue has been studied relentlessly, using mechanical properties
and mathematical modeling of coronary intima, media, and adventitia to gain information
that explains how the arterial wall reacts under physiological conditions [120, 265, 266,
269-273]. Ultimately, each layer in an artery has a specific function to allow the vessel to
continue transporting blood and nutrients. A vascular graft must provide this same
function over an extended period of time, avoiding aneurysm formation, graft rupture, and
intimal hyperplasia.
Using a multi-layered technique, grafts can be tailored to exact specifications and
optimized thereafter. Aneurysms and graft rupture could be avoided through the use of a
“jacketlike” outer layer that would prevent the graft from overextending itself. The middle
layer can be tailored to have the lowest modulus, providing the distension required for
proper compliance and blood flow, similar to native artery. The inner most layer can be
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manufactured so that ECs will attach and proliferate, creating a confluent, nonthrombogenic surface, preventing or significantly decreasing intimal hyperplasia.

Conclusion
In conclusion, we were able to produce nano- to micro-fibrous three-layered small

diameter vascular grafts with distinct material properties for each layer. These layers
proved to change the overall graft properties in regards to fiber diameter, suture retention,
and compliance, containing values that were within the range of native artery. Individual
layer evaluation and mathematical modeling proved to be beneficial in the overall analysis
of graft behavior, and can be used in the future to help predict how certain material
combinations will act. This prediction will allow for future graft optimization,
electrospinning multiple combinations of polymers in order to develop the highest quality
vascular replacement. Additionally, future work will investigate possible limitations such
as delamination of the layers while the scaffold undergoes degradation in addition to
adequate pore size for cellular infiltration. To test this, both acellular and cellular in vitro
degradation studies will be performed under static and dynamic culture. These tests will
determine both the migratory capabilities of the scaffolds and how they will effectively
degrade under physiological conditions.

115

CHAPTER 4: Investigating Crosslinking Parameters for
Polycaprolactone, Elastin, Collagen, and Silk Blended Scaffolds
Abstract
The purpose of this study was to evaluate the affect of two different cross-linking

reagents: EDC and genipin. These two cross-linkers had undergone preliminary
investigation by our lab, however, we aimed to elucidate any microscopic or macroscopic
differences using three different biopolymers, ELAS, COL, and SF, blended with a
biodegradable polymer, PCL. Results from the study determined through a TNBS assay
that percent cross-linking increased as higher molarities of reagents were used.
Additionally, BCA protein assays indicated that higher concentrations of cross-linking
molarity also tended to cross-link scaffolds at a faster rate than lower concentrations. Fiber
diameter measurements displayed differences as ELAS protein content was increased in
addition to an increase in diameter due to genipin cross-linking. Tensile strength testing,
on the other hand, did not produce significant changes in material properties between the
two cross-linkers. This study provided insight into the reaction rates, degree of crosslinking, and macroscopic properties of EDC and genipin.

Introduction
Electrospinning can be used to process native, synthetic or blended polymers into

fibrous mats that show considerable promise as tissue engineering scaffolds [274]. Both
scaffold and fiber-level properties can be adjusted at several stages in the electrospinning
process. Fiber composition and diameter can be tailored based upon polymer/solvent
concentrations and polymer identity. Once completed, the material properties of a protein116
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based scaffold can be further modified through various cross-linking protocols [275]. Each
of these variables can be manipulated and tuned to produce a scaffold that meets two basic
criteria. First, the macroscale material properties and architectural features of the
electrospun scaffold must be consistent and mimic the profile of the native tissue of
interest. Second, the local microscale environment must provide physiologically relevant
binding sites to anchor cells to the surrounding scaffold [274]. In vivo, COL possesses a
specific amino acid sequence, Arginine-Glycine-Aspartic acid (RGD), which provides a
specific site for cell-integrin attachment. Although ELAS does not contain these RGD
peptides, it possesses a Valine-Glycine-Valine-Alanine-Proline-Glycine (VGVAPG)
peptide sequence which is conducive to cellular attachment at the ELAS receptor or
through the αvβ3 integrin protein [137].
The native ECM of the vasculature is composed mostly of COL and ELAS. These
ECM components are constantly synthesized, secreted, oriented, and modified by the
cellular components that they support. Classically, the function of native ECM was only
believed to be as a structural framework for tissues. However the ECM, through
interaction with receptors on the surfaces of cells, directly takes part in promoting cell
adhesion, migration, growth, differentiation, and apoptosis. The ECM also plays a role in
cytokine activity and intracellular signaling, both of which serve numerous functions in
cell regulation and activation [258]. COL is the most abundant protein in the human body,
a key element of the ECM, and imparts structural integrity and tensile strength to tissues.
Within the native architecture of an artery, particularly the adventitia, collagens type I and
III prevent aneurysmal formations under high physiological pressures by providing a
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“jacket-like” structure. ELAS is one of the main structural components of the vascular
ECM. Its principal role is to provide elastic recoil properties and resilience to proper
function of tissues that are subject to repetitive distension and physical stress. Natively
both COL and ELAS are insoluble proteins containing isodesomosine and desmosine
crosslinks [139, 142, 276]. However, when these proteins are extracted for biomedical
use, they become soluble structures, leaving them readily dissolvable by aqueous
environments.
In addition to native proteins, other proteins have been gaining some momentum
for biomaterials research. SF is an intriguing natural protein, used for centuries as a
medical grade suture, which is gaining momentum as a tissue engineering scaffold due to
its unique blend of material characteristics and bioactivity. SF exhibits excellent
biocompatibility with a foreign body response comparable to other degradable sutures,
hemocompatibility, and oxygen and water permeability. SF also possesses remarkable
mechanical properties not seen in other naturally occurring proteins [218-220]. SF has
also been recently utilized in the creation of electrospun bioresorbable vascular grafts with
promising results. Zhang et al. successfully seeded electrospun SF with both human aortic
endothelial cells (hAEC) and human coronary artery smooth muscle cells (hCASMC)
[277]. Both hAECs and hCASMCs demonstrated an affinity for the electrospun SF.
In order to successfully create a three dimensional scaffold structure containing
COL and ELAS, fixation techniques must be investigated to fine tune both macroscopic
and microscopic properties. By themselves, COL and ELAS are unable to support their
own structure without fixation. Several studies have demonstrated this, where both
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proteins immediately dissolve upon immersion in an aqueous solution [110, 278]. Stable
proteins that have the potential to improve cell adhesion and infiltration of the scaffolds
alongside an improved mechanical performance would be essential to a tissue engineered
vascular replacement. The most common crosslinker, glutaraldehyde, has been used with
numerous types of electrospun scaffolds [222, 233, 237-240], but with cytotoxic
drawbacks [241]. EDC and genipin (GEN), on the other hand, have exhibited lower
cytotoxicity [241-243], making them better suited for implantation. While COL and ELAS
require the use of a chemical crosslinker, SF has been shown to form β-sheet crosslink
formations when SF scaffolds were dipped in either ethanol or methanol for 30 minutes
[279]. Therefore, this study aimed to determine suitable cross-linking conditions using
both EDC and GEN dissolved in ethanol for blended electrospun scaffolds composed of
ELAS, COL, and SF blended with a synthetic biodegradable material, PCL.

Materials and Methods

Protein Extraction
SF was extracted from the cocoons of Bombyx mori silk worms (The Yarn Tree)
through an established protocol [280]. Briefly, the cocoons are cut into pieces and boiled
in a 0.02 M Na2CO3 (Sigma Aldrich) solution for 30 minutes to remove the sericin gum,
followed by thorough rinsing in de-ionized water (DI), and drying in a fume hood. The SF
is then dissolved in a LiBr (Fisher Scientific) solution at 60°C for 4 hours. This solution is
then dialyzed against deionized water for 3 days using 3500 MWCO dialysis tubing
(Fisher Scientific). The SF solution is then frozen and lyophilized to provide a pure SF for
electrospinning.
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COL type I was extracted from 6 month bovine corium through an acetic acid
based process previously described [262]. Briefly, tissue is homogenized, suspended in
acetic acid, and subsequently purified via a series of dissolutions, precipitations (using
NaCl (Fisher Scientific) and Tris (Fisher Scientific)), and dialyses [263]. Following the
final dialysis, COL solutions are frozen and lyophilized.
Electrospinning
The electrospinning setup consisted of a syringe pump (KD Scientific), a high
voltage power supply (Spellman CZE1000R, Spellman High Voltage Electronics Corp.), a
plastic Becton Dickinson syringe used as the polymer reservoir, attached to an 18-gauge
blunt-tip needle. Concentrations of 150 mg/ml of PCL (MW: 125,000, Lakeshore
Biomaterials), 200 mg/ml of soluble ELAS from bovine neck ligament (Elastin Products
Co. Inc.), 70 mg/ml of COL I (6 month bovine corium), and 80 mg/ml of SF were
dissolved in HFP (TCI America). These were then blended in ratios of 50-50 PCL-ELAS,
PCL-COL, and PCL-SF. Additionally, scaffold materials were blended in ratios of 45-4510, 55-35-10, 65-25-10, 45-10-45, 55-10-35, and 65-10-25 PCL-ELAS-COL and PCLELAS-SF. To evaluate both cross-linking and material properties, blended scaffolds were
electrospun onto rectangular mandrels measuring 2.5 cm wide x 10.2 cm long x 0.3 cm
thick. The parameters for electrospinning were kept constant with an applied voltage of
25 kV, air gap distance (distance between the needle and rotating drum) of 15 cm, and
solution dispensing rate of 4 ml/hr
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Cross-linking
Scaffolds were cross-linked using EDC (FlukaBiochemika), genipin (GEN, Wako
Pure Chemical Industries, Ltd.). In order to determine optimal cross-linking parameters, a
range of concentrations, solvent additives, and time points were used to crosslink ELAS,
COL, and SF blended scaffolds. Using EDC, a 5 and 50 mM cross-linking solution was
prepared in 90 % ethanol (Fisher Scientific) with a 0, 5, and 10% addition of PBS to the
ethanol mixture. EDC has been previously shown to cross-link PCL-COL scaffolds at a
concentration of 5 mM [281]. Therefore, 50 mM was chosen as a significantly higher
concentration. The addition of an aqueous solution, PBS, to the ethanol was used to
determine the extent of cross-linking that would occur prior to protein dissipation. In this
way, we wanted to optimize cross-linking parameters and determine if the addition of PBS
would affect the cross-link ability of the scaffolds. Scaffolds for TNBS Assay (Research
Organics) were placed in the EDC solution, and allowed to cross-link for 18 hours [275]
followed by a 0.1M Na2HPO4 rinse for 1 hour and a PBS rinse for 1 hour.
Using GEN, a 10 and 30 mM cross-linking solution was prepared in 90 % ethanol
(Fisher Scientific) with a 0, 5, and 10% addition of PBS to the ethanol mixture. In the case
for GEN, 30 mM has been previously shown to fully cross-link collagen samples over a
period of 72 hours at room temperature [245]. Therefore, a lower concentration was also
chosen for GEN, 10 mM, however, based on the length of time it takes for GEN to
chemically cross-link protein structures we did not choose a 10x lower concentration. Like
the EDC cross-linked scaffolds, we again wanted to determine the cross-linking parameters
due to the addition of PBS in the ethanol mixture. Scaffolds for TNBS were electrospun

121

122
and placed in the cross-linking solution for a period of 72 hours [245], followed by a PBS
rinse for 2 hours.
TNBS Assay
The concentration of free primary amine groups present in cross-linked electrospun
protein scaffolds (ELAS, COL, and SF) was determined using a TNBS Assay (Research
Organics) [244]. Scaffold samples were electrospun, punched using a 12 mm biopsy
punch, massed and cross-linked using the procedures listed above. Samples were placed in
15mL Fisherbrand® centrifuge tubes. NaHCO3 (1.0 mL 4% w/v) and TNBS (1.0 mL 0.5%
w/v) were added and placed in an incubator at 40oC for 2 hr. 3.0 mL of 6M HCL was then
added to the solution, which was placed in an oven at 60oC for 2 hr. The samples were
diluted with 9 mL of PBS, cooled to room temperature. The absorbance at 345 nm was
measured using a SPECTRAmax® PLUS384microplate spectrophotometer. Measured
absorbance values were then placed into a percent cross-linking equation
⎤
⎡ Absc
Massc ⎥
⎢
%Cross − linked = 1 − ⎢
⎥
Absnc
⎥
⎢
Mass
nc ⎦
⎣

WhereAbsc is the measured absorbance of the cross-linked solution, Absnc is the measured
absorbance of the non-cross-linked solution, Massc is the dry mass of the cross-linked
scaffold, and Massnc is the dry mass of the non-cross-linked scaffold. The sample size for
each measured absorbance group was n = 3, and each sample was run in triplicate.
Protein Assay
In order to determine time dependence of cross-linking at room temperature,
scaffolds were cross-linked using EDC protocols at times of 0, 10, 30, 60, 180, and 1080
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minutes, and using GEN protocols at times of 0, 6, 24, 48, and 72 hours. Following the
specified cross-linking time periods, the EDC or GEN mixture was immediately removed
and scaffolds were washed in 2 ml of 90 % ethanol 4 times. These cross-linked scaffolds
were then placed in a 48 well plate and filled with 500 μl of PBS. The scaffolds were
allowed to incubate overnight at room temperature and their protein release was measured
using a Pierce BCA Protein Assay Kit (Thermo Scientific) with a working range of 20 –
2000 μg/ml. Briefly, 25 μl of each standard and unknown were pipetted into a 96 well
plate. 200 μl of the working reagent was then mixed with the standard and unknowns, and
subsequently incubated at 37oC for 30 minutes. After incubation, the samples were
measured at an absorbance wavelength of 562 nm. The sample size for each measured
absorbance group was n = 3, and each sample was run in triplicate.
Scaffold Characterization
Scaffold characterization was performed using scanning electron microscopy on the
electrospun mats (SEM, Zeiss EV050). SEM images were analyzed with ImageTool 3.0
software (Shareware provided by UTHSCSA). Measurements for fiber diameter were
defined such that no fibers beyond the superficial surface were considered for
measurement. For each SEM image, sixty random fibers were measured. Additionally,
calibration of the ImageTool software was done with the scale bar on each image for all
measurements.
Uniaxial Tensile Testing
Uniaxial tensile testing was performed on six samples (n = 6) from one cross-linked
electrospun sheet hydrated in PBS for 24 hours. “Dog-bone” shaped samples were
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punched from electrospun mats (2.75 mm wide at their narrowest point with a gage length
of 7.5 mm) and tested on a MTS Bionix 200 testing system with a 100 N load cell (MTS
Systems Corp.) and an extension rate of 10.0 mm/min. Peak stress, modulus, and strain at
break were calculated using TestWorks version 4.
Results

% Cross-linked
The aim of this portion of the experiment was to test samples for their optimal
cross-linking conditions. This was done through the use of two different molarities, two
different crosslinkers, and three sets of PBS additions. The hypothesis behind the
experiment was that higher molarities of cross-linking solution would have more available
moieties to form cross-linked structures, further stabilizing the materials to produce a
higher percent cross-linked value. The different crosslinkers, EDC and GEN, were chosen
because of their aforementioned low cytotoxicity and biocompatibility. Finally, 0, 5 and
10% PBS additions to the ethanol/crosslinker solutions were chosen to determine how PBS
would affect the percentage of cross-linking. It was hypothesized that if a higher amount
of PBS was added to the solution then a larger portion of protein would dissipate out of the
scaffold prior to the TNBS assay, leaving a lower number of free amine groups left in
solution and thereby possessing a lower absorbance value.
According to the results displayed in Figure 19, absorbance values using the EDC
crosslinker displayed a clear upward trend for both ELAS and COL samples, where both
COL and ELAS cross-linked absorbance values were significantly different (p < 0.05)
from their no treatment (NT) values. Specifically for ELAS, 0% PBS for 50mM
concentrations was different (p < 0.05) from both 5 and 10% PBS additions to the cross124
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linking solution. This would indicate that both 5 and 10% successfully dissipated free
amine groups prior to TNBS treatment. For COL, 10% PBS for a concentration of 5 mM
was different (p < 0.05) from 5% PBS, while 10% PBS for a concentration of 50 mM was
different (p < 0.05) from both 0 and 5%. PBS additions to the COL solutions did not
exhibit the same trends as ELAS. Instead, the addition of water appears to not have
dissipated the free amine groups prior to TNBS treatment, but it seems to have made them
more readily available to dissociate during TNBS treatment, decreasing cross-linking.
Both ELAS and COL results aim to confirm that a larger number of free amine groups
exist in solutions of uncross-linked materials while less free amine groups existed in crosslinked materials with the use of EDC. For SF, NT absorbance values were not different
from any of the 5 mM concentrations nor were any of the 5mM concentrations different
from each other, however, the SF 50 mM concentrations were different (p < 0.05) from
NT values, indicating that there may have been some carboxyl groups available on SF for
EDC cross-linking but that a higher concentration of crosslinker was needed to
successfully create an amide bond.
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Figure 19. Absorbance values at 342 nm for TNBS assays with EDC cross-linking for 5050 PCL-ELAS, PCL-COL, and PCL-SF.* indicates that 0, 5, and 10 % PBS were
significantly different from NT. + indicates either 0 or 5 % PBS significantly different
from 10 % PBS.
Results displayed in Figure 20 demonstrate similar trends for ELAS cross-linked
samples; ELAS NT samples are significantly different (p < 0.05) from both 10 and 30 mM
GEN concentrations. Additionally, 10% PBS is different (p < 0.05) from 0% PBS for both
10 and 30 mM concentrations, where higher absorbance values were seen in the 0% PBS
samples. This would again indicate that free amine groups were dissipated from the
scaffold during the cross-linking process, producing smaller absorbance values. Similar
trends are seen in 30 mM COL samples, however, NT COL samples possess lower
absorbance values than any of the 10 or 30mM concentrations. This possibly indicates an
interference from the GEN cross-linking given that GEN turns a green-blue color during
the cross-linking process and the absorbance values are measured at 345 nm, a wavelength
within the range of green. This interference can be seen again in the SF samples, which
also possess higher absorbance values than their NT samples.
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Figure 20. Absorbance values at 342 nm for TNBS assays with GEN cross-linking for 5050 PCL-ELAS, PCL-COL, and PCL-SF. * indicates that 0, 5, and 10 % PBS were
significantly different from NT. + indicates either 0 or 5 % PBS significantly different
from 10 % PBS.
Figure 21 demonstrates the percent cross-linked values for all EDC samples.
Averages suggested an upward trend as EDC concentration increases with 21.8% for 0% 5
mM ELAS and 33.1% for 0% 50 mM ELAS and values of 8.0% for 0% 5 mM COL and
20.4% for 0% 50 mM COL. However, no differences between EDC concentrations occur
for ELAS, and only one difference for COL exists between 5% 50 mM and 0% 5 mM.
Although closely clustered together, results from Figure 19 would suggest that a lower
absorbance value would have created a lower percent cross-linked value. However,
original weight values were used in the calculation of these percentages, which would
skew the results of absorbance values and appear as a higher percentage of cross-linking
than in actuality. The way in which weight values skew the results for percent crosslinking can be most readily seen in the SF samples where values contain extremely large
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standard deviations and averages around 25% which would be expected to be more near
0%.
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Figure 21. Percent cross-linking based on absorbance values obtained from Figure 19 and
dry mass values for 50-50 PCL-ELAS, PCL-COL, and PCL-SF cross-linked with EDC.
Observing Figure 22, again similar trends to EDC concentrations are displayed
with ELAS samples increasing in percent cross-linking as GEN concentrations increase
from 22.7% to 33.4% cross-linking for 10 and 30mM concentrations, respectively.
However, COL samples display a wide range of negative values further exacerbating the
affect of the green-blue color due to the GEN crosslinker. Meanwhile, SF samples again
display similar results as with Figure 21, containing high standard deviations and no
significant differences. The results from the GEN TNBS assay demonstrated that a
significant amount of protein needed to be present within the scaffold in order to create a
successful experiment, as with the ELAS samples, without the negative effects of the GEN
crosslinker interference.
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Figure 22. Percent cross-linking based on absorbance values obtained from Figure 20 and
dry mass values for 50-50 PCL-ELAS, PCL-COL, and PCL-SF cross-linked with GEN.
Cross-linking Kinetics
In order to further determine the characteristics of cross-linking with regards to
time dependency, a protein assay was used to measure protein release from the scaffold
materials pre- and post-cross-linking. These results demonstrated the kinetics of the
reactions that occur within the scaffolds and the differences between either COL or ELAS
blended structures. Figure 23 displays the reaction of GEN at concentrations of 10 and 30
mM. These results showed similar reaction rates regardless of the protein being crosslinked. Figure 23 (top) demonstrated a quicker rate of reaction time with COL structures
and a slower reaction time with ELAS, dropping from an intial protein concentration of 4.1
and 4.6 mg/ml to a protein concentration of 0.9 and 2.9 mg/ml for COL and ELAS blended
samples, respectively, within the first 6 hours. Figure 23 (bottom) displays similar reaction
rates with a higher cross-linking molarity dropping from 4.5 and 5.6 mg/ml to 0.8 and 2.4
mg/ml for COL and ELAS, respectively, within the first 6 hours. These reactions begin to
slow down, but continually decrease their protein release from the scaffold materials until
times of 48 and 72 hours. These results may have been influenced by the green-blue color
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that bleeds from the genipin cross-linked scaffolds, interfering with the absorbance output
at a wavelength of 562 nm.
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Figure 23. Results from BCA protein assay measuring protein concentration as a function
of time. (Top) Represents time dependency with 10mM GEN cross-linking. (Bottom)
Represents time dependency with 30mM GEN cross-linking.
While results from GEN displayed interference with the protein assay, results from
the EDC cross-linked scaffolds showed slower reactions rates with COL blended scaffolds
when cross-linking molarity was decreased to 5 mM. This is evident in Figure 24 (top)
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where the protein concentration of the COL blended scaffolds decreases from 0.44 to 0.42
mg/ml after a period of ten minutes; however, 50 mM EDC, in Figure 24 (bottom), crosslinked the COL scaffolds at a much higher rate decreasing from 4.1 to 0.6 mg/ml. ELAS
blended scaffolds were almost fully cross-linked after 10 minutes decreasing protein
release concentrations from 3.5 to 1.1 mg/ml for 5mM EDC and 4.6 to 1.4 mg/ml for
50mM EDC. For both COL and ELAS blended scaffolds, cross-linking is still occurring
after 10 minutes with significant differences between 10 and 30 minute samples.
However, it is clearly evident that cross-linking occurs faster in ELAS blended scaffolds
than it does for COL blended scaffolds, where no significant differences are present after
30 minutes of cross-linking time in ELAS samples. Nevertheless, differences are present
between 30 and 180 minutes for 50mM cross-linked COL samples, and 30, 60, and 180
minutes are all different from each other with 5mM samples. These results prove that
EDC reacts faster in ELAS samples and that crosslinker molarity plays a vital role in
reaction rates, providing more available chemical to produce crosslinks with carboxyl
groups.
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Figure 24. Results from BCA protein assay measuring protein concentration as a function
of time. (Top) Represents time dependency with 5mM EDC cross-linking. (Bottom)
Represents time dependency with 50mM EDC cross-linking.
Fiber Diameter
Fiber diameter results were measured to determine whether or not chemical crosslinking with either EDC or GEN would result in an increase, decrease, or no change in
fiber diameter. Observing the general trends in fiber diameter from Figure 25 (top), ELAS
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has an evident affect on the PCL-ELAS-COL blended scaffolds, where as ELAS content is
increased the overall average fiber diameter increases as well. This is apparent with
uncross-linked scaffold averages ranging from 1.1 – 2.3 μm. Interestingly, cross-linking
significantly increases average fiber diameter. This is especially apparent in 45-45-10
scaffolds where the average fiber size is 3.1 and 3.9 μm for EDC and GEN, respectively.
Additionally, these 45-45-10 samples were all significantly different from each other. 5535-10 samples also displayed significant differences, where GEN cross-linked scaffolds
were different from both EDC and uncross-linked (No Xlink) scaffolds. Both trends in 4545-10 and 55-35-10 scaffolds with GEN cross-linking displayed increased fiber diameters
when compared to either EDC or No Xlink. Significant differences were present in 65-2510 scaffolds where GEN was different from both EDC and No Xlink, however, the average
fiber diameter for the GEN cross-linked scaffolds of 65-25-10 were lower than both EDC
and No Xlink, indicating the existence of a threshold for the relationship between fiber
diameter increase with GEN and ELAS concentration in the electrospun solution. When
the solution ratios were reversed and higher quantities of COL were added to the
electrospun solution, there were very few trends and cross-linking did not seem to affect
fiber diameter as pronounced as when higher quantities of ELAS were added to the
solutions. No differences existed for either 45-10-45 or 65-10-25, however, differences
were present for 55-10-35 where No Xlink was different from both GEN and EDC crosslinked scaffolds.
In Figure 25 (bottom), it is evident that higher quantities of ELAS did not affect the
fiber diameter size when COL was replaced by SF in the electrospun solution. This was
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shown through the lack of significant differences amongst the cross-linked and uncrosslinked samples. For 45-45-10 there were no differences, and for both 55-35-10 and 65-2510 differences were between No Xlink and both EDC and GEN cross-linked scaffolds.
Additionally, as less ELAS was added to the polymer solution, average fiber diameter
increased amongst No Xlink scaffolds. When the SF and ELAS ratios were reversed, fiber
diameter increased appreciably. Trends demonstrated that as SF quantities incrementally
decreased from 45 to 65 fiber diameter also decreased. This was present regardless of
crosslinker type. Differences amongst the groups were as such: 45-10-45 No Xlink was
different from both EDC and GEN, 55-10-35 were all different from each other, and 6510-25 GEN cross-linked scaffolds were different from both EDC and No Xlink. None of
the significant differences present amongst the groups displayed any similar
characteristics, except that No Xlink scaffolds had a higher average fiber diameter than
either cross-linked group.
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Figure 25. Results from fiber diameter measurements to determine differences between
cross-linkers. (Top) Represents fiber diameters with PCL-ELAS-COL blended scaffolds
(Bottom) Represents fiber diameter measurements with PCL-ELAS-SF blended scaffolds.
* represents a significant difference between EDC and GEN. + represents a significant
difference between No Xlink and both EDC and GEN.
Figure 26 portrayed both fiber diameter and % cross-linked to determine whether
or not a correlation existed between the two for blended scaffolds with PCL, ELAS, COL,
and SF. These scaffolds exhibited an incremental increase in fiber diameter of 0.64, 0.60,
1.4, and 2.8 μm with the addition of COL, ELAS, and SF cross-linked with 10mM GEN,
respectively. These results also confirmed the fiber diameter results from Figure 25, where
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GEN caused an increase in fiber diameter for ELAS blended scaffolds when compared to
EDC, but no difference was seen in either SF or COL blended samples. % cross-linked
displayed incremental increases in cross-linking percentage as fiber diameter increased as
well. However, as mentioned previously, the standard deviations of SF still make its
TNBS results suspect. Therefore, according to the data in Figure 26, it appears that as
fiber diameter increases, an increase in % cross-linking can be seen as well. Nonetheless,
further testing would have to be done to determine if this was correct.
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Figure 26. Comparing percent cross-linked and fiber diameter to determine correlations.
Material Properties
Uniaxial tensile testing was performed on 50-50 samples of PCL-COL, PCLELAS, and PCL-SF to determine if differences between GEN and EDC occurred. Results
from Figure 27 presented a decrease in average peak stress and modulus when any protein
was added to the electrospun polymer solution, where PCL-ELAS scaffolds displayed the
lowest peak stress values and PCL-SF scaffolds displayed the lowest modulus values. This
is consistent with previous research [113, 152]. One of the main questions was whether or
136

137
not different chemical fixations would impact the material properties of the scaffolds. For
both peak stress and modulus values, no differences were seen between EDC and GEN
cross-linked groups. A difference was seen between EDC and GEN with PCL-COL for
strain to break values. This could be indicative that the molecular length of the crosslinker
could impact the strain values, although since this is the only case it is unlikely. Despite
no significant differences, it is worth noting that average moduli values for COL, ELAS,
and SF decreased when cross-linked with GEN, where PCL-COL decreased from 6.8 to
5.8 MPa, PCL-ELAS decreased from 4.5 to 3.5 MPa, and PCL-SF decreased from 3.5 to
2.7 MPa.

137

138
4.5

Peak Stress (Mpa)

4
3.5
3
2.5

5mM EDC
10mM Genipin

2
1.5
1
0.5
0
100-0-0-0

50-0-50-0

50-50-0-0

50-0-0-50

PCL-Elastin-Collagen-Silk

18
16

Modulus (MPa)

14
12
10

5mM EDC
10mM Genipin

8
6
4
2
0
100-0-0-0

50-0-50-0

50-50-0-0

50-0-0-50

PCL-Elastin-Collagen-Silk

Strain to Break (mm/mm)

1.8

*

1.6
1.4
1.2
1

5mM EDC
10mM Genipin

0.8
0.6
0.4
0.2
0
100-0-0-0

50-0-50-0

50-50-0-0

50-0-0-50

PCL-Elastin-Collagen-Silk

Figure 27. Uniaxial tensile test values for peak stress, tangential modulus, and strain to
break for PCL, 50-50 PCL-COL, 50-50 PCL-ELAS, and 50-50 PCL-SF. * indicates a
difference between EDC and GEN.
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Discussion
The aim of this study was to further elucidate the affect of two different

crosslinkers, EDC and GEN, on scaffold properties composed of different combinations of
PCL, COL, ELAS, and SF. EDC and GEN crosslink proteins through two different
methods. EDC involves the activation of carboxylic acid groups of glutamic and aspartic
acid residues present in the polypeptide chains to give O-acylisourea groups. Zero length
cross links are formed after nucleophilic attack by free amine groups of lysine or
hydoxylysine residues found on other polypeptide chains [282]. GEN, on the other hand,
is not as well understood and is still being investigated by other groups to determine the
exact cross-linking mechanism. As of now, the first step is the nucleophilic attack of the
GEN C3 carbon atom from a primary amine group to form an intermediate aldehyde
group. The just formed secondary amine reacts with the aldehyde group to from a
heterocyclic compound. The following step is a nucleophilic substitution reaction that
involves the replacement of the ester group on the G molecule by a secondary amide
linkage. The reaction is complicated by the oxygen radical-induced polymerization of
GEN that occurs once the heterocyclic compound has formed, giving the scaffold a blue
color [283, 284].
The primary goal of this experiment was to optimize the parameters of the solution
concentrations for EDC and GEN. One of the key elements of this study was to determine
whether the molecular length of the crosslinker changed the microscopic and macroscopic
properties of the scaffolds. Other studies have shown mechanical properties to change
with different types of crosslinkers used alongside purely COL-based scaffolds [283].
Although a synthetic polymer would be used in addition to proteins for this study, it was
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thought that the differences in cross-linked protein structure would be great enough to
provide differences in scaffold properties. From the microscopic perspective, the
concentration of free amine groups and the concentration of free proteins were investigated
by setting up two different cross-linking assays. A TNBS assay was chosen to measure
percentage of cross-linked material, as it has been used in several different experiments.
This assay is one that measures the number of free amine groups available in the solution
into which the protein-based scaffold has dissolved, reacting readily with primary amino
groups. In order to determine the most optimal percentage of cross-linking that occurs for
both EDC and GEN, the TNBS assay was carried out at different molarities with the
addition of different percentages of PBS. A method used to partially dissipate proteins
from the scaffold and determine its affect on the process of cross-linking.
Both Figures 20 and 21 portrayed the raw TNBS absorbance data for the two
crosslinkers. In Figure 19, EDC cross-linked scaffolds with ELAS demonstrated a
dissipation of free amine groups during the cross-linking process with the addition of both
5 and 10% PBS for 50mM concentrations. However, COL did not display dissipation
during the cross-linking process. Instead, its average absorbance values were higher for 5
and 10%, indicating that the COL dissipated during the TNBS assay, which would further
indicate that the COL proteins may have made them more readily available to dissociate
during TNBS treatment, decreasing cross-linking and causing them to not form stable
bonds and eventually dissipate. SF only seems to have been affected by the 50mM
concentration of EDC, which may signify that some carboxyl groups are available for
cross-linking. Figure 20 also displayed the raw absorbance data for GEN cross-linked
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scaffolds. These values displayed similar trends to EDC for ELAS blended scaffolds,
where 5 and 10% PBS decreased the absorbance values when compared to 0% PBS. This
indicated that free amine groups had dissipated during the cross-linking process. However,
the results were slightly skewed due to the interference of the green-blue color of GEN
after dissolution during the TNBS assay. This is very evident in the COL scaffolds where
the absorbance values are higher for the GEN treated scaffolds than they are for the NT
scaffolds. Although these scaffolds turned a green-blue color prior to the assay, which
would indicate that they were cross-linked, the absorbance values determined that there
was negative cross-linking.
Figures 22 and 23 demonstrated the percentage of cross-linking for all three
protein-based scaffold types. Figure 21 shows that for EDC the cross-linking percentage
was slightly increased with an augment in EDC molarity. However, this increase was not
pronounced enough to determine significant differences, and, therefore, did not indicate
any benefit to using an increased molarity with either COL or ELAS scaffolds. Figure 22
also displayed similar finding where ELAS-based scaffolds increased in cross-linking
percentage, yet they failed to produce any significant differences. Based on the TNBS
assay and percent cross-linked data there were only slight differences with the addition of
PBS to the cross-linking solution. However, this may have been a result of the loss of free
amine groups during the cross-linking process, subsequently skewing the data to have a
larger cross-linking percentage than in actuality.
Although the results from the TNBS assay had some variability, the raw
absorbance data did demonstrate that ELAS and COL proteins seemed to behave
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differently in terms of reaction rates when PBS was added to the solution. Therefore, the
second protein assay was conducted so as to determine the time dependence of crosslinking and further elucidate optimal conditions. Since it was assumed that GEN scaffolds
cross-linked at a slower rate than EDC scaffolds, based on the accepted time frame of 3
days for GEN and 18 hours for EDC, time periods were chosen as such: 0, 10, 30, 60, 180,
and 1080 minutes for EDC scaffolds and 0, 6, 24, 48, and 72 hours for GEN scaffolds. For
GEN scaffolds, a 6 hour period was enough time to begin the cross-linking process and
decrease the protein released from the scaffolds. Surprisingly, these reactions occurred
faster in COL than ELAS. This could be explained by the larger amount of ELAS protein
available in the scaffold due to the electrospinning conditions with ELAS’s 200 mg/ml
compared to COL’s 70 mg/ml. This could have allowed more protein to be released into
solution. For both ELAS and COL scaffolds, it appears that with either 10mM or 30mM
concentrations of GEN the reaction rates are similar and that most of the cross-linking
occurs within the first 24 hours. Looking at Figure 24 (top) and (bottom) for EDC
scaffolds, a difference between molarities was observed where 5mM tended to react slower
than 50mM, especially with the COL-based scaffolds. With either ELAS or COL added to
the electrospun polymer solution, it appears that the majority of cross-linking occurred
within the first 30 minutes and only slightly changed thereafter.
Based on the results from both the TNBS assay and the protein release assay, a
decision point had to be made so as to narrow down the cross-linking parameters and carry
out the study further. Therefore, it was determined that 5mM and 10mM EDC and GEN,
respectively, without the addition of PBS would provide optimal cross-linking parameters.
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Additionally, it was theorized that a lower molarity could be more conducive to cellular
attachment and proliferation. These molarities were then used to determine fiber diameter
characteristics and material properties. According to the fiber diameter results, ELAS
plays a major role when combined with COL. However, it does not have as pronounced of
an impact when it is combined with SF. Conventionally, fiber diameter is affected by an
increased polymer concentration, which subsequently increases the number of chain
entanglements and the density of these entanglements [285]. Shenoy et al. explains this
phenomenon as such: “Chain entanglements are essentially the physical interlocking of
polymer chains, which is a direct consequence of chain overlap. In a polymer solution,
chain overlap, and hence the number of entanglements, increases with polymer chain
length or molecular weight…It is worth noting that physical chain entanglements behave
in a similar manner as chemical cross-links, although the chains can slide past one another
affecting viscoelastic behavior.” Therefore, the molecular weight and concentration have a
large effect on fiber diameter. PCL has a molecular weight of 125 kDa, COL has proteins
within the molecular weight range of 120-220 kDa (based on SDS-PAGE), ELAS has
molecular weight of 60 kDa, and SF has a molecular weight of 188 kDa [286].
By itself and when mixed with a synthetic polymer, ELAS has proven to possess
large fiber diameters [109, 110, 152]. Observing Figure 26, COL did not affect the overall
fiber diameter with an average of 0.6 μm. However, both ELAS and SF do affect fiber
diameter with average values of 1.4 and 2.8 μm, respectively. The lower molecular weight
of ELAS could explain the lower average fiber diameter values compared to SF, if the
concentration of the two proteins is just above the critical value of chain entanglements.
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When Figures 26 (top) and (bottom) are examined, SF tends to bring the average values of
the higher ELAS content scaffolds down whereas COL, which has a similar average
molecular weight to SF, tends to keep fiber diameter values high. Therefore, both the
structure of these proteins and their chain entanglement densities are interacting with one
another to produce different results. These combinations could be leading to a doping or
“poisoning” of the each different polymer in solution, changing their electrospun
properties and parameters.
Several studies have investigated the ideal fiber diameter size for tissue engineered
scaffolds. This ideal electrospun fiber size would then dictate the pore diameter as well,
allowing for adequate cellular infiltration. A study performed by Ju et al. determined that
PCL-COL blended scaffolds with an average fiber diameter size of 2.39 μm had the best
cellular infiltration under static cell seeding conditions at four weeks. Additionally, in this
same study, average fiber diameters between 0.27 and 1.00 μm, demonstrated low cellular
infiltration after four weeks with cells mainly concentrating on the surface of the scaffolds
[133]. In this study we found that fibers diameters ranged from 1.1 – 2.3 μm in uncrosslinked scaffolds while cross-linked scaffolds demonstrated a range from 0.8 – 3.9 μm.
While the low end of the values could inihibit cellular infiltration, the higher numbers from
2.0 up to 3.9 μm could prove to be extremely beneficial. This demonstrates that future
studies need to investigate the limitations of certain scaffold blends based on both fiber
size and protein composition.
Chemical cross-linking could also attribute some of the changes seen in fiber
diameter results, especially GEN. When GEN cross-links, it produces a large molecular
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structure that retains the ability to create cross-links within the electrospun fibers. This has
the potential to lead to fiber swelling, or to create cross-links between electrospun fibers,
which could lead to fiber welding. Additionally, ELAS is electrospun at a high
concentration which would produce a large number of sites for cross-linking. Each of
these different scenarios explains the larger fiber diameter results with higher ELAS
content when combined with COL. When higher ELAS concentrations are combined with
SF, however, there is a marked decrease in fiber diameter values with no affect due to
GEN cross-linking. This could be due to the interaction of SF with the ELAS proteins.
For SF, cross-linking occurred at a minimum due to GEN or EDC. Instead, cross-linking
was due to the ethanol, as it is well known that SF materials can be converted into a more
stable crystalline β-sheet structure through the use of alcohols [279, 287]. The β-sheet
formation could attribute some initial encapsulation of ELAS proteins, preventing interfiber cross-links with the use of GEN. Finally, higher SF scaffolds displayed larger fiber
diameters, consistent with the 50-50 PCL-SF results.
Uniaxial tensile testing is an excellent method to determine the macroscopic
material properties of a tissue engineering scaffold. Studies have shown that different
types of fixation and the amount of fixation can affect the overall material properties for
the same initial untreated scaffold [274, 282, 283, 288]. Therefore, this study aimed to
determine whether differences would existed between EDC and GEN cross-linked
scaffolds. As it turns out, there were no significant differences. This could be due to PCL
dominating the mechanical properties, where only infinitesimal changes in material
properties would be seen owing to the chemical cross-linking of the electrospun proteins.
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Despite no significant differences, the average moduli values for COL, ELAS, and SF
decreased when cross-linked with GEN. This was consistent with some of our previous
findings with the use of EDC and GEN on pure ELAS constructs [110]. This could point
toward the long molecular chain of GEN. A longer cross-linked molecular structure could
produce a scaffold with a decreased stiffness due to its ability to slide further than a zero
length molecular bond. This is evident in PCL-COL GEN cross-linked scaffolds, but is
not consistent over the course of all materials and would, consequently, require future
testing to fully investigate.

Conclusion
In conclusion, we were able to successfully crosslink PCL, COL, ELAS, and SF

blended scaffolds using either EDC or GEN. These cross-linked scaffolds were assessed
for % cross-linking and reaction rate using two different protein assays. The results from
these assays allowed the study to be narrowed to the optimal cross-linking parameters,
which wre found to be the lower cross-linking molarities of 5 mM EDC and 10 mM GEN.
From that point on the remainder of the study was performed under those conditions.
Results from fiber diameter and material properties demonstrated changes in the scaffolds
when cross-linked with GEN, a longer molecule, and demonstrated little to no changes
with EDC, a zero length crosslink. However, these results did not transfer over to material
properties, where no significant changes were found between the two crosslinkers. Since
the degree of cross-linking demonstrated large amounts of variability for certain polymer
blends, other quantification techniques should be investigated in future studies. One type
of investigatory method is the degree of swelling that a substrate has once cross-linked.
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This method is standard and can be correlated with the degree of cross-linking [289, 290].
Additionally, the shrinkage of a cross-linked scaffold due to increased temperature can also
be correlated to the degree of cross-linking. This is also a standard method and has been
used previously to demonstrate how increases in degree of cross-linking also increase the
temperature required to shrink the scaffold [282]. Once the swelling and shrinkage studies
have been performed, future studies will investigate the use of these optimal cross-linking
conditions for vascular graft design.
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Chapter 5: Tri-layered Vascular Grafts Composed of Polycaprolactone,
Elastin, Collagen, and Silk: Optimization of Graft Properties

Abstract
The purpose of this study was to create seamless, acellular, small diameter

bioresorbable arterial grafts that attempt to mimic the extracellular matrix and mechanical
properties of native artery using synthetic and natural polymers. SF, COL, ELAS, and
PCL were electrospun to create a tri-layered structure for evaluation. Dynamic compliance
testing of the electrospun grafts ranged from 0.4–2.5 %/100 mmHg, where saphenous vein
(1.5 %/100 mmHg) falls within this range. Increasing PCL content caused a gradual
decrease in medial layer compliance, while changes in PCL, ELAS, and SF content in the
adventitial layer had varying affects. Mathematical modeling was used to further
characterize these results. Burst strength results ranged from 1614–3500 mmHg, where
some exceeded the capacity of the pressure regulator. Four week degradation studies
demonstrated no significant changes in compliance or burst strength, indicating that these
grafts could withstand the initial physiological conditions without risk of degradation.
Overall, we were able to manufacture a multi-layered graft that architecturally mimics the
native vascular wall and mechanically matches the gold standard of vessel replacement,
saphenous vein.
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Introduction
Native artery is an extremely complex multi-layered tissue composed of a number

of different proteins and cell types, which each plays an integral role in the mechanical
behavior of the structure. In order to withstand the high flow rate, high pressure, and
pulsatile nature of blood flow, an artery is comprised of three distinct layers: intima,
media, and adventitia. Each of these layers has a different composition and plays a
different physiological role. The intimal layer is the innermost layer of the vessel wall and
is made up of a single layer of ECs on a thin basal lamina and a subendothelial layer made
of COL type IV and ELAS. This layer contacts the bloodstream and therefore provides a
critical barrier to platelet activation. The thick medial layer is composed of several layers
of SMCs in a matrix of COL types I and III, ELAS, and proteoglycans. The outermost
adventitial layer is made of FBs and randomly arranged COL type I [2, 291, 292]. The
major protein components of native artery, COL and ELAS, provide tensile support and
prevent vessel rupture, and confer elasticity to the vessel, providing the ability to recover
from pulsatile deformation, respectively [148, 149]. It is the elastic nature of ELAS that
dominates the low-strain mechanical response of the vessel to blood flow and prevents
pulsatile energy from being dissipated as heat [293, 294].
The capabilities of electrospinning to mimic the microenvironment of a cell are
especially important when dealing with vascular grafts. The dynamic situation of a blood
vessel creates a complicated sequence of events in which the walls are stretched and the
inner lumen is sheared. A microenvironment capable of withstanding these forces with
minimal energy loss is essential for proper blood vessel functioning. Electrospinning of
polymer fibers into a vascular conduit has been demonstrated to be a potential technique
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that not only creates scaffolds simulating the ECM, but also contributes tailorable
mechanical properties and minimal energy loss [111].
Currently, the most common vascular materials are Dacron (polyethylene
terephthalate) and ePTFE. Dacron is widely known for its use in aortic and iliac grafts. Its
success in these areas of the body is due mainly to larger diameters and flow rates, which
are not conducive to thrombus formation and the subsequent decrease in luminal diameter.
However, for a small diameter graft of 5 mm or less, the following properties must be
attained for successful grafting to occur: biocompatibility, lack of chemical reactivity, very
low thrombogenicity, porosity, and mechanical strength, including compliance matching
that of native artery and resistance to aneurysm formation [222, 225, 295].
Inner luminal wall thickening, hyperplasia, and subsequent occlusion and loss of
blood flow in vascular grafts is one of the most critical concerns when designing a vascular
prosthetic. Mechanical problems such as compliance mismatch between the natural vessel
and prosthetic contribute to this effect, and are a key component to the creation of a
successful vascular graft. Recently, our laboratory performed compliance testing of
electrospun PDO and ELAS in an effort to match natural arterial compliance. Various
ratios of PDO:ELAS were electrospun and tested in a bioreactor with internal pressures
changing cyclically from 120mmHg to 80mmHg at 60 Hz, where a blend of 50:50 showed
particular promise [248]. This study demonstrated the advantageous aspects of the
addition of ELAS proteins to synthetic biodegradable polymers in a physiological setting.
The biomechanics of vascular grafts is one of the most essential components to its
success. Previously, we designed a preliminary study to mimic the vascular architecture
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through producing a tri-layered vascular analogue [152]. Using a multi-layered technique,
grafts can be tailored to exact specifications and optimized thereafter. Aneurysms and
graft rupture could be avoided through the use of a “jacketlike” outer layer that would
prevent the graft from overextending itself, while the middle layer can be tailored to have
the lowest modulus, providing the distension required for proper compliance and blood
flow, similar to native artery. Blends of PCL, ELAS, and COL were electrospun in all
three layers and mechanically tested through uniaxial tensile, compliance, suture retention,
and burst strength. PCL was chosen as a synthetic polymer based on promising results
from in vivo rat studies that have been conducted by Pektok et al., whereby histological
analysis revealed rapid enthothelialization of the inner lumen of the graft and becoming
confluent at 12 weeks [93]. Vascular tissue contains between 25-30 % COL and 40-50 %
ELAS. Therefore, ratios were chosen for each of the three layers based on native
extracellular matrix design while keeping mechanical integrity throughout the graft
structure. Results from this tri-layered study revealed that as the modulus of the middle
layer was changed, the compliance values increased to within native arterial range, while
burst strength remained strong due to the outer layer.
Building off of this blueprint, this study was designed to observe a large range of
scaffolds containing high amounts of natural polymer in combinations of ELAS, COL, and
SF. Previous research indicated that combinations of ELAS, COL, and SF required
fixation in order to retain proteins within the scaffold matrix. Both GEN and EDC were
used in a comparison model to determine the proper molarity for each cross-linker.
Concentrations of 5 and 50 mM for EDC and 10 and 30 mM for GEN were tested, and it
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was concluded that 5 mM EDC and 10 mM GEN had similar cross-linking results to their
higher concentrations counterparts. Therefore, in this study, we aimed to evaluate the
mechanical properties of tri-layered vascular grafts through uniaxial tensile testing,
compliance, and burst strength.
As described earlier, artery is subjected to circumferential, longitudinal, torsional,
and shear stress. Although important to the study of coronary arteries, torsion and shear
stresses do not ultimately dictate the mechanical behavior of an artery when considering
blood pressure supplying a force to the arterial wall in vivo. Therefore, mathematical
modeling was implemented to help describe CWS of the individual layers and their
mechanical effects on surrounding layers using the equations developed by Vorp et al.
[120, 261]. Combining mathematical modeling with the results of compliance and burst
strength would aid in the optimal design of the tri-layered vascular graft, providing
valuable information regarding layered behavior.

Materials and Methods

Protein Extraction
SF was extracted from the cocoons of Bombyx mori silk worms (The Yarn Tree)
through an established protocol [280]. Briefly, cocoons are cut into pieces and boiled in a
0.02 M Na2CO3 (Sigma Aldrich) solution for 30 minutes to remove the sericin gum,
followed by thorough rinsing in de-ionized water (DI), and drying in a fume hood. The SF
is then dissolved in a LiBr (Fisher Scientific) solution at 60°C for 4 hours. This solution is
then dialyzed against deionized water for 3 days using 3500 MWCO dialysis tubing
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(Fisher Scientific). The SF solution is then frozen and lyophilized to provide a pure SF for
electrospinning.
COL type I was extracted from 6 month bovine corium through an acetic acid
based process previously described [262]. Briefly, tissue is homogenized, suspended in
acetic acid, and subsequently purified via a series of dissolutions, precipitations (using
NaCl (Fisher Scientific) and Tris (Fisher Scientific)), and dialyses [263]. Following the
final dialysis, COL solutions are frozen and lyophilized.
Electrospinning
The electrospinning setup consisted of a syringe pump (KD Scientific), a high
voltage power supply (Spellman CZE1000R, Spellman High Voltage Electronics Corp.), a
plastic Becton Dickinson syringe used as the polymer reservoir, attached to an 18-gauge
blunt-tip needle. Concentrations of 150 mg/ml of PCL (MW: 125,000, Lakeshore
Biomaterials), 200 mg/ml of soluble ELAS from bovine neck ligament (Elastin Products
Co. Inc.), 70 mg/ml of COL I (6 month bovine corium), and 80 mg/ml of SF were
dissolved in HFP (TCI America). These were then blended in ratios of 50-50 PCL-ELAS,
PCL-COL, and PCL-SF. Additionally, ELAS-based scaffold materials were blended in
ratios of 45-45-10, 55-35-10, 65-25-10, 45-10-45, 55-10-35, and 65-10-25 PCL-ELASCOL and PCL-ELAS-SF. To evaluate material properties, blended scaffolds were
electrospun onto rectangular mandrels measuring 2.5 cm wide x 10.2 cm long x 0.3 cm
thick. The parameters for electrospinning were kept constant with an applied voltage of
25 kV, air gap distance (distance between the needle and rotating drum) of 15 cm, and
solution dispensing rate of 4 ml/hr.
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To create vascular tubes, each polymer mixture was loaded into a 3 ml plastic
Becton Dickinson syringe with an 18 gage blunt tip needle. Insulated Tygon tubing was
then run from the needle tip to a 3-1 (input-output) nozzle charged to 25 kV at an air gap
distance of 15 cm. The solutions were sequentially electrospun onto a 2 mm diameter
cylindrical mandrel rotating at 500 RPM with a translational speed of 6 cm/s over a
distance of 12 cm. Flow rates and volumes were as such: the material for the intima was
kept constant at 100-0-0 PCL-ELAS-COL and electrospun at a rate of 4 ml/hr and a
volume of 0.25 ml followed by a transition combining both intimal and medial syringes for
0.1 ml at 2 ml/hr each for a combined flow rate of 4 ml/hr. The intimal syringe was then
shut off and the medial layer was allowed to spin for 0.6 ml at 4 ml/hr followed by a
transition between the media and adventitia for 0.1 ml of polymer solution at 2 ml/hr each
for a combined flow rate of 4 ml/hr. Finally, the media was stopped and the adventitia was
allowed to spin for 0.3 ml at 4 ml/hr.
Medial layers were 45-45-10, 55-35-10, and 65-25-10 PCL-ELAS-COL and PCLELAS-SF. Adventitial layers were 45-10-45, 55-10-35, and 65-10-25 PCL-ELAS-COL
and PCL-ELAS-SF. Vascular tubes were created using each possible combination and
cross-linked using both EDC and GEN to determine layered graft behavior based on
differences in protein type and cross-linker type.
Crosslinking
Scaffolds were cross-linked using EDC (FlukaBiochemika), genipin (GEN, Wako
Pure Chemical Industries, Ltd.). Using EDC, a 5 mM crosslinking solution was prepared in
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90 % ethanol (Fisher Scientific) and allowed to cross-link for 18 hours followed by a 0.1M
Na2HPO4 rinse for 1 hour and a PBS rinse for 1 hour.
Using GEN, a 10 mM crosslinking solution was prepared in 90 % ethanol (Fisher
Scientific) and scaffolds were placed in the cross-linking solution for a period of 72 hours
[245], followed by a PBS rinse for 2 hours.
Material Properties of Individual Layers
Uniaxial tensile testing was performed on six samples (n = 6) from one electrospun
sheet hydrated in PBS for 24 hours. “Dog-bone” shaped samples were punched from
electrospun mats (2.75 mm wide at their narrowest point with a gage length of 7.5 mm)
and tested on a MTS Bionix 200 testing system with a 100 N load cell (MTS Systems
Corp.) and an extension rate of 10.0 mm/min. Peak stress, modulus, and strain at break
were calculated using TestWorks version 4.
Mathematical Modeling
The constitutive equations developed by Vorp et al. [120, 261] are based on the
principle of the Lamé equations. Following similar assumptions as previously described
[261], a three-layered model (Figure 9) was used, describing CWS, at any radius, r, of the
three layers. Through this we come up with:
CWS =

R 2I PI − RO2 PO
RO2 − RI2

+

( PI − PO ) RI2 RO2
for RI≤ r ≤ RO
( RO2 − RI2 )r 2

Where RI is the inner radius of a particular layer, RO is the outer radius of a particular layer,
PI is the inner pressure of a particular layer, and PO is the outer pressure of a particular
layer.
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2 a 2b
P2 = Pi 2
(b − a 2 ) EINT

⎡
⎤
(c 2 − b 2 ) 2 EMED k2
⎢ 2
2 2 2
3 3⎥
⎣ (c − b ) EMED k2 k1 − 4b c ⎦

2 a 2b
(b 2 − a 2 ) EINT

⎡
⎤
2(c 2 − b 2 ) EMEDb 2c
⎢ 2
2 2 2
3 3⎥
⎣ (c − b ) EMED k2 k1 − 4b c ⎦

P3 = Pi

k1 =

b3 (1 − υ INT ) + a 2b(1 + υ INT ) b3 (1 − υMED ) + b 2c(1 + υ MED )
+
(b 2 − a 2 ) EINT
(c 2 − b 2 ) EMED

c3 (1 − υMED ) + b 2c(1 + υMED ) c3 (1 − υ ADV ) + d 2c(1 + υ ADV )
k2 =
+
(c 2 − b 2 ) EMED
(d 2 − c 2 ) E ADV
Where k1 and k2 are constants, EINT, EMED, and EADV represent the moduli for the intimal,
medial, and adventitial layers, respectively, υINT, υMED, and υADV represent Poisson’s ratio
for the intimal, medial, and adventitial layers respectively, and a, b, and c are the inner
radii for the intimal, medial, and adventitial layers, respectively, and d is the outer radii of
the adventitial layer (equations are adopted from [120, 261]).
Burst Strength
Burst strength testing on six samples (n = 6) from six different electrospun grafts
was completed using a device designed in accordance with section 8.3.3.3 of ANSI/AAMI
VP20:1994 [29]. Tubes, 2–3 cm in length, were hydrated in PBS, fitted over 1.5 mm
diameter nipples attached to the device, and secured with 2-0 silk suture. Air was
introduced into the system, increasing the pressure at a rate of 5 mmHg/s until the tubes
burst. Results are reported as the pressure in mmHg at which tubes ruptured.
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Dynamic Compliance
Dynamic compliance was determined for six 2 mm inner diameter tubular grafts (n
= 6) taken from six different electrospun grafts at a length of 3 cm under simulated
physiological conditions in accordance with section 8.10 of ANSI/AAMI VP20:1994
[264]. Both individual layers and multi-layered tubular constructs were electrospun and
tested under the same conditions. The specimens were tested in an Intelligent Tissue
Engineering via Mechanical Stimulation (ITEMS™) Bioreactor developed by Tissue
Growth Technologies (Minnetonka, MN) filled with PBS at 37°C. The bioreactor
provided a cyclic (1 Hz, representing 60 beats per minute) pressure change to the inside of
the graft; three different pressure levels (90/50, 120/80, and 150/110 mmHg
systolic/diastolic) were investigated. Briefly, specimens were secured at either end to a
nipple with 2-0 silk suture and placed in the bioreactor chamber. PBS then filled the
chamber and was run continuously on the outside of the graft to maintain a temperature of
37oC and a pressure of 0 mmHg. Simultaneously, PBS was pumped through the inside of
the graft and an actuator in the bioreactor created the difference in pressure. Prior to
compliance measurements for each pressure level, all grafts were allowed to stress relax
for 30 minutes or 1800 cycles.
Internal pressure was measured with a pressure transducer capable of measuring
dynamic pressure up to 200 ± 2 mmHg, while the external diameter was recorded with a
laser micrometer system with an accuracy of ±0.001 mm. Prior to insertion into the
bioreactor, the grafts were soaked in PBS at 37°C for 24 hours, after which time their
average wall thickness was measured. From this, the internal radii of the graft was
determined and used in the following equation to calculate compliance for each specimen:
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% Compliance =

( R P 2 − R P1 ) / R P1

(P2 − P1 )

× 10 4

Where R is the internal radius, P1 is the lower internal pressure, and P2 is the higher
internal pressure [296]. Grafts were tested with individual layers electrospun at a wall
thickness of 200 μm, and with whole graft samples with an overall wall thickness of 500
μm.
Degradation
Grafts were tested for degradation using a 55mL rotating cell culture system
(RCCS, Synthecon, Inc.). First, chosen grafts were electrospun according to the protocols
mentioned above. Second, 55 mL of Dulbeco’s Modified Eagle Medium F12 (DMEM
F12, Invitrogen) supplemented with 10 % fetal bovine serum (Hyclone) and 1 %
penicillin/streptomycin (Invitrogen) was placed in each bioreactor. Twelve tri-layered
vascular grafts (n = 4) from one polymer blend group were placed in one bioreactor to
create three separate timed groups: 1, 2, and 4 weeks. Each bioreactor containing the
vascular grafts was then placed in an incubator at 37oC with 5 % CO2 for 1, 2, and 4
weeks. Media was changed once every 7 days to remove any degradation products and
replace enzymatic capabilities. At each time period, grafts were taken out of culture and
tested for compliance and burst strength in accordance with the above protocols.

Statistical Analysis
Unless otherwise stated, all statistical analysis was based on a Kruskal-Wallis one
way analysis of variance on ranks and a Tukey-Kramer pair-wise multiple comparison

158

159
procedure (α = 0.05) performed with the JMP®IN 4.0.3 statistical software package (SAS
Institute, Inc).

Results

Material Properties
The primary goal of assessing material properties was to analyze how combinations
of PCL, ELAS, COL, and SF interact with one another when PCL-ELAS-COL and PCLELAS-SF was electrospun at ratios of 45-45-10, 55-35-10, 65-25-10, 45-10-45, 55-10-35,
and 65-10-25. The purpose of choosing these volumetric ratios was to incrementally
change PCL and ELAS ratios while COL or SF were kept constant. This process was then
reversed with COL or SF whereby the ratios of PCL, COL, and SF were incrementally
changed and the ELAS protein level was kept constant in solution. Tables 10 and 11
display the data of peak stress, modulus, strain to break, and energy to break. One of the
important factors in this portion of the study, as in Chapter 4, was to determine whether or
not changes in any of the output values for materials testing occurred between the two
different crosslinked scaffolds. Looking at Table 10, peak stress values for EDC
crosslinked scaffolds with PCL at volumetric ratios of 65 % were significantly different (p
< 0.05) from their GEN counterparts. 65-25-10 EDC had a value of 2.31 MPa and 65-2510 GEN had a value of 2.02 MPa, while 65-10-25 EDC had a value of 1.49 MPa and 6510-25 GEN had a value of 1.21 MPa. Both of these groups of scaffolds contained average
values where the GEN crosslinked scaffold decreased in peak stress in comparison to the
EDC crosslinked scaffold. Although, none of the other crosslinked scaffolds were
different from one another, they each possessed a decrease in average peak stress,
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excluding the 45-10-45 PCL-ELAS-COL scaffolds. Additionally, as ELAS incrementally
increased from 25 to 45% it gradually caused a decrease in peak stress with differences (p
< 0.05) between 65-25-10, 55-35-10, and 45-45-10 for both EDC and GEN crosslinked
scaffolds. Additionally, 65-10-25 COL based structures differed (p < 0.05) from 45-10-45
strucutres.
Modulus values are especially important to determine a scaffold’s stiffness. They
can be good determinants or predictors of how well a vascular material will behave under
physiological pressures. Crosslinked scaffolds were investigated for differences between
EDC and GEN to understand if the crosslinking procedures caused a dramatic change in
the overall scaffold properties due to chemical crosslink or crossbridges that would form.
As seen in Chapter 4, these values did not differ from one another. Nevertheless, trends
still implicated that something could be happening with mechanical properties between the
two types of crosslinkers. Examining the values, 65-10-25 PCL-ELAS-COL scaffolds
exhibited the highest stiffness, where EDC was the highest and GEN was the lower of the
two. Average moduli for GEN scaffolds were also lower than their EDC counterparts for
55-10-35 and 55-35-10. Trends amongst the scaffolds also demonstrated that for both
COL and ELAS based scaffolds 65% PCL content was significantly different (p < 0.05)
from 45% PCL content. This continues to show that as total protein content increases,
stiffness decreases.
Strain to break values for all scaffolds ranged from 1.2 – 0.29 mm/mm. The higher
strain values were present in scaffolds with increased PCL content for ELAS based
scaffolds. Averages for these scaffolds illustrated how the addition of proteins to a
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scaffold significantly decreased (p < 0.05) strain values in upwards of 75%. Differences
(p < 0.05) between EDC and GEN occurred for 45-45-10 and 45-10-45 scaffolds. Where
GEN crosslinking caused the strain values to decrease for ELAS-based scaffolds and
increase for COL based scaffolds. Again, incremental changes in PCL content displayed
significant differences (p < 0.05) between 65-25-10 and 45-45-10, and 65-10-25 and 5510-35.
Energy to failure data is calculated based on the area underneath the stress-strain
curve; as a sample increases in strain and in peak force, so does the energy to failure.
These values are good determinants of scaffold toughness, or how much energy a material
can absorb prior to failure. In the case of a vascular graft it is advantageous for a sample to
exhibit an energy to break that will allow the material to withstand the physiological
pressures imposed on its walls. Amongst these samples, significant differences (p < 0.05)
occurred between 65-25-10 EDC and GEN scaffolds. These scaffolds demonstrated a
decrease in energy to break when GEN was used as the crosslinker, decreasing from 10.5
to 9.4 N*mm. For almost every case, the energy to break values decreased when GEN was
used as the crosslinker, excluding the 45-10-45 scaffolds. Moreover, as PCL content
decreased energy to break values also decreased with significant differences between 6525-10 and 45-45-10, and 55-10-35 and 45-10-45.
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Table 10. Material Property Results PCL-ELAS-COL.* indicates a significant difference
between EDC and GEN. # indicates a significant difference between 65 % and 45 % PCL
content scaffolds.

45-45-10
45-45-10
55-35-10
55-35-10
65-25-10
65-25-10
45-10-45
45-10-45
55-10-35
55-10-35
65-10-25
65-10-25

Xlink
EDC
Genipin
EDC
Genipin
EDC
Genipin
EDC
Genipin
EDC
Genipin
EDC
Genipin

Peak Stress
(MPa)
0.4 ± 0.1
0.3 ± 0.1
1.0 ± 0.1
0.8 ± 0.1
* 2.3 ± 0.1
2.0 ± 0.1
1.0 ± 0.2
1.1 ± 0.2
1.2 ± 0.3
1.1 ± 0.2
* 1.5 ± 0.2
1.2 ± 0.4

Modulus
(MPa)
# 2.5 ± 0.55
2.6 ± 0.33
9.5 ± 1.61
7.2 ± 2.25
10.1 ± 0.63
10.4 ± 0.60
6.6 ± 0.85
#
7.1 ± 0.79
9.7 ± 2.76
8.1 ± 1.94
13.5 ± 3.08
11.8 ± 5.51

Strain to Break
(% Elongation)
* 48.0 ± 5.0
29.0 ± 3.0
43.0 ± 7.0
42.0 ± 3.0
112.0 ± 11.0
120.0 ± 13.0
* 33.0 ± 5.0
49.0 ± 6.0
29.0 ± 8.0
30.0 ± 4.0
43.0 ± 9.0
40.0 ± 8.0

Energy to Break
(N*mm)
0.52 ± 0.17
0.23 ± 0.07
0.98 ± 0.31
0.88 ± 0.30
10.45
± 1.39
*
9.35 ± 1.60
0.76 ± 0.37
1.49 ± 0.41
0.55 ± 0.33
0.49 ± 0.11
1.90 ± 0.61
1.38 ± 0.93

According to Table 11, overall average values for peak stress and modulus
demonstrated decreases when crosslinked with GEN, while average values for strain to
break exhibited decreases for ELAS-based scaffolds, 45-45-10, 55-35-10, and 65-25-10,
but had increases for SF-based scaffolds, 55-10-35 and 65-10-25. Specifically looking at
the peak stress values, significant differences (p < 0.05) existed between 65-25-10, 45-4510, and 45-10-45 EDC and GEN scaffolds with marked decreases of 0.2, 0.3, and 0.2 MPa,
respectively. In addition to the differences (p < 0.05) between scaffold crosslinkers, there
were differences between groups of scaffolds. ELAS and SF-based scaffolds with 65%
PCL content were different (p < 0.05) from those containing 45% PCL, each with a
decrease in peak stress. 65-25-10 EDC and GEN scaffolds decreased from 1.4 and 1.2
MPa to 1.1 and 0.8 MPa for 45-45-10, respectively. At the same time, 65-10-25 EDC and
GEN scaffolds decreased from 1.2 and 1.1 MPa to 0.9 and 0.7 MPa for 45-10-45,
respectively.
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Moduli displayed average values for all GEN crosslinked ELAS-based scaffolds
which were lower than their EDC crosslinked counterparts. For example, 65-25-10 EDC
scaffolds decreased from 13.2 to 12.7 MPa, 55-35-10 EDC scaffolds decreased from 11.3
to 9.6 MPa, and 45-45-10 EDC decreased from 4.1 to 3.9 MPa. SF-based scaffolds,
however, did not display the same trends with values for 65-10-25 and 45-10-45 increasing
from 10.2 to 10.7 MPa and 9.1 to 9.2 MPa, respectively, when crosslinked with GEN.
None of the values for either ELAS or SF-based scaffolds were significantly different from
one another. Staying consistent with Table 10, differences did exist between the moduli of
scaffold groups; 65-25-10 was different from 45-45-10 and 65-10-25 was different from
45-10-45.
Shifting over to strain to break results, the majority of the results are in the range of
0.4-0.7 mm/mm, except for the 65-10-25 and 55-10-35 scaffolds crosslinked with GEN.
Significant differences (p < 0.05) between EDC and GEN scaffolds existed only for 65-2510, 65-10-25, and 55-10-35, where values decreased from 0.7 to 0.5 mm/mm for 65-25-10
and increased from 0.3 to 1.5 mm/mm for 55-10-35 and from 0.5 to 1.5 mm/mm for 65-1025. These increases, when using GEN as the crosslinking reagent, were particularly
interesting. In the previous chapter, 50-50 PCL-SF scaffolds did not demonstrate these
increases when using GEN as the crosslinking reagent. In fact, the majority of the results
from Chapter 4, pointed to the fact that SF did not have many available binding sites
available for crosslinking to occur, containing low absorbance values for untreated TNBS
assays and performing the majority of its crosslinking within the first 30 minutes due to the
non-aqueous alcohol-based substance, ethanol, used to dissolve the crosslinking reagent.
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Therefore, the results seen here could be attributed to the low amount of ELAS present
within the scaffold. The ELAS present in the 45-10-45 scaffold may not interact with the
PCL and SF in the same specific way that both the 55-10-35 and 65-10-25 scaffolds do,
whereby the SF protein dominates the polymer solution.
Energy to break revealed decreases in the amount of energy absorbed by the
scaffolds when crosslinked with GEN for all ELAS-based scaffolds, while the SF-based
scaffolds of 55-10-35 and 65-10-25 displayed increases in the amount of energy absorbed.
This can be attributed to the large strain to break values seen by these scaffolds, increasing
the area under the curve as the scaffolds continued to elongate under a constant strain rate.
Significant differences (p < 0.05) between EDC and GEN occurred for the 55-10-35, 6510-25, and 65-25-10 PCL-ELAS-SF scaffolds, clearly demonstrating that a change is
occurring when a different crosslinker is used, and that this change is dependent on the
ratios of PCL to ELAS and to SF. Additionally, scaffold groups were again different (p <
0.05) from each other with differences between 65-25-10 and 45-45-10 and between 6510-25 and 45-10-45. This showed that as ELAS or SF were incrementally increased their
energy to break decreased with average values decreasing by 3.2 Nmm and 2.6 Nmm for
ELAS and SF-based scaffolds, respectively.

164

165
Table 11. Material Property Results PCL-ELAS-SF.* indicates a significant difference
between EDC and GEN. # indicates a significant difference between 65 % and 45 % PCL
content scaffolds.

45-45-10
45-45-10
55-35-10
55-35-10
65-25-10
65-25-10
45-10-45
45-10-45
55-10-35
55-10-35
65-10-25
65-10-25

Xlink
EDC
*,#
Genipin
EDC
Genipin
EDC
Genipin
EDC *,#
Genipin
EDC
Genipin
EDC
Genipin

Peak Stress
(MPa)
1.1 ± 0.2
0.8 ± 0.2
1.4 ± 0.8
1.2 ± 0.1
1.4 ± 0.1
1.2 ± 0.1
0.9 ± 0.1
0.7 ± 0.1
0.8 ± 0.1
0.7 ± 0.1
1.2 ± 0.1
1.1 ± 0.1

#

#

Modulus
(MPa)
4.1 ± 0.6
3.9 ± 0.6
11.3 ± 1.1
9.6 ± 1.8
13.2 ± 1.0
12.7 ± 2.7
9.1 ± 2.0
9.2 ± 1.3
9.3 ± 1.1
8.1 ± 1.6
10.2 ± 1.9
10.7 ± 0.8

Strain to Break
(% Elongation)
50.0 ± 12.0
40.0 ± 6.0
50.0 ± 10.0
50.0 ± 3.0
* 70.0 ± 4.0
50.0 ± 3.0
50.0 ± 8.0
50.0 ± 7.0
* 30.0 ± 3.0
150.0 ± 5.0
50.0 ± 5.0
*
150.0 ± 33.0

#

*
#
*
*

Energy to Break
(N*mm)
0.9 ± 0.5
0.7 ± 0.2
2.1 ± 0.6
1.9 ± 0.4
4.1 ± 0.8
2.1 ± 0.5
2.0 ± 0.3
1.7 ± 0.3
1.0 ± 0.1
3.1 ± 0.3
2.3 ± 0.3
4.3 ± 0.8

Mathematical Modeling
Mathematical modeling was implemented in order to determine where we could
effect a change in graft behavior by altering individual layer moduli. Therefore, both
Figures 29 and 30 took into account the material properties obtained from uniaxial tensile
testing results in Tables 10 and 11 and utilized them in equations 3-8 to predict how
individual layers affect one another. Figure 28 depicts how changing the medial layer (a,
b, and c) affects the transmural stress distribution when physiological pressures are
imposed on the graft material. Each medial layer is then tested for an adventitial layer to
predict which type of material combinations will be best suited for future testing and
implantation. The medial layers tested in these cases are ELAS-based materials of 45-4510, 55-35-10, and 65-25-10, while adventitial layer testing was performed with 45-10-45,
55-10-35, and 65-10-25. A few assumptions were made prior to calculating the results. 1.)
The wall thickness of the scaffolds was 450 μm where the starting internal radius was 0.95
mm and the external radius was 1.4 mm. 2.) Layer thickness was calculated based on the
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percentages of thickness of the individual layers for native muscular arteries. 3.) Materials
were homogenous, incompressible, and linearly elastic.
Each of the calculated results were compared to a study done by Holzapfel et al.
[266], where the individual layers of a human coronary artery were separated and tested for
material properties. Observing the trends between Figures 29A-C, we were able to see
how the medial layer affects the overall CWS with a gradual decrease in the amount of
initial stress exerted onto the intimal layer. In addition to this there is a marked decrease in
CWS present in the adventitial layer. These results make sense because as the amount of
ELAS is decreased in the electrospun polymer solution, the increase in PCL allowed the
scaffold to take on more mechanical load, thereby relieving the intimal and adventitial
layers and increasing the load imposed on the medial layer, increasing its CWS.
Specifically, Figure 28A displayed an extremely close match with the CWS in the medial
layer to the Holzapfel et al. results. This could be indicative of a close match between the
45-45-10 moduli and the native artery and could prove beneficial under whole graft
analysis with compliance and burst strength. As the adventitial layer is changed,
increasing its COL content while its ELAS content stays constant from 65-10-25 to 55-1035 to 45-10-45, the 55-10-35 and 45-10-45 results appeared to have the best impact on
overall transmural stress distribution and consistently possessed the closest adventitial
layer properties to that of native artery. One of the interesting facts of Figures 29B and
29C was the way in which the changes in the medial layer affected how the stress imposed
on the intimal and adventitial layers changed. As PCL content increased in the adventitial
layers, the CWS of the intimal decreased while the adventitial layers increased. This was
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especially evident in the 65-25-10 medial layers, where, as the adventitial layer ratios
increased in PCL content, the intimal layer decreased the amount of stress imposed on it
while the adventitial layer took on more stress. This altered the structure of the stress
distribution where the 65-10-25 adventitial layer caused the CWS imposed on the intimal
layer to be less than that of the medial layer, a design that was clearly not intended in
native artery.
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Figure 28. Mathematical modeling using equations 3-8 to determine CWS on increases in
adventitial stiffness, while being compared to the moduli found in [32] and [33] for PCLELAS-COL samples. (a) Top graph represents the 45-45-10 medial layer, (b) middle
graph represents the 55-35-10 medial layer, and (c) bottom graph represents the 65-25-10
medial layer.
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Figure 29A-C displayed similar results to that of 28A-C where as the medial layer
was changed from a high ELAS content, 45-45-10, to a lower ELAS content, 65-25-10,
increased the amount of stress imposed on it. This was clearly evident through the
separation that occurred from the comparative CWS medial layer values of the Holzapfel
et al. study. Again, like Figure 28A the 45-45-10 medial layer seemed to have the best
match to the stress distribution of native coronary artery. As PCL content increases from
45-45-10 to 55-35-10, there is a marked increase in the CWS of medial layer and a
subsequent decrease in the stress of the intimal and adventitial layers. This is even more
pronounced with the 65-25-10 medial layer, where all scaffold combinations have a lower
CWS present in the intimal layer, an increase in CWS as it transitions to the medial layer,
and another drop in CWS as the stress transitions into the adventitial layer. Like some of
the results from Figure 28C, the stress distribution profile determined from the equations
did not match that of native artery, indicating that it could be too stiff.
The next step in modeling the stress distribution was to determine the how altering
the adventitial layers of the SF-based scaffolds changed the overall stress distribution for
each medial layer. Figure 29A showed that as PCL content was decreased there was a
slight increase in the CWS of the intimal layer, while there was also a slight decrease in the
CWS of the adventitial layer. This decrease in PCL content demonstrates a decrease in
modulus values and, therefore, a decrease in the amount of stress that is imposed on the
adventitial layer. Instead, this decreased stress is compensated by the intimal layer, which
increases in CWS. These results are seen also in Figures 30B and C. Interestingly, the
material which takes on the most stress in the intimal layer is 55-10-35 as opposed to 45169
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10-45. This indicates that the 55-10-35 adventitial layer should be one of the better
candidates for further investigation.
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Figure 29. Mathematical modeling using equations 3-8 to determine CWS on increases in
adventitial stiffness, while being compared to the moduli found in [32] and [33] for PCLELAS-SF samples. (a) Top graph represents the 45-45-10 medial layer, (b) middle graph
represents the 55-35-10 medial layer, and (c) bottom graph represents the 65-25-10 medial
layer.
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Compliance
Mean values for PCL-ELAS-COL vascular grafts, Figure 30, displayed average
results in the range of 0.4 - 1.8 %/100mmHg, while individual values went up as high as
2.4 %/100mmHg. While results demonstrated values not within the range of native artery,
they did provide some insight into crosslinking dependence. While material property
values demonstrated some differences between EDC and GEN crosslinked scaffolds,
compliance results displayed differences, which demonstrated that grafts crosslinked with
GEN, on average, had higher compliance values than those crosslinked with EDC. This is
especially evident for grafts electrospun with a 45-45-10 PCL-ELAS-COL medial layer,
where grafts with a 45-10-45 and 55-10-35 GEN crosslinked adventitial layers are
significantly higher (p < 0.05) than their EDC counterparts with values of 1.4 and 1.3
%/100mmHg, respectively, compared to 0.6 and 0.4 %/100mmHg for EDC, respectively.
In the 55-35-10 medial layer group, both 45-10-45 and 55-10-35 GEN crosslinked
adventitial layer grafts are significantly different (p < 0.05) from the same EDC
crosslinked grafts, portraying values of 1.2 and 1.4 %/100mmHg compared to 0.7 and 0.6
%/100mmHg. The 65-25-10 medial layer group did not display any significant differences
between EDC and GEN crosslinked grafts. Moreover, the GEN crosslinked grafts
exhibited significant differences (p < 0.05) as the medial layer changed from 45-45-10 to
65-25-10, where combinations of 45-45-10 medial layer with a 45-10-45 adventitial layer
were significantly different (p < 0.05) from combinations of 65-25-10 medial layer with a
45-10-45 adventitial layer. This was the same case for combinations containing the 55-1035 adventitial layer.

172

Compliance (% / 100mmHg)

173
2.4
2.2
2
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

45-45-10 EDC
55-35-10 EDC
65-25-10 EDC
45-45-10 Genipin
55-35-10 Genipin
65-25-10 Genipin

+

45-10-45

+

55-10-35

65-10-25

Adventitial Layer

Figure 30. Compliance values determined from external radii at arterial pressures of
120/80 mmHg for PCL-ELAS-COL tri-layered grafts.+ indicates significant difference
between 45-45-10 and 65-25-10 medial layer. Bars indicate significant differences
between samples.
Looking at Figure 31, grafts with an adventitial layer of 45-10-45 PCL-ELAS-SF
tend to increase in compliance as PCL content is increased in the medial layer where
average compliance of 45-45-10 medial layers with EDC and GEN crosslinking increase
from 0.6 and 0.3 %/100mmHg, respectively, to 0.9 and 1.3 %/100mmHg for EDC and
GEN 55-35-10 medial layers. Furthermore, GEN crosslinked 45-45-10 is significantly
different (p < 0.05) from 55-35-10. These results are opposite the expected results, and
could indicate that the amount of stiffness seen within the compliance results is due to SF.
Additionally, in order to overcome the stiffness caused by SF and result in an increased
distension of the graft wall, higher amounts of PCL must be added to the solution. In the
55-10-35 adventitial layer group, there were no significant changes for EDC crosslinked
scaffolds as PCL content was increased; however, GEN crosslinked scaffolds have
significant differences (p < 0.05) between the 45-45-10 medial layers, 1.4 %/100mmHg,
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and 65-25-10 medial layers, 0.3 %/100mmHg. Additionally, EDC 45-45-10 medial layers
with 55-10-35 adventitial layers are significantly different (p < 0.05) from GEN
crosslinked grafts. Finally, in the 65-10-25 adventitial layer group EDC crosslinked 4545-10 medial layer grafts have the highest compliance of the three medial layers and
amongst the whole group with a value of 1.0 %/100mmHg. GEN crosslinked 45-45-10
medial layer grafts have the second highest compliance in the group with a value of 0.9
%/100mmHg. Therefore, there were no significant differences between the EDC and GEN
45-45-10 medial layer grafts when combined with 65-10-25 adventitial layers.
Furthermore there were no significant differences between any of the EDC and GEN
crosslinked grafts in the 65-10-25 group. However, there was a decrease in average
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Figure 31. Compliance values determined from external radii at arterial pressures of
120/80 mmHg for PCL-ELAS-SF tri-layered grafts.+ indicates significant difference
between 45-45-10 and 65-25-10 medial layer. Bars indicate significant differences
between samples.
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Burst Strength
The burst strength of all the PCL-ELAS-COL grafts in Figure 32 exceeded the
standard 1600 mmHg that is associated with saphenous vein [163]. Notably, the only
grafts that possessed values which increased as the PCL content of the medial layer was
increased were the grafts in the 45-10-45 adventitial layer group. While EDC crosslinked
grafts did not significantly change as the stiffness of the medial layer was increased, GEN
crosslinked grafts did change (p < 0.05) increasing from a value of 1614 mmHg, 45-45-10,
to a value of 2403 mmHg, 65-25-10. These increases due to an increase in medial layer
stiffness were also seen in the 55-10-35 adventitial layer group for both EDC and GEN
crosslinking. For this group, 45-45-10 and 65-25-10 EDC crosslinked scaffolds increased
from an average value of 2465 to 3059 mmHg and 45-45-10 and 65-25-10 GEN
crosslinked scaffolds increased from 2635 to 2946 mmHg, both of which were
significantly different (p < 0.05). Looking at the 65-10-25 adventitial group, the results for
EDC crosslinked grafts were all very similar and exhibited no significant differences.
However, GEN crosslinked grafts, while retaining very high values, increased in burst
strength from values of 3055 to 3464 mmHg for 45-45-10 and 65-25-10 medial layers,
respectively. These values were not significantly different. Lastly in Figure 32, there is a
gradual trend from the 45-10-45 to the 65-10-25 adventitial group, indicating that as PCL
the adventitial layer becomes stiffer the burst pressure increases which reinforced the
results from the mathematical modeling.
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Figure 32. Burst pressure results for tri-layered specimens with changes in the both the
medial layers and adventitial layers for PCL-ELAS-COL grafts. + indicates significant
difference between 45-45-10 and 65-25-10 medial layer. Bars indicate significant
differences between samples.
Examining Figure 33, PCL-ELAS-SF burst strength results revealed very different
results from PCL-ELAS-COL. Studying the 45-10-45 adventitial layer group, it was
evident that neither EDC nor GEN produced significantly different results from each other
or from amongst them. For example, 45-45-10 medial layer combinations are no different
from 65-25-10 medial layer combinations for EDC crosslinking, and averages for GEN
crosslinked 45-45-10 combinations are only slightly less than 65-25-10 combinations with
values of 2146 and 2361 mmHg. The 55-10-35 adventitial layer grafts demonstrated
gradual increases in burst strength as the medial layer incrementally increased in PCL
content for both EDC and GEN crosslinked grafts. Again for this 55-10-35 group, there
were no differences between EDC and GEN crosslinked grafts. However, there were
differences as the medial layer increased its stiffness, where 45-45-10 grafts were
significantly different from 65-25-10 grafts for both EDC and GEN crosslinking.
Examining the 65-10-25 adventitial group, there were again differences (p < 0.05) between
176

177
the 45-45-10 and 65-25-10 medial layer combinations for both EDC and GEN
crosslinking. Moreover, for both 55-10-35 and 65-10-25 adventitial groupings there were
no differences between the 45-45-10 and 55-35-10 medial layer graft combinations.
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Figure 33. Burst pressure results for tri-layered specimens with changes in the both the
medial layers and adventitial layers for PCL-ELAS-SF grafts. + indicates significant
difference between 45-45-10 and 65-25-10 medial layer.
Compliance and Burst Degradation
Degradation was carried out over a period of 4 weeks to determine if there were
any immediate degradation characteristics which would impact the compliance and burst
strength properties of the top tri-layered vascular grafts. Figure 34A and B depict the
compliance results for grafts containing COL and SF, respectively. Figure 34A
demonstrated a significant increase (p < 0.05) in compliance for 65-10-25 adventitial layer
grafts with a 45-45-10 medial between week 0 and week 2 and between week 1 and week
2. Additionally, there was a significant increase (p < 0.05) in compliance from week 1 to
week 2 for grafts with a 45-10-45 adventitial layer and 45-45-10 medial layer. However,
week 4 compliance results were not different from weeks 0 and 1. Interestingly, the
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average values for the 55-10-35 adventitial layers with either a 45-45-10 or a 55-35-10
medial layer incrementally increased from week 0 to week 2, and compliance results for
55-35-10 medial layer displayed a significant difference from week 0. Furthermore, both
the compliance of the 65-10-25 adventitia 45-45-10 media and 55-10-35 adventitia 55-3510 media grafts were within range of native artery.
Figure 34B showed that SF grafts had significant decreases (p < 0.05) in
compliance between week 1 and 2 for 55-10-25 adventitial layer grafts with 45-45-10
medial layers. Additionally, the 65-10-25 adventitia with a 45-45-10 media increased in
average compliance from week 0 to week 2; however, the difference was not significant.
Average compliance values for SF grafts did not reach into the range of native artery.
Nonetheless, they did display fairly consistent values amongst the grafts. This would
indicate that there was no degradation over the course of two weeks whereas it seems that
in Figure 34A COL containing grafts may have experienced slight amounts of degradation.
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Figure 34. Compliance values for a 4 week degradation study determined from external
radii at arterial pressures of 120/80 mmHg. (a) Top graph represents PCL-ELAS-COL trilayered grafts and (b) bottom graph represents PCL-ELAS-SF tri-layered grafts. ^
indicates a significant difference from weeks 0 and 1.
Figure 35A and B described the burst strength properties of grafts degrading over a
4 week period. It was expected that if any degradation was happening to the grafts, then a
decrease in burst strength would have occurred. In the case of the PCL-ELAS-COL grafts
in Figure 35A, there was a significant decrease (p < 0.05) between week 0 and 2, week 0
and 1, and week 0 and 4 for 65-10-25 adventitia with 45-45-10 media. Additionally, grafts
with a 55-10-35 adventitia and a 55-35-10 media were significantly different (p < 0.05)
179

180
between week 1 and week 2. Furthermore, 45-10-45 adventitia 45-45-10 media grafts
significantly increased (p < 0.05) in burst strength from week 0 to week 4 but there were
no differences amongst weeks 1, 2, and 4.
Figure 35B revealed a significant decrease (p < 0.05) in burst strength for grafts
with a 55-10-35 adventitia and a 45-45-10 media between week 0 and week 4, while 4510-45 adventitia with a 55-35-10 media significantly increased in burst strength from week
0 to week 2. Finally, 65-10-25 adventitia with a 45-45-10 media significantly decreased (p
< 0.05) between week 1 and week 2, and the average burst pressure from week 4 was still
lower than that of week 1 but similar to week 0.
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Figure 35. Burst pressure results for tri-layered specimens with changes in the both the
medial layers and adventitial layers during a 4 week degradation study. (a) Top graph
represents PCL-ELAS-COL tri-layered grafts and (b) bottom graph represents PCL-ELASSF tri-layered grafts. * indicates a significant difference from week 4. # represents a
significant difference from week 2.
If a correlation is made between the compliance and burst results, then we could
determine whether or not degradation was truly occurring or if the differences were mere
coincidence. Observing the PCL-ELAS-COL grafts, the only graft to display a possible
difference in properties due to degradation was the 55-10-35 adventitia with a 55-35-10
media due to a simultaneous increase in compliance and decrease in burst strength from
week 0 to week 4. For PCL-ELAS-SF grafts, there was no correlation to indicate that
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degradation had occurred within a group of grafts. Therefore, some degradation may
perhaps be occurring with grafts containing COL whereas there is most likely no
degradation occurring amongst the SF grafts.

Discussion

Material Properties
The properties of individual layers provide some clues as to how a multi-layered
vascular graft should perform under physiological conditions when these results are used
in conjunction with a mathematical model. First, peak stress indicates how much stress or
pressure can be applied to the structure prior to rupturing. If the desired medial layer is
one that is fairly weak with stress values around 1 MPa, its surrounding layers need to be
able to take the majority of the imposed stress. Second, modulus indicates how stiff the
layer is going to be, which will contribute to the overall compliance of the graft. This is a
measure of the slope in the linear region of a material prior to reaching its yield point,
where it has undergone only elastic deformation. Third, strain to break indicates how far a
material will yield prior to failure. This is also important for vascular grafts because it
provides further insight into how a material will fail, brittle failure or ductile failure. Most
polymeric materials would be considered to fail under the ductile category; however, these
materials could have a more brittle ductile failure where the material does not yield a
significant distance. Fourth and finally, energy to failure displays information about how
much energy a material can absorb prior to rupture. This is calculated by taking the area
under the force v. strain curve. If the energy to failure is high, then a material could have
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either had a high peak stress with a short strain to break distance, or it could have had a
long strain to break distance with a low peak stress.
For a native artery, material properties are extremely important to be able to
decipher the specifics of a tissue. Previous studies which have investigated muscular
arteries were not based on experimental data of individual layers such as the intima, media,
and adventitia. Instead, these works were based on the biomechaincs of the whole tissue
[269, 273]. These early studies considered the vessel wall to consist of homogenous
material and the mechanical properties were considered to be uniform throughout the
vessel wall [297, 298]. However, native arteries are not completely homogenous materials,
containing three different layers, each of which possesses its own biomechical design to
support the functionality of the artery. Currently, there have been studies which aimed to
analyze the biomechanics of each individual layer either as a two layer model or as a three
layer model [265, 266, 271]. Two layer models typically leave the intima and media intact
and separate the adventitia, while three layer models carefully separate the intima, media,
and adventitia, a tedious process. These studies have demonstrated the specific
biomechanics in each layer through the use of uniaxial tensile testing. The results from
these tests are then utilized to determine composition, how the tissue behaves, and
eventually aid in the development of an equation to predict how a native artery will behave
under different circumstances. This same logical approach was used in this study.
Determining the specific mechanical properties of each electrospun material assists
in the overall design of a tri-layered vascular graft. According to Table 10, the only
significant differences that occurred between EDC and GEN were the 65% PCL groups.
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These results showed that when crosslinked with GEN there was a decrease in overall peak
stress. This same behavior was shown in a previous study for 50-50 PDO-ELAS scaffolds
and pure ELAS scaffolds [110], which helps to support the claim that slight changes exist
between the EDC and GEN crosslinked scaffolds. For PCL-ELAS-SF blended scaffolds in
Table 11, peak stress also decreased for each scaffold type, and significant differences
existed between 65-25-10, 45-45-10, and 45-10-45 EDC and GEN scaffolds. Unlike peak
stress, modulus did not display any type of similar trend except for the higher PCL content
scaffolds being different from the lower PCL content scaffolds for ELAS-, COL-, and SFbased scaffolds, a trend that is consistent amongst all materials tested in this study. While
both peak stress and modulus displayed similar trends for both PCL-ELAS-COL and PCLELAS-SF scaffolds, strain to break did not exhibit any similarities despite both sets of
failure values occurring mostly between 30.0 and 60.0 % elongation.
GEN is a crosslinker that has not received a great deal of attention and has been
used in only a handful of studies. Within these studies, mechanical testing has been
performed. One of the hypotheses made in this study was that the long molecular structure
of GEN would result in longer strain to breaks and lower elastic moduli and lower peak
stress values. In a study by Vieth et al., scaffolds were created through coacervation and
subsequent crosslinking of recombinant ELAS-based polypeptide with either
pyrroloquinoline quinone (PQQ), another zero-length crosslinker, or GEN [288]. The
results from the study demonstrated that PQQ-crosslinked sheets exhibited a lower
modulus and peak load, and a higher strain to break than GEN crosslinked sheets.
However, they also measured the number of lysines remaining, and PQQ had a
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significantly lower number of lysines remaining after crosslinking. Therefore, instead of
the molecular length of the crosslinking reagent making a difference in the tensile
properties for our particular study, the differences would most likely be due to how well
the electrospun materials crosslinked themselves. In another study, COL based constructs
were crosslinked using EDC, GEN, and formaldehyde [283]. Here, they found that COL
gels crosslinked with GEN had a higher strain to break than EDC constructs, while
modulus and peak stress remained similar. Interestingly, the study looked at gelation time
and tensile properties, finding that modulus increased as gelation time increased while
strain to break decreased, and peak stress remained unchanged.
Both these ELAS and COL gel studies demonstrate that crosslinking time is a clear
major issue that should be tailored when considering using crosslinking. The ELAS gel
study showed that PQQ contained less lysines which would indicate that it had a lower
amount of crosslinking. This increased strain to break and decreased modulus which could
be due to the crosslink bond built during the reaction period. If the bond was weaker due
to a lower crosslinking percentage, then the molecular structure would retain more
mobility to stretch, increasing its strain to break values. The COL gel study reiterated this
idea where gelation time increased modulus and decreased strain to break. This
demonstrated that as the bonds had more time to form their strength increased
significantly, making the structure stiffer and which caused the bonds to become more
“brittle”.
Turning back towards our hypothesis, these experiments by Vieth and Madhavan
do not support the idea that a longer molecular structure would cause the peak stress and
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modulus to decrease while strain to break increased. These, however, differ in a lot of
ways in comparison to this particular study. Both Vieth and Madhavan tested gelled
constructs which have a very different microstructure than electrospun fibers.
Additionally, our study utilizes a synthetic polymer as well, which dominates the
mechanical environment. The decreases seen in peak stress are most likely due to the
combination of PCL, ELAS, and COL. The interaction of these polymers in solution
created a different fiber composition for each construct with different chain entanglements
and molecular weights. In the ELAS-based constructs we have a decrease in peak stress
for 45-45-10 – 65-25-10. However, in the COL-based materials, there is a slight increase
in the 45-10-45 scaffolds for GEN crosslinking, but then as the content of COL decreases
the ELAS is able to take on more of the mechanical loading. When this ELAS is
crosslinked with GEN, it takes on a lower peak stress.
Energy to failure results demonstrated differences between the crosslinkers. For
almost every case, the energy to failure values decreased when GEN was used as the
crosslinker, excluding the 45-10-45 scaffolds. Differences between EDC and GEN for
energy to failure values were found for only the 65-25-10 PCL-ELAS-COL scaffold.
Nevertheless, based on the tensile test results, differences between the crosslinking
reagents could not be conclusively drawn. Since the moduli were similar for both EDC
and GEN structures, EDC crosslinked structures were chosen to be used in the modeling
equations so as to simplify the data presented in the models.
Mathematical Modeling
Mathematical modeling is an excellent way to use predictive methods and
compares those results to your experimental results. In this experiment, we wanted to be
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able to use the uniaxial tensile test results for each polymer of interest and plug those into a
set of equations. The intention was to compare those predicted results to the experimental
results from compliance and burst strength. This would then validate the model or
demonstrate the need to change the predictive model something more complex. Overall,
the model used in this experiment is a relatively simple, algebraic one, which was
previously developed by Vorp et al. to help predict how implanted vascular grafts would
behave as they degraded and were subsequently taken over by ECM [261]. Native tissue
has been studied relentlessly, using mechanical properties and mathematical modeling of
coronary intima, media, and adventitia to gain information that explains how the arterial
wall reacts under physiological conditions [120, 265, 266, 269-273]. Many of these
models use a strain-energy function in a quasi–linear viscoelastic equation. These
equations are typically complicated and require time consuming efforts to derive results.
The Vorp et al. model used in this experiment, however, displays the necessary
information required, such as the CWS, to predict how materials will behave with one
another. The results from the compliance and burst strength data were tested and
subsequently compared to the model predictions.
Compliance and its Relation to Modeling
It is commonly agreed upon that compliance mismatch between native artery and
an implanted graft is one of the fundamental causes of intimal hyperplasia and long-term
graft occlusion. At the small diameter level, grafts that retain compliant properties on the
order of native artery are highly necessary. The low flow environment exponentially

187

188
increases the opportunity for complications to occur. This is the predominant reason why
ePTFE grafts possess a very low patency rate for small diameter blood vessels. It is also
the reason for the use of saphenous vein as the coronary bypass gold standard. Although
native vein contains an altered ECM in comparison to artery, it retains a tri-layered
structure, has an endothelial lining, and will adapt itself well to the new physiological
pressures imposed on its wall.
An off-the-shelf vascular graft would be ideal for bypass graft cases because it
would not involve tissue excision from a vascular site. A tri-layered vascular graft is an
ideal vascular replacement because of its tailorability. In this case, we tested how the
stiffness of a biodegradable material affects compliance values through changes to the
medial and adventitial layer. The results from this study exhibited differences from the
trends seen in the preliminary study, where medial layer stiffness was changed while
intimal and adventitial layers remained constant. Differences between that study and this
are demonstrated through the types of materials used in the adventitial layer. The
preliminary study only used a combination of 70-30 PCL-COL which exhibited excellent
qualities, but with the side affects of frequent delamination, causing several grafts to be
electrospun prior to obtaining one that was free from delamination. One of the main
objectives with this study was to find a way to fine tune the adventitial layer so that
delamination would no longer be an issue. This was accomplished through the inclusion of
a small percentage of ELAS, and allowed us to test adventitial layers containing high
amounts of COL protein (45-10-45), a beneficial addition to enhance cellular adhesion,
growth, and migration.
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In Figure 30, PCL-ELAS-COL blends, EDC crosslinked grafts displayed results
opposite what was found in the preliminary study; compliance increased as ELAS content
decreased regardless of the adventitial layer. GEN crosslinked grafts, all manufactured in
the same manner as EDC grafts, exhibited trends like those seen in the preliminary study,
where combinations of 45-45-10 medial layer with a 45-10-45 adventitial layer were
significantly different from combinations of 65-25-10 medial layer with a 45-10-45
adventitial layer. This was also the same case for combinations containing the 55-10-35
adventitial layer. There were no changes in the 65-10-25 adventitial layer group.
Additionally, as PCL content incrementally increased in the adventitial layer, the
compliance decreased incrementally. When a linear regression analysis was performed to
quantify these changes, the 45-45-10 medial layers contained an r-squared value of 0.91
while 55-35-10 medial layers contained an r-squared value of 0.59; an indication that both
medial layers displayed adequate increases in stiffness as the adventitial layer increased in
stiffness. The results of the GEN crosslinked scaffolds matched the predicted data from
the mathematical analysis. However, EDC crosslinked scaffolds did not match the
predicted model, where a stiffer medial layer would produce a lower compliance. The data
did match when the adventitial layer stiffness increased. For example, the 65-25-10 medial
layer exhibited an R-squared value of 0.86 in addition to the 45-45-10 medial layer
displaying an R-squared value of 0.56. 55-35-10 medial layer displayed an R-squared
value of 0.68, but its trend line increased in compliance as the adventitial layer increased in
stiffness.

189

190
Figure 31 displays the results from the PCL-ELAS-SF vascular grafts. According
to the mathematical model, the SF grafts in combination with the 55-10-35 adventitial
layer should prove to be beneficial with a high compliance while 45-10-45 and 65-10-25
incrementally increased in stiffness. Unfortunately, all of the EDC crosslinked grafts from
this 55-10-35 group failed to produce desirable compliance values. Moreover, the only
graft which possessed attractive compliance results out of the 55-10-35 adventitia group
was the GEN crosslinked 45-45-10 medial layer. The GEN crosslinked group also
produced results that matched that mathematical model where the compliance decreased as
the medial layer stiffened. This is demonstrated through a linear regression analysis where
the R-squared value is 0.83. 45-10-45 adventitial layer grafts displayed average
compliance results between 0.8 and 1.3 %/100mmHg. However, neither the EDC nor the
GEN crosslinked grafts matched the model as the PCL content of the medial layer
increased. It appeared that 65-10-25 adventitial layer grafts displayed results that matched
the modeling data for both EDC and GEN where the compliance decreased as the medial
layer gained more PCL. When these results were analyzed further for the 65-10-25 group,
EDC grafts displayed regression R-squared values of 0.85 while the GEN crosslinked
group had an R-squared value of 0.12. Based on the linear regression analysis GEN grafts
did not satisfy the mathematical model despite their decrease in compliance.
Burst Strength and its Relation to Modeling
Burst strength of the all grafts demonstrated ample ability to withstand pressure.
The bursting properties also showed how changing the medial or adventitial layers of the
graft material influenced its final burst pressure, proving that as the medial stiffness is
increased the stresses imposed on both the intimal and adventitial layers are reduced and
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allowing the graft to take on more pressure prior to bursting. This is demonstrated in the
PCL-ELAS-COL grafts depicted in Figure 32. Grafts within the 45-10-45 adventitial layer
group displayed, on average, the lower burst pressures of the three adventitial groups, the
lowest belonging to GEN 45-45-10 at 1614 mmHg. On the other side of the spectrum,
grafts within the 65-10-25 adventitial layer group showed averages around 3000 mmHg.
As the adventitial layers were incrementally increased with PCL, the burst pressure
incrementally increased as well. This was shown through linear regression analysis where
medial layers of 45-45-10 had an R-squared value of 0.94, 55-35-10 with incrementally
increased adventitia had a value of 0.99, and this value was the same for 65-25-10 grafts.
Additionally, as the medial layer was increased burst values rose. Linear regression proves
this with R-squared values of 0.94, 0.89, and 0.99 for 45-10-45, 55-10-35, and 65-10-25
adventitial groups, respectively. Therefore, PCL-ELAS-COL grafts, under burst pressure,
exhibited values which were in agreement with the mathematical model, demonstrating
that as PCL content increased and the materials became stiffer there was a subsequent
relief of stress from other layers, allowing them to take on more pressure, thereby
increasing burst strength.
Observing grafts from Figure 33, PCL-ELAS-SF grafts demonstrate that they do
not fit with the mathematical model. Examining each of the adventitial layer groups, both
the EDC and GEN 45-45-10 and 55-35-10 medial layers with increasing adventitia
stiffness displayed a decrease in burst strength. This was echoed by their linear regression
R-squared values of 0.99 and 0.47 for EDC 45-10-45 and 55-10-35, and R-squared values
of 0.99 and 0.69 for GEN 45-10-45 and 55-10-35, respectively. Additionally, EDC 65-25191
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10 medial layers with increasing adventitia had a positive increase in burst strength with an
R-squared value of 0.93. GEN 65-25-10 medial layers displayed a positive increase but
the R-squared values were 0.30. This clearly demonstrates that burst pressure in fact went
down for adventitial layers of 45-10-45 and 55-10-35, indicating that as less SF was
introduced to the scaffold, the overall graft stiffness decreased. However, an encouraging
fact was that as the medial layer increased in stiffness, PCL-ELAS-SF grafts increased in
burst pressure, indicating that ELAS was still interacting as it should with the graft
materials. This was shown through the R-squared values of 0.88 and 0.73 for EDC 55-1035 and 65-10-25 adventitial layers and values of 0.80 and 0.88 for GEN 45-10-45 and 5510-35 values, respectively. Both EDC 45-10-45 and GEN 65-10-25 displayed regression
lines which were flat so they were not considered to have increased in burst pressure.
Choosing the Best Grafts: Compliance v. Burst Strength
With the large amount of data available through this study, considering two
different polymer blends and observing the differences that occur when the ratios of their
electrospun materials are changed. Simultaneously, these different structures are
crosslinked with two different reagents in incrementally changed combinations. In the
end, a total of 36 different graft and crosslinking combinations were used in this
experiment. In order to narrow down the data to the top 3 grafts from the COL group and
the top 3 from the SF group, burst strength and compliance were plotted together. These
results are displayed in the scatter plot below in Figures 35 and 36. One of the key features
of Figure 34 demonstrates how the majority of EDC crosslinked scaffolds are clustered
together at lower compliance values and higher burst strength. This portrays the idea that
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scaffolds with lower burst strength values acquire higher compliance values. This is
equally evident in Figure 35. However, there are grafts that have burst strength values
around 1600 mmHg, yet they fail attain higher compliance values. This only further
demonstrates how PCL-ELAS-SF grafts did not behave as expected. This unexpected
behavior can be attributed to the SF. Prior to the beginning of the experimental design,
preliminary studies were done to determine if SF would be a good candidate for vascular
testing. Under these tests it demonstrated more than desirable results with high
compliance values and adequate burst pressures. This has been further shown in several
experiments which have researched SF and electrospun SF [277, 299]. For reasons not yet
determined, the SF scaffolds exhibited lower average burst strength than the COL
scaffolds. Several reasons can be speculated.
1. Chapter 4 displayed the fiber diameter results and SEM images of the different
blends. The larger fiber diameters that occurred with higher SF content could have easily
created large pores which would have a great deal of permeability. This permeability
could account for the low compliance values tested on the ITEMS® bioreactor, failing to
provide even pressure on the fibers where the majority of the PBS (the incompressible
fluid to cause cyclic distension) would be pushed out of the graft. 2. SF has a significant
amount of strength. Naturally, SF displays a great deal of strength. When this is
electrospun with a synthetic polymer, it may produce results that impart stronger tensile
properties as compared to SF by itself. In a recent study done by our lab, PCL-SF and
PDO-SF grafts were electrospun in random and aligned forms. These were then tested for
compliance yielding averages near 0.5 %/100mmHg [113]. Although those compliance
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values were larger than PCL, it could mean that a limit is reached when SF is added to the
system. These speculations can be tested in future studies to determine permeability
results using the ITEMS® bioreactor without fluid on the outside of the graft. The inlet
flowrate would be set and the amount of time would be measured to reach a specific
volume. Additionally, further whole graft testing with SF would be made in specific
combinations with ELAS and PCL to examine grafts under compliance, burst, and uniaxial
tensile testing.
In any case, GEN crosslinked scaffolds displayed the top results for both Figure 36
and 38. For Figure 36, a cut-off point was made at 1.3 %/100mmHg compliance. In
Figure 38, a cut-off point was made at 1.0 %/100mmHg. These cut-off marks provided the
top results which were: 1.) GEN 45-45-10 with 45-10-45, 2.) GEN 45-45-10 with 55-1035, 3.) GEN 55-35-10 with 55-10-35, and 4.) EDC 45-45-10 with 65-10-25 PCL-ELASCOL. 1.) GEN 45-45-10 with 55-10-35, 2.) GEN 55-35-10 with 45-10-45, and 3.) EDC
45-45-10 with 65-10-25 PCL-ELAS-SF. Each of these grafts was electrospun again and
examined for degradation characteristics.
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Figure 37. Burst strength v. Compliance to determine best overall PCL-ELAS-SF trilayered grafts for future testing.
Compliance and Burst Degradation
When biodegradable materials are implanted in vivo, they experience both
hydrolytic and enzymatic degradation. PCL is a long degrading polymer that has been
shown to degrade, in vitro, over a period of 12 months. Studies have been performed in
vivo with electrospun PCL vascular grafts implanted in the descending aorta of rats [93].
This study found that PCL, at both molecular weights of 120 and 80 kDa, began to degrade
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after 3 weeks implantation and had degraded by 20% after 24 weeks of implantation. They
concluded that the degradation characteristics were most likely due to the cleavage of the
ester linkages, but may have also been produced by enzymatic degradation by lipases,
although these characteristics had not been shown in humans. Additionally, degradation of
biodegradable polymers such as PCL has exhibited faster degradation in vivo rather than in
vitro. This accounted for the dramatic drop in molecular weight seen over 24 weeks.
Other studies have, such as Bolgen et al. [94] have revealed a molecular weight
degradation of 30% after just 3 months.
While PCL degrades mainly due to hydrolytic properties, crosslinked ELAS, COL,
and SF would all have to undergo enzymatic degradation. In a study done by Mercuri et
al., a comparison was done between glutaraldehyde (GLUT), EDC, and periodate fixations
for a glycosaminoglycan (GAG) aortic leaflet [300]. Once fixed, these GAG scaffolds
were placed in degrading enzymatic media. Quantification of hexosamines was then
performed to determine the amount that the structure had degraded over a period of 24
hours. Results determined that fresh leaflets and GLUT crosslinked were significantly
digested. However, EDC crosslinked scaffolds significantly resisted enzymatic digestion.
Therefore, crosslinking of scaffolds can significantly alter the amount of time taken to
digest the molecular bonds within ELAS and COL proteins. Moreover, SF proteins have
also been found to degrade by way of proteolytic digestion [301], which can take in excess
of 12 months.
Looking at the degradation characteristics, it appears that a 4 week period did not
degrade the polymeric scaffolds. It appears that in some cases there may have been some
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batch to batch variations which could have been caused by degradation, non-homgeneity
from the electrospinning process, or non-homogeneity in the cross-linking process. For
example, there was an increase in compliance and a slight decrease in burst strength for the
EDC crosslinked 65-10-25 adventitia with a 45-45-10 media PCL-ELAS-COL after 2
weeks. However, week 4 compliance results revealed similarities to weeks 0 and 1.
Meanwhile, 55-10-35 adventitia 55-35-10 media PCL-ELAS-COL grafts showed a gradual
increase in compliance and a decrease in burst from week 0 to week 4, which could
demonstrate degradation. Nonetheless, week 2 burst strength for these same grafts was the
highest of the 4 values. While other PCL-ELAS-COL scaffolds seemed to slightly
increase in compliance, yet they did not yield lower burst strength values. PCL-ELAS-SF
grafts did not indicate that any degradation had occurred amongst the scaffolds. This is
indicative that not only did PCL slightly degrade, but COL and ELAS may have also
degraded as well due to the FBS inclusion in the degradation media. FBS has been shown
to contain enzymes which would increase degradation rates. Additionally, COL scaffolds
demonstrated higher degradation characteristics when compared to SF scaffolds. This
could have transpired due to either a low crosslinking molarity, producing weaker
crosslinks in both EDC and GEN, or SF’s slow degradation process. As future degradation
time periods are assessed, it will become clear whether or not degradation of the graft wall
is occurring.

Conclusion
In conclusion, we were able to produce nano- to micro-fibrous three-layered small

diameter vascular grafts with distinct material properties for each layer. These layers were
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then applied to a mathematical model which displayed the transmural stress distribution in
the wall of the graft. The results from the compliance and burst strength data proved to
change the overall graft properties with incremental changes in scaffold protein. From
these experiments, grafts with the best combined compliance and burst properties were
chosen to be tested in a 2 week degradation experiment. This experiment displayed signs
that some of the grafts were degrading, increasing compliance without a loss of burst
strength below 1600 mmHg, and with no signs of delamination between the layers. This is
encouraging for future work towards an implantable tri-layered vascular graft, where we
will evaluate the cellular characteristics of the graft materials.
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Chapter 6: Integrin Binding Analysis of PCL, Collagen, Elastin, and Silk
Abstract
It is well known that a number of integrins (α1β1, α2β1, α3β1) bind to Type I COL

in a RGD independent manner and the αvβ3 integrin binds with high affinity to denatured
COL in a RGD-dependent manner. It has also been suggested, in some cases, that the
αvβ3 integrin binds to ELAS through the VAVPG complex. However, debates still
circulate about electrospun COL dissolved in hexafluoroisopropanol (HFP) maintaining its
ability to bind β1 integrins. Additionally, limited adhesion research has been performed on
SF to determine whether any ligand binding sites exist. The hypothesis of this study was
that cells would adhere to electrospun COL and ELAS mostly through integrin β1 and β3,
respectively. Human umbilical artery smooth muscle cells (hUASMC) were seeded onto
crosslinked and uncrosslinked COL, ELAS, and SF blended scaffolds to test for cell
adhesion. Cell seeding was done in the presence or absence of anti-integrin β1 and β3 to
quantify adhesion to electrospun scaffolds. In addition, an SDS Page was run to compare
both extracted COL and electrospun COL to known COL type I sources in addition to
soluble ELAS compared to electrospun ELAS. The western blot results demonstrated that
extracted and electrospun COL retained its α1(III), α1(II) and α2(I) chains unlike
electrospun gelatin (denatured COL). ELAS did not demonstrate any specific molecular
weights, appearing as a smear; however, its recovered electrospun form contained no
smear possibly showing a change in structure. Cell adhesion data showed that COL
dissolved in HFP had excellent adhesion, a significant decrease in cell number with antiintegrin β1, indicating that COL was not denatured by HFP. ELAS dissolved in HFP
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demonstrated poor adhesion which was similar to that of bovine serum albumin (negative
control), while ELAS dissolved in PBS decreased cell adhesion but did not completely
inhibit it. SF blended scaffolds demonstrated a decrease in adhesion when anti-integrin β3
was utilized compared to no treatment. Finally, cross-linking appeared to significantly
decrease cellular adhesion to electrospun scaffolds. In conclusion, COL dissolved in PBS
or HFP enhanced cell adhesion when uncross-linked, but lost those properties when crosslinked with EDC. ELAS blocked adhesion, while PCL alone proved to be adherent
independent from integrins β1 or β3, and SF proved to be adherent independent from
integrin β1.

Introduction
The architecture of the vascular wall is highly intricate and requires unique

biomechanical properties in order to function properly. Native artery is composed of a mix
of COL, ELAS, ECs, SMC, FBs, and proteoglycans arranged into three distinct layers: the
intima, media, and adventitia. Throughout artery, COL and ELAS play an important role,
providing a mechanical backbone, preventing vessel rupture, and promoting recovery
while undergoing pulsatile deformations [2]. The low-strain mechanical response of artery
to blood flow is dominated by the elastic behavior of ELAS which prevents pulsatile
energy from being dissipated as heat [293]. Previous work has shown the ability to
fabricate multi-layered electrospun scaffolds composed of PCL, ELAS, COL, and SF, and
their associated mechanical advantages. PCL was chosen, in this case, to provide
mechanical integrity and elasticity, while ELAS, SF, and COL would provide further
elasticity and bioactivity [104, 253]. However, when the grafts were implanted in the
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descending aorta of a rat, cellular results depicted adherence of cells to the outer surface
and inner lumen without infiltration. Therefore, further graft optimization was required.
The hypothesis of this study was that blended polymers and biopolymers would be
conducive for cellular attachment through specific integrin binding sites.
Integrins are a family of the extracellular matrix (ECM) receptors that bind a broad
variety of ligands. A functional integrin receptor is a bidirectional signaling complex that
is composed of two transmembrane subunits, an alpha (α) and a beta (β) chain [302-304].
Typically, an integrin binding event is mediated by these α and β subunits, anchoring the
extracellular environment to the intracellular environment. These binding events allow a
cell to detect and respond to specific extracellular constituents, essentially allowing the
cells to evaluate the composition of the surrounding microenvironment. Once a cell is
bound to a specific ligand, that bound complex can either produce mechanical or
biochemical signaling conditions which can influence events that impact the local
microenvironment that surrounds the cell. The identity and profile of integrins present on
the cell surface may be modulated in response to developmental events in the progression
of pathophysiological disease states [302].
The mechanistic events that regulate SMC migration into the arterial intima play an
important role in atherosclerosis. While these mechanisms may seem to play a negative
role in native tissue, they could prove to be advantageous in the tissue engineering of a
blood vessel. During arterial remodeling, both nondividing and proliferating SMCs
migrate out of the muscle media and through the internal elastic lamina to increase the
intimal SMC number. Factors that affect the cell’s ability to adhere to the ECM alter the
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balance between cells stability and cell mobility [305]. In terms of tissue engineering, the
desired role of a cell is to first enter the mobile state and then progress towards a more
stable state as the scaffold material is taken over by cells and remodeled. Two of the major
components of the ECM which surround medial SMCs are COL type I and ELAS. COL
type I is known to promote cell adhesion and migration in addition to influencing the
phenotypic appearance of the SMC [305]. In vivo, it has been traditionally thought that
ELAS was a protein which did not retain the typical ligands which bind cellular integrins
and therefore did not participate in cellular adhesion. However, recent evidence points
towards an EBP sequence, Val-Ala-Pro-Gly (VAPG), which has shown to possess
adhesive properties when seeded with SMCs. These ELAS sequences have been shown to
bind to non-integrin receptors, a galactoside-binding protein, with high affinity [306].
Furthermore, the ανβ3 integrin has demonstrated an affinity to the VGVAPG sequence
which is associated with the EBP sequence [307].
The ligands which bind integrins to COL have been well established. There are
four COL-binding integrins, α1, α2, α10, and α11 which each complex with a β1 subunit
to form a functioning receptor. The α1β1 integrin has been implicated in activation of the
Ras-MAPK signaling cascade, which directs cellular functions such as proliferation and
survival [308]. The α2β1 integrin on ECs is involved in angiogenesis; however, this
integrin also play a role in platelet activation and aggregation [303, 308, 309]. A defining
feature of COL is a tightly packed left-handed triple helix made of polypeptide segments
with repeating GXY triplets. The small Gly residue fits in the interior of the triple helix,
and the X and Y positions are often occupied by proline and hydroxyproline residues
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[310]. Several recognition sequences have been identified, GFOGER and GLOGER
(where O is hydroxyproline) represent binding sites for α1β1 and α2β1 [308, 311].
Additionally, these same integrins can interact with other amino acid sequences present in
COL, which can be more promiscuous, such as Arg-Gly-Asp (RGD). Nevertheless, the
binding of the α1β1 and α2β1 integrins to RGD sequences are done in an RGDindependent manner, whereas ανβ3 binds very strongly to denatured COL in a RGDdependent manner [312].
In order to display these proteins to SMCs in matrix form via a scaffold, several
scaffolding techniques have been employed. One of those, electrospinning, has
demonstrated great promise in the field of vascular tissue engineering. Our lab has
recently electrospun vascular materials in combination with COL type I, ELAS, and SF
[109, 111-113, 152]. Additionally, there have been multiple other studies performed on
electrospun COL, ELAS, and SF scaffolds, displaying cell adhesion under normal cell
culture conditions [131, 133, 287, 313], which include fetal bovine serum (a liquid
containing high concentrations of adhesive proteins). However, none of those studies
performed any analysis on their integrin binding characteristics. Therefore, we aimed to
study the adhesion of human umbilical artery smooth muscle cells (hUASMC) to blends of
PCL, COL, ELAS, and SF through a cell adhesion inhibition experiment using antiintegrin β1 and anti-integrin β3 to further elucidate the cellular properties of these
commonly electrospun proteins.
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Materials and Methods

Protein Extraction
SF was extracted from the cocoons of Bombyx mori silk worms (The Yarn Tree)
through an established protocol [280]. Briefly, SF cocoons are cut into pieces and boiled
in a 0.02 M Na2CO3 (Sigma Aldrich) solution for 30 minutes to remove the sericin gum,
followed by thorough rinsing in de-ionized water (DI), and drying in a fume hood. The SF
is then dissolved in a LiBr (Fisher Scientific) solution at 60°C for 4 hours. This solution is
then dialyzed against deionized water for 3 days using 3500 MWCO dialysis tubing
(Fisher Scientific). The SF solution is then frozen and lyophilized to provide a pure SF for
electrospinning.
COL type I was extracted from 6 month bovine corium through an acetic acid
based process previously described [262]. Briefly, tissue is homogenized, suspended in
acetic acid, and subsequently purified via a series of dissolutions, precipitations (using
NaCl (Fisher Scientific) and Tris (Fisher Scientific)), and dialyses [263]. Following the
final dialysis, COL solutions are frozen and lyophilized.
Electrospinning
The electrospinning setup consisted of a syringe pump (KD Scientific), a high
voltage power supply (Spellman CZE1000R, Spellman High Voltage Electronics Corp.), a
plastic Becton Dickinson syringe used as the polymer reservoir, attached to an 18-gauge
blunt-tip needle. Concentrations of 150 mg/ml of PCL (MW: 125,000, Lakeshore
Biomaterials), 200 mg/ml of soluble ELAS from bovine neck ligament (Elastin Products
Co. Inc.), 70 mg/ml of COL I (6 month bovine corium), and 80 mg/ml of SF were
dissolved in HFP (TCI America). To create scaffolds for cellular adhesion testing,
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polymers were blended in volume ratios of 100-0 and 50-50 PCL-COL, PCL-ELAS, and
PCL-SF.
Crosslinking
Scaffolds were cross-linked using EDC (FlukaBiochemika). Using EDC, a 50 mM
crosslinking solution was prepared in 90 % ethanol (Fisher Scientific). Prior to cellular
adhesion scaffolds were placed in the EDC solution, and allowed to cross-link for 18 hours
followed by a 0.1M Na2HPO4 rinse for 1 hour and a 2 PBS rinses each for 1 hour.
Cell Culture
Human umbilical artery smooth muscle cells (hUASMC, Lonza CC-2579) were
cultured in smooth muscle growth media purchased from Lonza (SmGM-2 Bulletkit, CC3182) and incubated at 37oC in 5% CO2. hUASMCs were grown to 90% confluency and
subsequently trypsinized using 0.05 % Trypsin (Gibco) and suspended in serum-free 1x
DMEM (Invitrogen) at a density of 500,000 cells/ml between passage 3 and 7 (according
to Lonza protocols hUASMCs have a maximum passage limit of 15).
Antibodies
For antibody experimentation cell were suspended in serum-free medium at a
concentration of 500,000 cells/ml and were incubated with a 1:100 dilution of antibody for
a period of 30 minutes at room temperature (RT). For this experiment, anti-integrin beta 1
(β1, Millipore, MAB1987Z) and anti-integrin beta 3 (β3, Millipore, MAB2023Z) were
used to inhibit cell adhesion to protein substrates.
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TCP Protein Coating Adhesion Assay
Cells were initially tested to determine antibody effectiveness in a 96-well plate.
Figure 38a displays the optimal cell seeding density for using the LiCor Odyssey imaging
technique. Cells were plated at densities of 0, 2500, 5000, 7500, 12500, and 25000
cells/well to determine the ideal density so that the inhibition assays would not be
influenced by cell-cell adhesion. According to Figure 38a, the preferred cell density for
hUASMCs were 7500 cells/well. Figure 38b displays an adhesion inhibition assay using
integrin antibodies β1 and β3 on COL coated wells with 50 μg/ml of PureCol COL (pCol,
Inamed). Here, cells were plated at 7500 cells/well and incubated at 37oC and 5% CO2 for
20, 30, and 40 minutes. This determined the effectiveness of the antibodies at inhibiting
cell adhesion to the protein coated well. According to Figure 38b, antibodies appeared
most effective at an incubation period of 30 minutes with a significant difference between
β1 and β3.
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Once these protocols were established, a protein experiment was carried out using 50
μg/ml pCol, 50 μg/ml fibronectin (FN) dissolved in 1x PBS, 200 mg/ml ELAS (Elastin
Products Company, ES12) dissolved in 1x PBS and HFP, 50 μg/ml extracted COL (6
month bovine corium) dissolved in 1x PBS and 70 mg/ml dissolved in HFP, and 1 %
bovine serum albumin (BSA) dissolved in 1x PBS. Proteins dissolved in HFP were plated
into the 96-well plate and allowed to dry overnight under a fume hood. Proteins dissolved
in 1x PBS were plated at 100 μl along with 100 μl of 1x PBS placed into the wells
containing HFP dissolved protein. The 96-well plate was then covered and incubated at
4oC for 24 hours. After 24 hours, wells were washed 3 times with 1x PBS, and
subsequently seeded with 7500 cells/well and incubated for 30 minutes at 37oC and 5 %
CO2. All samples were done in triplicate.
LiCor Odyssey Imaging
After 30 minutes of incubation, 96-well plates were inverted and shaken twice to
remove non-adherent cells. Immediately following, wells were washed once with 100 μl
of 1x PBS and fixed using a 10 % buffered formalin solution (Fisher Scientific) for 24
hours at 4oC. Next, fixing solution was removed and cells were permeabilized with five
washes using 1x PBS containing 0.1% Triton X-100 for 5 minutes per wash. This was
followed with Odyssey Blocking Buffer (LiCor) for 1.5 hours at RT. Next, the primary
antibody, glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Sigma, G9545-200UL),
was diluted 1:5000 in blocking buffer and incubated with the scaffold at 4oC for 24 hours.
The scaffolds were then washed with 0.1 % Tween-20 for 5 minutes at RT for 5 washes.
IRDye 800 (LiCor) was then diluted at 1:1000 and incubated with the scaffolds at RT for 1
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hour. Finally, the scaffolds were then washed again with 0.1 % Tween-20 for 5 minutes at
RT for 5 washes. The scaffolds were then placed on the Odyssey Imager scanning bed for
imaging at 800 nm.
Scaffold Cell Adhesion Assay
Scaffolds were either cross-linked as described above or left uncross-linked. All
scaffolds were then sterilized in 90% ethanol for 30 minutes and subsequently washed for
10 minutes 3x at RT. Next, scaffolds were secured in a 96-well Bio-Rad® Dot Blot and
150 μl of proteins were added to specific lanes. Lane 1 = no cells, lane 2 = cells no
treatment (NT), lane 3 = 1% BSA, lane 4 = 50 μg/ml FN, lane 5 = anti-integrin β1, and
lane 6 = anti-integrin β3. All lanes were done in triplicate. Lanes 1, 2, 5, and 6 were filled
with 150 μl of 1x PBS since they did not contain proteins in order to maintain scaffold
wetness. The blotter/scaffolds were then covered with parafilm and stored at 4oC for 24
hours. All wells were then filled with 100 μl of 1 % BSA for 5 minutes and washed 3x
with 200 μl of 1x PBS prior to cell seeding.
hUASMCs were first passaged using 0.05 % Trypsin and suspended in serum-free
1x DMEM at a density of 500,000 cells/ml. Figure 39 determined the proper seeding
density for PCL-COL scaffolds to ensure only cell-substrate adhesion. Cells were seeded
onto both electrospun PCL and PCL-COL scaffolds at densities of 0, 2500, 5000, 10000,
25000, and 75000 cells/well. Scaffolds were incubated for 30 minutes at 37oC and 5 %
CO2, inverted and shaken twice to remove non-adherent cells. The blotter was then opened
and scaffolds were washed twice in 1x PBS and fixed with 10 % buffered formalin.
Scaffolds were then imaged using 4',6-diamidino-2-phenylindole (DAPI, Invitrogen)
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fluorescent stain and counted. According to the graph, 0, 2500, and 5000 cells/well was
too low a number to produce significant differences between PCL and PCL-COL.
Therefore, 20,000 cells/well was chosen as a density which would provide significant
differences and cell-substrate adhesions.
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Figure 39. Represents the cells counted per unit of area as it relates the density of cells
seeded onto electrospun PCL and PCL-COL scaffolds.
For all scaffolds, 400,000 cells/ml was placed in a separate vial, where a primary
antibody for integrin β1 or β3 was added at a 1:100 dilution. Both vials containing antiintegrin β1 and anti-integrin β3 were allowed to sit at RT for 30 minutes. Following this,
each well of the blotter was filled with 50 μl of serum-free 1x DMEM, and 50 μl of
untreated cell suspensions were added to each well for lanes 1, 2, 3, and 4. 50 μl of antiintegrin β1 and anti-integrin β3 was added to lanes 5 and 6, respectively. The
blotter/scaffolds were then placed in the incubator for 30 minutes at 37oC and 5 % CO2.
After time expired, the blotter was inverted and shaken twice. Scaffolds were then
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extracted from the blotter and washed twice in 1x PBS followed immediately with fixation
in 10% buffered formalin for 24 hours at 4oC.
DAPI Imaging
To image, scaffolds were prepared as mentioned above. After fixation, scaffolds
were incubated with a 1:1000 dilution of DAPI for 10 minutes. Each blot was then imaged
in 4 separate areas at a magnification of 10x. These images were then used to count the
cell nuclei using the Cell Counting plugin for ImageJ version 1.44. The area in which the
cells were counted was then measured and cell counts were reported as cells counted per
square millimeter and as a percentage of the positive control, FN.

Results
SDS-page gel results in Figure 40 demonstrated that extracted and electrospun

COL retained its α1(III), α1(II) and α2(I) chains, indicating a retention of the triple helical
structure. Gelatin (denatured COL) has been shown to produce a smear [314]. This
indicates that gelatin has undergone a change in its overall structure due to denaturation,
losing its triple helical qualities, and, more importantly, its alpha chains. ELAS did not
demonstrate any specific molecular weights, appearing also as a smear; however, its
recovered electrospun form contained no smear possibly showing a change in structure.
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Figure 40. SDS-page gel electrophoresis of Sigma COL, extracted COL dissolved in DI
water, extracted COL dissolved in HFP, ELAS dissolved in DI water, ELAS dissolved in
HFP, and BSA dissolved in DI water.
A preliminary cell adhesion experiment (Figure 41A and B) using protein coatings
in a 96 well plate was performed to determine if differences amongst the proteins existed
and if differences in integrin binding affinity occurred. Extracted COL, pureCol COL, and
FN (dissolved in deionized (DI) water) were tested with anti-integrin β1 and anti-integrin
β3 to determine if the antibodies were decreasing SMC adhesion. All three proteins
displayed a decrease in adhesion with both β1 and β3 antibodies. It was expected that
COL proteins would display a more significant decrease using the β1 antibody in
comparison to using the β3 antibody. However, since COL has been shown to present
both RGD peptides and COL specific peptide sequences then it is possible that both of
these protein would display a decrease in adhesion but not a knockout. Additionally, the
hUASMCs used in this experiment contain integrins with both β1 and β3 specificity. A
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major question surrounding the electrospinning of proteins is the possibility of denaturing
the proteins using a fluoroalcohol such as HFP. The results from this preliminary adhesion
study demonstrated that COL dissolved in HFP had excellent adhesion, a significant
decrease (p < 0.05) in cell number with anti-integrin β1, but no difference with antiintegrin β3, indicating that COL was not denatured by HFP especially since the β3
antibody did not display a greater decrease in adhesion when compared to the β1 antibody.
ELAS dissolved in HFP demonstrated poor adhesion which was similar to that of BSA
(negative control), while ELAS dissolved in PBS decreased cell adhesion but did not
completely inhibit it. The results from the ELAS study demonstrated that a conformational
change in the soluble ELAS protein occurs when dissolved in HFP, possibly denaturing the
VAVPG peptide sequence. This preliminary study thus led to a full electrospun scaffold
experiment.
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In view of the fact that the data in Figure 41 displayed formidable characteristics of
β1 and β3 antibodies, scaffolds containing a 50-50 blend using PCL-COL, PCL-elasitn,
and PCL-SF were electrospun. Figure 42 exhibited similar results to the data in Figure 41,
where COL blended scaffolds displayed a significant decrease (p < 0.05) in adhesion using
both β1 and β3 antibodies. In this case, β1 exhibited a larger decrease in cellular adhesion
compared to β3. Furthermore, NT scaffolds were not different from the positive control,
FN. This indicated that peptides to which the integrins were bound were not denatured in
the COL scaffolds due to HFP being used as the solvent. BSA, the negative control, also
displayed significant differences (p < 0.05) from NT and FN, which could indicate a
number of non-specific binding sites were blocked, an unexpected result. The data from
the scaffold experiments also demonstrated that the ELAS had no available binding sites
for the hUASMCs. Finally, PCL-SF displayed adequate protein adsorption characteristics
where FN was significantly different (p < 0.05) from β1, β3, BSA, and NT. There was no
β1 integrin binding specificity to the SF blended scaffolds. The NT scaffolds for PCL-SF
were significantly different (p < 0.05) from both BSA and β3, a possible suggestion that
there is some binding affinity occurring for β3 which may involve a promiscuous RGD
peptide. NT PCL-COL demonstrated a significant increase in cell attachment (288
cells/mm2) when compared to NT PCL (49 cells/mm2), displaying the advantages of the
inclusion of COL.
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Figure 42. Cell adhesion using DAPI staining with uncross-linked PCL, PCL-COL, PCLELAS, and PCL-SF. Results are displayed as cells/mm2. * represents a significant
difference from β1 and β3. # represents a significant difference from β3. ^ represents a
significant different from Cells NT.

Figure 43 displayed the data using 50mM EDC cross-linked scaffolds to determine
if cross-linking would affect the presentation of the peptide sequences. The data suggested
no significant differences between PCL and PCL-COL scaffolds. This is clearly presented
in Figure 43, where there are no differences between β1, β3, BSA, NT, and FN for both
PCL and PCL-COL scaffolds. PCL-ELAS, similar to Figure 42, exhibited differences
from both PCL and PCL-COL where cellular attachment was almost non-existent.
According to the data presented here, cross-linking using a high molarity of EDC, 50 mM,
significantly affected the adhesion of hUASMCs to the electrospun substrates.
Additionally, average cell counts for PCL between Figures 43 and 44 display similarities,
indicating that it was the cross-linking of cellular adhesive proteins and not the EDC itself.
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Furthermore, average values of cell counts between uncross-linked and cross-linked NT
PCL-COL scaffolds decreased by 73% when cross-linked with EDC.
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Figure 43. Cell adhesion using DAPI staining with EDC cross-linked PCL, PCL-COL,
and PCL-ELAS. Results are displayed as cells/mm2.

In order to normalize the data presented in Figures 43 and 44, each sample group
was calculated as a percentage of FN for both uncross-linked and cross-linked electrospun
scaffolds. Results depicted here displayed the same results as found in Figures 43 and 44.
This supported those findings through the normalization of the number of cells counted per
square millimeter, thereby removing any slight variances in number of cells seeded
between each sample run. ELAS blended scaffolds were not displayed in the percentage of
FN graphs because of their low and variable cell number, which did not properly
demonstrate their low adhesive qualities. The results from Figure 44 reiterate the results
found in both Figures 43 and 44, demonstrating that the normalized data still reflected the
results from the actual cell counts. The association between these also demonstrated that
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cell counting using the DAPI stain technique produced formidable results, verifying its use
for future applications.
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Figure 44. Cell adhesion using DAPI staining with uncrosslinked (A) and EDC crosslinked (B) PCL, PCL-COL, PCL-SF, and PCL-ELAS. Results are normalized and
displayed as a percentage of FN.* represents a significant difference from β1 and β3. #
represents a significant difference from β3. ^ represents a significant different from Cells
NT.
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Discussion
Generally, native artery displays characteristics where the media bears the majority

of tension under in vivo conditions while the adventitia serves to protect the vessel from
overstretch. In our tri-layered vascular graft design, the addition of ELAS provided our
grafts with a higher compliance, while the addition of COL or SF served as the outer
jacket-like layer to protect the graft from overstretch. This design proved to be
advantageous through mechanical testing using dynamic compliance and burst strength.
In order to optimize the graft parameters using PCL, COL, ELAS and SF, cell
adhesion characterization was performed in order to determine the specifics of integrin
binding. It is well known that a number of integrins (α1β1, α2β1, α3β1) bind to COL in a
RGD-independent manner and the αvβ3 integrin binds with high affinity to denatured
COL in a RGD-dependent manner [312, 315]. It has also been suggested, in some cases,
that the αvβ3 integrin binds to ELAS through the VAVPG complex [306]. However,
debates still circulate about electrospun COL dissolved in HFP maintaining its triple
helical structure and ultimately being recognized by cells. Furthermore, experiments using
soluble ELAS have shown it to both bind cells and act as a binding inhibitor [316].
In past studies, we have demonstrated that electrospun COL exhibits a 67 nm
repeat that resembles the native polymer [130]. To examine whether or not the
electrospinning process alters the α chain content and thus the triple helix associated with
COL, we performed an SDS-page gel electrophoresis on both COL and ELAS proteins to
determine any degrees of denaturation due to HFP. According to the results, the recovered
electrospun COL dissolved in HFP resembled that of the same COL dissolved in an
aqueous medium. Additionally, COL from Sigma-Aldrich was tested using the same
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aqueous medium to confirm the results found with our extracted COL samples. No visible
denaturing of the alpha chains was present in the SDS gel. One difference seen between
the Sigma COL and our extracted COL was that our extracted COL seemed to contain a
few more proteins than anticipated, indicating that it may not be fully purified.
Both Zeugolis et al. and Yang et al. have found HFP to partially denature COL,
however, neither group discussed the amount of time the COL samples were allowed to
dissolve in HFP. If these proteins are becoming denatured when subjected to a
fluoroalcohols, then there very well may be a time dependency for the protein dissolution
prior to electrospinning. Under our conditions, both COL and ELAS are allowed to
dissolve in HFP for approximately 10-20 minutes. The solutions are then immediately
loaded into the syringe pumps and the electrospinning process is started. This appeared to
allow the alpha chains of the COL protein to remain intact. It should be noted though that
the SDS-page gel results did not include a pepsin digestion which could ultimately indicate
whether or not the triple helix of COL is slightly unfolded or fully intact. Regardless,
electrospun COL resembles nothing of gelatin either under SDS-page gels performed by
Zeugolis or according to subcutaneous implantations [317], where massive inflammation
and encapsulation was encountered with gelatin electrospun samples while COL
electrospun samples experienced a low inflammatory response.
Preliminary data in a 96 well plate demonstrated that COL bound cells via integrin
β1 and β3. Within this experiment, there did not seem to be a clear affinity for one over
the other although the average colorimetric intensity was lower for β1 antibodies for COL
coated samples. The fact that β1 antibodies were able to decrease cellular adhesion to the
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protein coated TCP indicated that COL ligands were present amongst control groups and
HFP dissolved groups. Once HFP dissolved COL had been established as non-denartured
through SDS-page gel and preliminary protein coated wells we set out to produce
electrospun scaffolds for containing 50-50 blends of PCL-COL compared to 100-0 blends.
In this portion of the experiment, the data acquisition method was switched from a LiCor
reader to nuclei counting due to the high background noise present on the electrospun
samples. Staining cells and subsequently counting them in a fixed field of view is an
established procedure which has been used in several publications [315, 318, 319].
Therefore, this technique, although labor intensive, was chosen to count the number of
adhered cells to cross-linked or uncross-linked electrospun substrates.
Figures 43 and 45 plainly demonstrate the benefits of electrospun COL, where
lanes with NT were similar to lanes treated with FN for both PCL and PCL-COL.
Additionally, β1 and β3 antibodies significantly attenuated adhesion of the hUASMCs to
the uncross-linked electrospun COL samples, whereas pure PCL samples had no affect.
Impressively, percentatges of anti-integrin β1 for PCL-COL shown in Figure 44 were no
different from PCL-β1 or BSA, and anti-integrin β3 was different from anti-integrin β1.
This demonstrated a dominate presence of COL binding ligands specific to either α1β1 or
α2β1, and a remaining percentage binding to RGD peptides through the β3 subunit.
Moreover, the affinity of hUASMCs to bind to COL scaffolds through the β1 integrin
demonstrated that electrospun COL retained its triple helical structure [308, 320]. Figure
43 and 44B, however, displayed results that implicated a loss of triple helical structure
when scaffolds were cross-linked with 50 mM EDC, where NT was not different from
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BSA, β1, or β3. Additionally, results from COL scaffolds were no different from PCL
scaffolds. This attenuation of cell adhesion to the surface has been shown on cross-linked
COL sponges following 7 and 10 days of culture [321], but has yet to be associated with
cell adhesion inhibition assays. Therefore, an in-depth study as to the molecular reasons
for this decrease in cell adhesion should be investigated in future studies.
ELAS samples were also studied in this experiment. As previously mentioned,
extensive research has been performed by our lab with the use of soluble ELAS proteins
and their mechanical benefits. However, recent implantation studies (data not shown)
displayed little to no cellular infiltration of the vascular graft after 6 months in vivo. This
was confounding and caused us to investigate the cellular characteristics of this protein
further. Preliminary protein coatings (Figure 41B) displayed no integrin binding affinity
for the β3 subunit in addition to showing adhesion characteristics similar to that of BSA
(negative control). This indicated that the soluble ELAS protein, when dissolved in HFP,
did not bind cells. This type of behavior was seen in a study done by Rodgers et al. where
they looked to identify an integrin binding site on tropoelastin [307]. Nonetheless, the
purchased soluble ELAS possesses the VAVPG peptide sequence, also known as the EBP.
The ES12 proteins are extracted through an oxalic acid process, producing α, β, and κ
ELAS proteins [140]. These proteins can be further purified into mainly α ELAS proteins.
It may be these other β and κ proteins, which are masking any integrin binding sites, as α
ELAS proteins have been shown to possess good adhesion properties [143]. Electrospun
ELAS samples were also tested and similar results to the initial protein coating experiment
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using a 96-well plate were found where cell numbers were almost non-existent regardless
of whether or not the scaffolds were cross-linked or uncross-linked.
Finally, SF has been implicated in many studies as an excellent biopolymer with
good cellular adhesion properties. Consequently, we observed whether or not SF
displayed any peptide sequences which would bind hUASMCs. It was determined that SF
did not contain integrin binding ligands for β1 subunits, but its NT was significantly
different from anti-integrin β3 treated wells. Likewise, SF had a significantly higher NT
cell count (81 cells/mm2) than its negative control, BSA (31 cell/mm2). This could
indicate that SF does possess some peptide sequences for binding hUASMCs, but that
these are significantly lower in number compared to either COL or FN. Sofia et al.
performed a serum-free adhesion study using SF films cast from HFP. These materials
were also supplemented with RGD peptides to increase binding affinity for osteoblasts
[322]. It was shown that SF films had the lowest cell number in comparison to RGD-SF
films. Here, electrospun SF displayed low cell number characteristics in comparison to
electrospun COL; however, there were still differences when antibodies were added. Other
studies have shown the amino acid composition of SF to contain large amounts of glycine
(49.32), alanine (30.08), and serine (7.02) with small amounts of arginine (0.53) and
aspartic acid (0.54) [323]. Therefore, it is possible that RGD peptide sequences do exist,
but their prevalence may be too low and could thereby require supplementation to create
adequate cell adhesion free of serum.
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Conclusion
In conclusion we were able provide evidence which would further dispute the

denaturation of COL proteins with the use of HFP through SDS-page gel electrophoresis
and integrin binding. Additionally, we showed that ELAS scaffolds were not conducive to
cellular attachment under serum-free conditions. This could explain the results that were
seen in the vascular graft implantation studies, where little to no cell infiltration was
observed. SF scaffolds demonstrated the possibility of containing small amounts of RGD
peptides which bound the β3 subunits of hUASMCs. Future studies will need to assess the
threshold concentrations for ELAS when it is added to PCL-COL or PCL-SF scaffolds.
Currently, preliminary adhesion studies have already been performed and have displayed
excellent cellular adhesion for 45-10-45 and 50-25-25 PCL-ELAS-COL scaffolds.
Nonetheless, there is a slight decrease in cell number as more ELAS is added to the
scaffold. More adhesion studies will be performed using 45-45-10 PCL-ELAS-COL
blends to determine if ELAS will mask any COL proteins available for cellular attachment.
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Conclusion and Future Studies
Overall this study demonstrated the ability to manufacture a tri-layered vascular
graft composed of PCL, COL, ELAS, and SF. The percentage of biopolymers to add to
the material blends was run through a series of tests to determine the optimal structure,
which could be used towards future research in vitro and in vivo. Tri-layered grafts were
found to be within the compliance range and exceeded the burst strength of native vessels.
This data points towards a promising future with tri-layered grafts. Ideally, presenting a
more tailorable degradation for each layer could bode well for potential graft testing.
Through cellular studies it becomes questionable as to whether ELAS should remain a part
of the material blends. Cellular testing also brought cross-linking into question as well. If
these grafts are to regenerate tissue, the materials should not decrease cell adhesion during
the intial periods after implantation. Therefore, several future experiments need to be
addressed prior to animal implantation. First, futher cellular adhesion experiments need to
be performed to determine the threshold of allowable ELAS in the graft layers. Second,
cellular adhesion experiments should be carried out to determine the threshold of crosslinking molarity. These two experiments will help to resolve issues that were previously
presented in the initial adhesion experiment. Finally, in order to design a more tailorable
degradation rate in each layer of the graft structure, other synthetic biodegradable
polymers, such as PDO, should be investigated. Preliminary data has already been
performed in a 6 week degradation study where PCL-PDO blends of 70-30, 50-50, and 3070 were tested for uniaxial tensile strength at time points of 1, 2, 4, and 6 weeks. These
results demonstrated that the addition of PDO decreased degradation time. The quest for
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the “Holy Grail” is a daunting one, but a multi-layered vascular graft design could
potentially provide a new path to the ideal vascular graft.
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APPENDIX A
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Scanning electron microscopy images taken at 5000x for the intimal, medial, and adventitial layers of the 45-45-10 (A-F), 55-35-10 (G-L), and
65-25-10 (M-S) PCL-Elastin-Collagen graft after cross-linking with 50 mM EDC, hydrated in PBS for 24 hours, frozen at -70oC, and
lyophilized dry to demonstrate differences in fiber morphology. (A,G,M) Inside Intima, (B,H,N-image missing due to inability to separate
layers without scaffold destruction) Outside Intima, (C,I,O-image missing due to inability to separate layers without scaffold destruction)
Inside Media, (D,J,P) Outside Media, (E,K,Q) Inside Adventitia, (F,L,S) Outside Adventitia. Scale bars = 10 μm.
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APPENDIX B
Scanning electron micrographs of 45-45-10, 55-35-10, 65-25-10,
45-10-45, 55-10-35, 65-10-25 PCL-Elastin-Silk uncrosslinked
(top right), cross-linked with EDC (bottom left), and crosslinked with GEN (bottom right). Micrographs were taken at
2500x.
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APPENDIX C
Scanning electron micrographs of 45-45-10, 55-35-10, 65-2510, 45-10-45, 55-10-35, 65-10-25 PCL-Elastin-COL
uncrosslinked (top right), cross-linked with EDC (bottom
left), and cross-linked with GEN (bottom right).
Micrographs were taken at 1000x.
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APPENDIX D

Biopolymer crosslinking mechanism using genipin (GEN) [283].
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APPENDIX E

Stable
amide bond
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The cross-linking reaction using EDC.Adapted from Pierce Biotechnology; Thermo Fisher Scientific, Inc. EDC.
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